Biofunctionality and immunocompatibility of starch-based biomaterials by Marques, A. P.
 UNIVERSIDADE DO MINHO 
ESCOLA DE ENGENHARIA 
3B’S RESEARCH GROUP – Biomateriais, Materiais Biodegradáveis, Biomiméticos 
DEPARTAMENTO ENGENHARIA POLÍMEROS 
 
 
 
 
BIOFUNCTIONALITY AND 
IMMUNOCOMPATIBILITY OF 
STARCH-BASED BIOMATERIALS 
 
 
Submetida por 
 
Alexandra Margarida Pinto Marques 
 
Para candidatura à obtenção do grau de Doutor em Ciência e 
Tecnologia de Materiais, área de conhecimento em Biomateriais 
 
 
 
 
Julho 2004 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my Parents 
(Aos meus Pais) 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Failure is the preamble to success. Most first efforts don’t 
work. If you persist, you’ll eventually figure it out”   
       -Thomas Fogarty 
 
 
 
 
 
 
 TABLE OF CONTENTS 
 
Page
Acknowledgements------------------------------------------------------------------------------------------------- i
Short Curriculum Vitae--------------------------------------------------------------------------------------------- iii
List of Publications-------------------------------------------------------------------------------------------------- v
Resumo --------------------------------------------------------------------------------------------------------------- vii
Abstract --------------------------------------------------------------------------------------------------------------- ix
List of Figures-------------------------------------------------------------------------------------------------------- xi
List of Tables--------------------------------------------------------------------------------------------------------- xix
List of Abbreviations------------------------------------------------------------------------------------------------ xxi
 
 
SECTION I 
 
CHAPTER 1 – INTRODUCTION 
1.1Biocompatibility – general introduction-------------------------------------------------------------- 3
1.1.1 In Vitro Testing------------------------------------------------------------------------------------ 4
1.1.2 In Vivo Testing------------------------------------------------------------------------------------ 8
1.2 Immunocompatibility------------------------------------------------------------------------------------ 10
1.2.1 Immune System---------------------------------------------------------------------------------- 11
1.2.2 Adhesion Molecules----------------------------------------------------------------------------- 14
1.2.3 Cytokines------------------------------------------------------------------------------------------- 16
1.2.4 Cytokines Regulation--------------------------------------------------------------------------- 21
1.2.5 Foreign Body Reaction To Implanted Materials------------------------------------------ 26
1.2.6 Hypersensitivity To Metals -------------------------------------------------------------------- 30
1.2.7 Cytokines in Orthopaedics--------------------------------------------------------------------- 31
1.2.8 Immunoreactivity To Natural Origin Materials Versus Synthetic 
         Degradable Systems---------------------------------------------------------------------------- 35
  
 
SECTION II 
 
CHAPTER 2 - THE BIOCOMPATIBILITY OF NOVEL STARCH-BASED POLYMERS AND 
COMPOSITES: IN VITRO STUDIES 
Abstract---------------------------------------------------------------------------------------------------------------- 69
2.1 Introduction------------------------------------------------------------------------------------------------ 70
2.2 Materials and Methods  
2.2.1 Tested Materials---------------------------------------------------------------------------------- 70
2.2.2 MTT Test------------------------------------------------------------------------------------------- 71
2.2.3 Direct Contact Assay---------------------------------------------------------------------------- 71
2.2.4 Preparation of cell-material surfaces for SEM observation---------------------------- 72
 2.2.5 LDH Quantification------------------------------------------------------------------------------- 72
2.3 Results 
2.3.1 Cytotoxicity Assessment----------------------------------------------------------------------- 73
2.3.2 Cell Morphology Evaluation------------------------------------------------------------------- 73
2.3.3 LDH – Cell Adhesion and Proliferation Quantification---------------------------------- 76
2.4 Discussion------------------------------------------------------------------------------------------------- 76
2.5 Conclusions----------------------------------------------------------------------------------------------- 78
References----------------------------------------------------------------------------------------------------- 78
 
 
CHAPTER 3 - EFFECT OF STARCH-BASED BIOMATERIALS ON THE IN VITRO 
PROLIFERATION AND VIABILITY OF OSTEOBLAST-LIKE CELLS 
Abstract---------------------------------------------------------------------------------------------------------------- 81
3.1 Introduction------------------------------------------------------------------------------------------------ 82
3.2 Materials and Methods 
3.2.1 Tested Materials---------------------------------------------------------------------------------- 83
3.2.2 Cell Culture---------------------------------------------------------------------------------------- 83
3.2.3 Extract Preparation------------------------------------------------------------------------------ 84
3.2.4 MTT Assay----------------------------------------------------------------------------------------- 84
3.2.5 LDH Quantification------------------------------------------------------------------------------- 84
3.2.6 DNA Quantification------------------------------------------------------------------------------ 85
3.2.7 Total Protein Quantification-------------------------------------------------------------------- 85
3.2.8 Direct Contact Assay---------------------------------------------------------------------------- 86
3.2.9 Statistical Analysis------------------------------------------------------------------------------- 86
3.3 Results------------------------------------------------------------------------------------------------------ 86
3.3.1 Cell Viability---------------------------------------------------------------------------------------- 87
3.3.2 Cell Proliferation---------------------------------------------------------------------------------- 89
3.3.3 Cell Adhesion ------------------------------------------------------------------------------------- 90
3.4 Discussion------------------------------------------------------------------------------------------------- 93
3.5 Conclusions----------------------------------------------------------------------------------------------- 95
References------------------------------------------------------------------------------------------------------------ 96
 
 
CHAPTER 4 - HYDROXYAPATITE REINFORCEMENT OF DIFFERENT STARCH-BASED 
POLYMERS AFFECTS OSTEOBLAST-LIKE CELLS ADHESION/SPREADING AND 
PROLIFERATION 
Abstract---------------------------------------------------------------------------------------------------------------- 99
4.1 Introduction---------------------------------------------------------------------------------------------- 100
4.2 Materials and Methods 
4.2.1 Materials------------------------------------------------------------------------------------------ 101
4.2.2 Cell Culture--------------------------------------------------------------------------------------- 101
4.2.3 Microscopy Analysis--------------------------------------------------------------------------- 102
4.2.4 Total Protein Quantification------------------------------------------------------------------ 102
4.2.5 Statistical Analysis----------------------------------------------------------------------------- 102
4.3 Results 
4.3.1 Cell Adhesion/Proliferation Quantification------------------------------------------------ 103
4.3.1.1 SEVA-C and Composites------------------------------------------------------------- 103
4.3.1.2 SPCL and Composites---------------------------------------------------------------- 104
 4.3.1.3 SCA and Composites------------------------------------------------------------------ 105
4.3.2 Surface Topography -------------------------------------------------------------------------- 107
4.3.3 Cell Adhesion/Morphology ------------------------------------------------------------------ 109
4.4 Discussion------------------------------------------------------------------------------------------------ 115
4.5 Conclusions---------------------------------------------------------------------------------------------- 120
References------------------------------------------------------------------------------------------------------------ 120
 
 
SECTION III 
 
CHAPTER 5 - EVALUATION OF THE POTENTIAL OF STARCH-BASED BIODEGRADABLE 
POLYMERS IN THE ACTIVATION OF HUMAN INFLAMMATORY CELLS 
Abstract---------------------------------------------------------------------------------------------------------------- 127
5.1 Introduction------------------------------------------------------------------------------------------------ 128
5.2 Materials and Methods 
5.2.1 Materials-------------------------------------------------------------------------------------------- 129
5.2.2 Neutrophil Isolation------------------------------------------------------------------------------ 129
5.2.3 Lysozyme assay---------------------------------------------------------------------------------- 130
5.2.4 Chemiluminescence----------------------------------------------------------------------------- 130
5.2.5 Evaluation of polymers potential to quench light----------------------------------------- 131
5.2.6 Statistical Analysis------------------------------------------------------------------------------- 131
5.3 Results and Discussion 
5.3.1 Lysozyme------------------------------------------------------------------------------------------ 131
5.3.2 Chemiluminescence----------------------------------------------------------------------------- 133
5.4 Conclusions----------------------------------------------------------------------------------------------- 137
References------------------------------------------------------------------------------------------------------------ 137
 
 
CHAPTER 6 - THE EFFECT OF STARCH-BASED BIOMATERIALS ON LEUKOCYTE ADHESION 
AND ACTIVATION IN VITRO 
Abstract---------------------------------------------------------------------------------------------------------------- 141
6.1 Introduction------------------------------------------------------------------------------------------------ 142
6.2 Materials and Methods 
6.2.1 Materials-------------------------------------------------------------------------------------------- 143
6.2.2 Neutrophil Isolation------------------------------------------------------------------------------ 144
6.2.3 Mononuclear Isolation (Lymphocytes and Monocytes/Macrophages)--- ---------- 144
6.2.4 Adhesion and Morphological Analysis------------------------------------------------------ 145
6.2.5 Lactate Dehydrogenase Quantification----------------------------------------------------- 145
6.2.6 Antibodies------------------------------------------------------------------------------------------ 145
6.2.7 Immunocytochemistry--------------------------------------------------------------------------- 146
6.2.8 Statistical Analysis------------------------------------------------------------------------------- 146
6.3 Results 
6.3.1 Cell Adhesion and Morphology--------------------------------------------------------------- 146
6.3.1.1 PMN----------------------------------------------------------------------------------------- 146
6.3.1.2 Monocytes/macrophages and Lymphocytes-------------------------------------- 148
6.3.2 Immunocytochemistry--------------------------------------------------------------------------- 151
6.4 Discussion------------------------------------------------------------------------------------------------- 154
 6.5 Conclusions----------------------------------------------------------------------------------------------- 158
References------------------------------------------------------------------------------------------------------------ 158
 
 
CHAPTER 7 - CYTOKINE SECRETION FROM MONONUCLEAR CELLS CULTURED IN VITRO 
WITH STARCH-BASED POLYMERS AND PLLA 
Abstract---------------------------------------------------------------------------------------------------------------- 163
7.1 Introduction----------------------------------------------------------------------------------------------- 164
7.2 Materials and Methods 
7.2.1 Materials------------------------------------------------------------------------------------------- 165
7.2.2 Mononuclear Cell Isolation and Culture--------------------------------------------------- 165
7.2.3 Cytokine Quantification------------------------------------------------------------------------ 166
7.2.4 Statistical Analysis------------------------------------------------------------------------------ 166
7.3 Results----------------------------------------------------------------------------------------------------- 167
7.3.1 IL-4-------------------------------------------------------------------------------------------------- 167
7.3.2 IL-6-------------------------------------------------------------------------------------------------- 168
7.3.3 IL-1β------------------------------------------------------------------------------------------------ 171
7.3.4 TNF-α---------------------------------------------------------------------------------------------- 173
7.4 Discussion------------------------------------------------------------------------------------------------- 175
7.5 Conclusions----------------------------------------------------------------------------------------------- 178
References----------------------------------------------------------------------------------------------------------- 178
 
 
CHAPTER 8 - AN IN VIVO STUDY OF THE HOST RESPONSE TO STARCH-BASED POLYMERS 
AND COMPOSITES SUBCUTANEOUSLY IMPLANTED IN RATS 
Abstract---------------------------------------------------------------------------------------------------------------- 183
8.1 Introduction------------------------------------------------------------------------------------------------ 184
8.2 Materials and Methods 
8.2.1 Materials-------------------------------------------------------------------------------------------- 186
8.2.2 Animals and Subcutaneous Implantation-------------------------------------------------- 186
8.2.3 Immunohistochemistry-------------------------------------------------------------------------- 187
8.2.4 Antibodies------------------------------------------------------------------------------------------ 187
8.3 Results------------------------------------------------------------------------------------------------------ 187
8.3.1 SEVA-C--------------------------------------------------------------------------------------------- 188
8.3.2 SCA and Composites--------------------------------------------------------------------------- 189
8.3.3 SPCL and Composites------------------------------------------------------------------------- 193
8.4 Discussion------------------------------------------------------------------------------------------------- 196
9.5 Conclusions----------------------------------------------------------------------------------------------- 198
References------------------------------------------------------------------------------------------------------------ 199
 
 
SECTION IV 
 
CHAPTER 9 - MAIN CONCLUSIONS 
9.1 Cytocompatibility of starch-based polymers and composites--------------------------------------- 205
9.2 Immunocompatibility of starch-based polymers and composites----------------------------------- 206
 ACKNOWLEDGEMENTS 
 
To thank everybody that supported and accompanied me during the work described in this thesis and 
its preparation is probably the most difficult part for me. Nonetheless, not wanting to disregard anyone, 
I have to reveal some names. 
I would like to address a very special recognition to Dr. Rui Reis, my supervisor, without whom I would 
not had the chance to concretise my dream of “doing real research”. Thanks to Rui I had great 
opportunities. During all this years working with him I was always learning and growing up in Science, 
feeling that with his support and advise I could overcome challenge after challenge. The most recent 
battle was the preparation of this thesis during which he knew when and how to motivate me to 
proceed and make another conquest.  
I also have to express some words of recognition to Dr. John Hunt, my co-supervisor at the University 
of Liverpool. He accepted to co-supervise this work without knowing me. Throughout my stays in 
Liverpool he was always extremely supportive and helpful, trying to make me fell at home. He was 
always able to rearrange his timetable to go to the lab or to discuss and give suggestions about the 
work. Working in Liverpool was a great opportunity and I enjoyed it very much. 
While I stayed in Liverpool I made many friends. They witnessed and shared my joys and despairs 
during the long days of lab work. In particular I am very grateful to Jude, Paul, Debbie, Lisa and Jill. A 
special word to Chris Oliver, who taught me how to work in a cell culture lab and gave me valuable 
advices in the beginning of this work, to Sandra for her help with the scanning electron microscopy 
and to Shirley for her day to day help. Finally I would like to acknowledge everybody from the Clinical 
Engineering Department; to several persons, thank you for the experimental help and to all of them for 
the support.    
I also have some friends in the 3B’s research group to whom I would like to acknowledge. Manuela is 
responsible for my awareness of the “Biomaterial’s World”. She has been my confident and adviser, 
helping me to take the best decisions and to achieve my objectives. Catarina, who worked with me in 
Liverpool, helped me to forget the most difficult phase of my PhD and to move forward. She also gave 
me some experimental help for which I am very grateful. Belinha and Helena have been the discrete 
but present friends who congratulated in the best and gave support in the worst situations. I would 
also like to thank all my other colleagues from the 3B’s research group for their concern and 
understanding. I would also like to thank Tírcia for her help and understanding in the final stage of 
preparation of this thesis. 
I must acknowledge the Department of Biology of the University of Minho, in particular to Dra. Olga 
Coutinho, for facilitating the access to the animal cell culture lab to perform some of the work 
described in this thesis. 
I would gratefully acknowledge the Portuguese Foundation for Science and Technology and the 
Portuguese Programme PRAXIS XXI for awarding me a PhD Grant. 
---------------------------------------------------------------------------------------------------------------------------------------------------------------  i ---- 
 
 I cannot forget my parents. During the last four years they were unconditionally present supporting me 
and giving me strength to pursue my dreams. Although we were not always in agreement, this PhD is 
also their dream therefore I dedicate it to them. 
To conclude, I have to express my gratitude to my husband Helder. Without him and his support 
throughout the many and long months apart I would never be strong enough to overcome the worst 
moments and to work the way I did. Without his persistence, comprehension and encouragement this 
dissertation would still be a plan.    
 
 
 
 
---------------------------------------------------------------------------------------------------------------------------------------------------------------  ii ---- 
 
 SHORT CURRICULUM VITAE OF ALEXANDRA P. MARQUES 
 
Alexandra P. Marques was born on 1975 in Águeda, Portugal. At the present she lives in Porto and 
works in Braga, as a researcher, in the 3B’s Research Group (Biomaterials, Biodegradables & 
Biomimetics). 
 
Alexandra P. Marques background includes: i) a four years graduation in Biochemistry, Faculty of 
Sciences, University of Porto (with 14 over 20); ii) a one year specialisation course as part of the 
Biomedical Engineering Master/Doctoral Programme, Faculty of Engineering, University of Porto (with 
15 over 20). She has just submitted her PhD thesis on Materials Science and Technology – 
Biomaterials to University of Minho, Portugal, which was prepared in cooperation with the University of 
Liverpool, United Kingdom. 
 
During the last year of her graduation, Alexandra P. Marques was involved in a research project in the 
veterinary field using her biochemical knowledge. Since 1998 she has been working with biomaterials, 
focusing the in vitro evaluation of the biocompatibility of natural origin polymers. She has also worked 
several periods abroad in the University of Liverpool in UK where she centred her research interests in 
the evaluation of the immunological response to biomaterials. 
 
While researcher of the 3B’s Research Group, she has been involved, at academic level, in the co-
orientation of final year projects of under-graduated students as well as supporting practical lectures of 
Biomaterials of the Applied Biology course. She was also involved in the organisation of two 
NATO/ASI Advanced Courses, one in Tissue Engineering (2001) and the second one in 
Biomineralisation (2003) in Alvor, Portugal. Alexandra P. Marques was also involved in the preparation 
of the proposal of the most recent European Network of Excellence approved (EXPERTISSUES), 
coordinated by Rui L. Reis, the director of the 3B’s Research Group. She was further implicated in the 
preparation of other research projects proposals both at European (framework VI) and National 
(Portuguese Foundation for Science and Technology) level. 
 
As a result of her research work she has attended the most important international meetings in the 
biomaterials field both with posters and oral communications. She has published in refereed journals 
(4 papers, 4 submitted), as book chapters (4 in press) and in international conference proceedings (15 
communications). A. P. Marques won the student prize at Tate- The Art of Tissue Engineering 
Seminar and Workshop in The Netherlands (2000) and was awarded an Honorary Mention by The 
Society for Biomaterials on the 29th Annual Meeting of The Society for Biomaterials in USA (2003).  
---------------------------------------------------------------------------------------------------------------------------------------------------------------  iii ---- 
 
  
 LIST OF PUBLICATIONS 
 
The work performed during this PhD resulted in the following publications: 
PAPERS IN REFEREED JOURNALS 
A. P. Marques, R. L. Reis, J. A. Hunt, In vitro evaluation of the biocompatibility of novel 
biodegradable starch-based polymeric and composite materials, Biomaterials, 23, (2002), 
1471-1478 
 
A. P. Marques, H. R. Cruz, O. P. Coutinho, R.L. Reis, Effects of starch-based polymers and 
composites on the in vitro proliferation and viability of osteoblast-like cells, Journal of Material 
Science: Materials in Medicine, submitted 
 
A. P. Marques, R.L. Reis, Hydroxyapatite reinforcement of different starch-based polymers 
affects osteoblast-like cells adhesion/spreading and proliferation, Materials Science and 
Engineering C, in press 
 
A. P. Marques, R. L. Reis, J. A. Hunt, Evaluation of the potential of starch-based 
biodegradable polymers in the activation of human inflammatory cells, Journal of Material 
Science: Materials in Medicine, 14 (2003) 1-7 
 
A. P. Marques, R. L. Reis, J. A. Hunt, Cytokine secretion from mononuclear cells cultured in 
vitro with starch-based polymers and PLLA, Journal of  Biomedical Materials Research, in 
press 
 
A. P. Marques, R. L. Reis, J. A. Hunt, The effect of starch-based biomaterials on leukocyte 
adhesion and activation in vitro, Journal of Material Science: Materials in Medicine, submitted 
 
A. P. Marques, R. L. Reis, J. A. Hunt, An in vivo study of the host response to starch-based 
polymers and composites subcutaneously implanted in rats, Journal of  Biomedical Materials 
Research, submitted 
 
 
BOOK CHAPTERS 
A. P. Marques, J. A. Hunt, R. L. Reis, Natural origin degradable materials: the barrier or the 
passage through the immune system?, in: Biodegradable Systems for Tissue Engineering 
and Regenerative Medicine, Ed: R. L. Reis and J. San Roman, CRC Press, Boca Raton, 
USA (2004), 355-375. 
 
A. P. Marques, J. A. Hunt, R. L. Reis, Mediation of the cytokine network in the implantation 
of orthopaedic devices, in: Biodegradable Systems for Tissue Engineering and Regenerative 
Medicine, Ed: R. L. Reis and J. San Roman, CRC Press, Boca Raton, USA (2004), 377-397. 
 
G. A. Silva, C. M. Alves, A. P. Marques, M. E. Gomes, O. P. Coutinho, R. L. Reis, 
Cytotoxicity screening of biodegradable polymeric systems, in: Biodegradable Systems for 
Tissue Engineering and Regenerative Medicine, Ed: R. L. Reis and J. San Roman, CRC 
Press, Boca Raton, USA (2004), 339-353. 
---------------------------------------------------------------------------------------------------------------------------------------------------------------  v ---- 
 
  
COMMUNICATIONS IN INTERNATIONAL CONFERENCES 
A. P. Marques, R. L. Reis, J. A. Hunt, Cell adhesion and proliferation on the surface of 
biodegradable starch-based polymers: qualitative and quantitative evaluation, 15th European 
Conference on Biomaterials, Bordeaux, France, Sept., (1999), poster 
 
A. P. Marques, R. L. Reis, J. A. Hunt, Effects of starch-based polymers and composites on 
human leukocytes, 16th European Conference of the European Society for Biomaterials, 
London, UK, Sept., (2001), T8 
 
A. P. Marques, R. L. Reis, J. A. Hunt, Evaluation of the potential of starch-based 
biodegradable polymers in the activation of human inflammatory cells, NATO-ASI, Polymer 
Based Systems on Tissue Engineering, Replacement and Regeneration, Alvor, Portugal, 
Oct., (2001), 73-74 
 
A. P. Marques, R. L. Reis, J. A. Hunt, In vitro evaluation of the effect of starch-based 
biodegradable polymers in human leukocytes, 28th Annual Meeting of The Society for 
Biomaterials, Tampa, Florida, USA, April, (2002) 
 
A. P. Marques, H. R. Cruz, O. P. Coutinho, R.L. Reis, Effects of starch-based polymers and 
composites on the in vitro proliferation and viability of osteoblast-like cells, 17th European 
Conference of the European Society for Biomaterials, Barcelone, Spain, Sept., (2002), T96 
 
A. P. Marques, I. Pashkuleva, F. Vaz, R. L. Reis, The effect of surface modification of starch 
based degradable biomaterials on the adhesion and proliferation of osteoblast-like cells, 29th 
Annual Meeting of The Society for Biomaterials, Reno, Nevada, USA, April 2003 
 
A. P. Marques, R. L. Reis, J. A. Hunt, The inflammatory reaction to starch-based polymers 
and composites, by in vitro and in vivo analysis, 18th European Conference of the European 
Society for Biomaterials, Stuttgart, Germany, Oct., (2003), P084 
 
A. P. Marques, R. L. Reis, Hydroxyapatite reinforcement of different starch-based polymers 
affects osteoblast-like cells adhesion and proliferation, NATO-ASI, Learning from Nature How 
to Design New Implantable Biomaterials: From Biomineralization Fundamentals to 
Biomimetic Materials and Processing Routes, Alvor, Portugal, Oct., (2003), 66 
 
A. P. Marques, R. L. Reis, J. A. Hunt, In Vitro and In Vivo Inflammatory Reaction to Starch-
Based Biomaterials. Cellular and Chemical Mediators, 7th World Biomaterials Congress, 
Sydney, Australia, May, (2004), 1331 
 
A. P. Marques, R. L. Reis, J. A. Hunt, Parallelism in the In Vitro and In Vivo Evaluation of the 
Host Response to Starch-Based Biomaterials for Regenerative Medicine, Regenerative 
Medicine: The Advent of Combination Products, Philadelphia, USA, October, (2004), 
Submitted 
 
---------------------------------------------------------------------------------------------------------------------------------------------------------------  vi ---- 
 
 RESUMO 
A procura de novos biomateriais que desempenhem funções específicas sem, no entanto, 
desencadearem respostas negativas nos hospedeiros constitui um desafio permanente e 
actual nesta área. Biomateriais degradáveis foram uma das soluções propostas e 
actualmente em aplicação mas, embora possuam vantagens inegáveis, também apresentam 
alguns problemas nomeadamente no que diz respeito aos seus produtos de degradação e 
respectivos efeitos negativos consequentes. Outros biomateriais, entre os quais polímeros 
de origem natural, foram propostos considerando que os seus produtos de degradação 
poderão ser incorporados nas vias metabólicas normais evitando efeitos secundários no 
hospedeiro.   
Até ao momento, e apesar de todos os esforços e do grande número de dispositivos 
biomédicos desenvolvidos, o biomaterial ideal para uma aplicação específica ainda não foi 
encontrado. Estudos com polímeros biodegradáveis à base de amido demonstraram que 
estes materiais possuem propriedades promissoras abrindo novas perspectivas para a sua 
possível aplicação numa variedade de aplicações biomédicas. Assim, de modo a 
demonstrar que estes materiais têm de facto potencial para serem utilizados em, por 
exemplo, substituição óssea, sistemas de libertação controlada, cimentos ósseos e 
engenharia de tecidos, seria imperativo avaliar com maior profundidade a resposta biológica 
desencadeada pelos mesmos. Para tal foi delineado um plano de trabalhos com três 
objectivos principais: i) avaliar a citocompatibilidade dos polímeros e compósitos à base de 
amido com monitorização da citotoxicidade e análise da adesão e proliferação celulares nas 
suas superfícies. Foi dada particular atenção a osteoblastos considerando uma possível 
aplicação ortopédica para estes materiais; ii) estabelecer modelos in vitro para analisar e 
prever, tanto quanto possível, uma situação real de resposta inflamatória; iii) validar os 
resultados in vitro com um modelo in vivo já estabelecido em outros trabalhos de análise da 
resposta inflamatória a biomateriais. 
Foram estudadas misturas de amido de milho com três componentes sintéticos (álcool 
etileno vinílico, acetato de celulose e policaprolactona) assim como os respectivos 
compósitos com percentagens crescentes de um cerâmico bioactivo (hidroxiapatite). Numa 
primeira fase de avaliação do efeito dos produtos de degradação dos materiais em estudo 
foi concluído que duas das misturas apresentam baixa toxicidade, mesmo inferior à 
determinada para o biomaterial biodegradável padrão Poly-L-Lactic Acid (PLLA). No entanto, 
os testes de adesão celular revelaram que, para além dos produtos de degradação, as 
propriedades das superfícies podem determinar se um material possui ou não as 
características apropriadas para a melhor resposta celular. O efeito da incorporação de HA 
nos materiais à base de amido foi também analisado concluindo-se que a presença deste 
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 cerâmico não induz, de um modo geral, um efeito significativo no desempenho celular de 
células do tipo osteoblastos. 
A avaliação in vitro da imunocompatibilidade dos polímeros e compósitos à base de amido 
foi efectuada numa segunda fase. Esta centrou-se essencialmente na identificação de 
variações na produção de radicais livres e enzimas degradativas por neutrófilos assim como 
na capacidade desses materiais activarem, in vitro, outras células do sistema imune. Na 
presença de alguns materiais, os neutrófilos foram estimulados a níveis muito inferiores ao 
seu potencial máximo enquanto que na presença de outros materiais as espécies reactivas 
de oxigénio produzidas pelos neutrófilos activados e que provocam lesões tecidulares, foram 
inactivadas por “scavangers” presentes nos materiais à base de amido. Verificou-se ainda 
que algumas citoquinas específicas não foram produzidas na presença de alguns dos 
materiais estudados enquanto que outras não foram mesmo segregadas em nenhuma das 
condições. A incorporação de hidroxiapatite nos polímeros à base de amido não afectou 
significativamente a activação das células do sistema imune ou resultou, dependendo da 
mistura em causa, numa menor activação.  
De um modo geral, a avaliação da imunocompatibilidade in vitro permitiu concluir que os 
polímeros e compósitos à base de amido têm um fraco potential para desencader uma 
resposta inflamatória. Após implantação in vivo, estes resultados puderam ser confirmados 
validando os modelos experimentais estabelecidos in vitro. Macroscopicamente não foram 
observados sinais de uma reacção inflamatória considerável. O facto de não se ter formado 
qualquer exsudado celular, de os materiais terem sido encapsulados por uma cápsula 
fibrosa fina e da amplitude da resposta nos tecidos não ter sido muito forte para a maioria 
dos materiais em estudo, permitiu afirmar que os polímeros e compósitos à base de amido 
não induzem uma resposta inflamatória severa para os tempos de implantação estudados.  
Em resumo, os estudos de citocompatibilidade e imunocompatibilidade demonstraram que 
os polímeros e compósitos à base de milho são biomateriais promissores. Em comparação 
com os biomateriais degradáveis actualmente em uso, possuem propriedades capazes de 
induzir um comportamento semelhante, ou mesmo melhor, em termos de citotoxicidade. 
Estes dados foram reconfirmados com a adesão e proliferação de células do tipo 
osteoblastos na superfície de alguns dos materiais à base de amido, que demonstraram ser 
comparáveis às observadas no PLLA, evidenciando a possibilidade de usar esses materiais 
em aplicações ortopédicas. As conclusões retiradas dos estudos in vitro e in vivo de 
imunocompatibilidade reforçam as observações das experiências de citocompatibilidade e 
em conjunto, evidenciam a possibilidade de utilização dos biomateriais à base de amido, 
com fraca capacidade de desencadear uma reacção inflamatória, em aplicações 
biomédicas.  
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 ABSTRACT 
There is an increasing demand for the development of new biomaterials that perform their 
function without eliciting negative effects in the host. Biodegradable biomaterials have arisen 
as the solution for some problems which currently involve traditional devices. However, and 
not neglecting the advantages of the degradable systems, some drawbacks have been found 
especially in terms of deleterious effects originated from their degradation products. 
Therefore, natural origin polymers are emerging within the biomaterials field. The rationale is 
that the incorporation of their degradation products into normal metabolic pathways will avoid 
secondary effects in the host.  
So far, and although there are many biodegradable biomedical devices being used, the ideal 
biomaterial for a specific application is yet to be discovered. Studies with biodegradable 
starch-based polymers have demonstrated that these biomaterials possess a range of 
properties which make them suitable for different biomedical applications. Thus, to gain 
further inside in the suitability of these natural origin biomaterials for different biomedical 
applications such as bone replacement, drug delivery systems, bone cements and tissue 
engineering scaffolding, we considered that it was imperative to further assess the biological 
response provoked by them. For that the PhD work plan that culminated in this thesis was 
delineated having in mind three main goals: i) to assess the cytocompatibility of the starch-
based polymers and composites by means of screening the cytotoxicity and evaluating cell 
adhesion and proliferation behaviour on their surfaces, particularly osteoblasts since we 
pursue a potential orthopaedic application for these materials; ii) to establish in vitro models 
to analyse and to try to predict, as much as possible, the real in vivo situation in terms of host 
response, thus to evaluate immunocompatibility of the materials; iii) to validate the in vitro 
results with an in vivo model previously used to study host response. 
Blends of corn starch with three different synthetic components (ethylene vinyl alcohol, 
cellulose acetate and polycaprolactone) and their respective hydroxyapatite (HA) reinforced 
composites with increasing percentages of HA ceramic were studied. The short-term effects 
of the degradation products was analysed and it was possible to observe that two of the 
studied blends possess a low degree of toxicity, being even better than the gold standard 
biodegradable biomaterial. Nonetheless, cell adhesion tests revealed that surface properties 
can determine if a material has the appropriated characteristics for the best cellular 
behaviour. Generally, the reinforcement of the polymers with hydroxyapatite did not induce a 
significant effect in terms of improvement of osteoblast-like cells performance with the 
studied conditions. 
The in vitro evaluation of the immunocompatibility of starch-based polymers and composites 
was focused on changes in the free radical and degranulation activity of neutrophils as well 
as on their potential to activate immune system cells in vitro. Neutrophils were in some cases 
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 not stimulated to their potential maximum and in other situations scavengers of the reactive 
oxygen species, which are known to provoke tissue damage, produced by activated 
neutrophils reduced their negative action. In addition, specific pro-inflammatory cytokines 
were not produced in the presence of some of the studied materials while others were even 
undetectable under any of the stipulated conditions. In terms of inflammatory reaction, the 
presence of hydroxyapatite either did not induce a significant effect or resulted in low cell 
activation.  
Thus, the in vitro results allow for concluding that starch-based polymers and composites 
possess a weak potential to break out an inflammatory response. After in vivo implantation 
no macroscopic signs of a considerable inflammatory reaction in any of the animals were 
observed, no cellular exudate was formed and a thin fibrous capsule surrounded all implants. 
Although there were some materials that stimulated stronger tissue responses, generally 
biodegradable starch-based biomaterials did not induce a severe reaction for the studied 
implantation times. The in vitro results were therefore confirmed by these in vivo 
observations which validate the established in vitro models.   
In general, the cytocompatibility and immunocompatibility studies showed that starch-based 
polymers and composites are promising biomaterials. Comparatively to the currently used 
biodegradables, they possess properties that induce similar to better cytotoxicity behaviour. 
The adhesion and proliferation of osteoblast-like cells on some of these materials was also 
comparable to that of PLLA which demonstrates their potential to be used in orthopaedic 
applications. The in vitro and in vivo immunocompatibility remarks further support the 
suitability of starch-based biomaterials to be used in biomedical applications due to their 
weak potential to break out an inflammatory reaction.  
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CHAPTER 1 
INTRODUCTION 
 
1.1 BIOCOMPATIBILITY – AN OVERVIEW 
The performance of a medical device is controlled by two sets of characteristics, those which 
determine the ability of a device to perform the appropriate and specific function and those 
which determine the compatibility of the material within the body - biofunctionality and 
biocompatibility.1 As such, the approach in the assessment of material biocompatibility 
encompasses the evaluation of the effects of physiological environments on materials and of 
the materials effects on the environment.2
The effect of the biomaterials on biological systems can be evaluated at different levels 
composing the consecutive stages of assessment. The assessment of the in vitro toxicity of a 
biomaterial is the initial step on a biocompatibility study, and is usually performed using 
immortalised cell lines3,4 being often a qualitative analysis, based on the morphological 
examination of cell damage and growth when in direct5,6 or indirect contact7,8 with the 
materials. Toxicity involves the disturbance of cellular homeostasis9 therefore affecting 
cellular functions that can be very subtle or lead to a multiplicity of biochemical changes.  
The types of tests to determine potential adverse or toxic effects of medical devices include 
procedures designed to evaluate cytotoxicity, acute and chronic toxicity, irritation to skin, 
eyes and mucosal surfaces, sensitization, hemocompatibility, genotoxicity and 
carcinogenicity10-12. However, depending on the intended use of the devices, as well as the 
nature of their body contact, these general tests are not sufficient to demonstrate the 
appropriateness of the devices. Thus, the specific clinical application of the newly developed 
biomaterial determines which tests are further indicated.3,13,14
The emergence of new technologies in the development of biomaterials increases the need 
for adaptation of the existing standards.10,11,15 For example, in the evaluation of the 
biocompatibility of biodegradable materials several variables, which were not considered for 
non-biodegradable materials, have emerged. In focus were the possible effects of the 
metabolites resulting from the degradation, the local and remote interactions of cells with 
those products and the rate and mechanism of degradation of the devices.4,16-20 Considering 
that the results obtained with the standard tests could be influenced by those new 
parameters, adaptations have been made along the way. Long term tests were initially 
considered only in vivo but the study of degradable materials has to predict in vitro, as much 
as possible, the continuous effect of those systems and mainly of their degradation 
products.4,16-20 Of course it is not possible to maintain in vitro cell cultures for indefinite time 
thus, the need to mimic long-term degradation, launched biocompatibility tests using extracts 
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of the materials obtained under different conditions.15-17,19 High temperature degradation 
assays are based on the assumption that the degradation of biodegradable materials can be 
accelerated at high temperatures thereby releasing products that are expected to be 
released in vivo after long-term implantation.15,21 However, there is still some controversy 
about the veracity of these high temperatures having the same influence on the degradation 
behaviour to what might occur in vivo. The so called “real-time degradation tests” were 
suggested by International Standard Organisation (ISO) standards.15,17,19 Extracts are 
obtained at 37°C, body temperature, at different times which can go up to 52 weeks. 
Furthermore, since the human body is a dynamic system with constant changes of fluids, the 
simulation of the degradation of the materials under movement/shaking was also considered 
as a way of simulate better the in vivo conditions.15
Generally the biocompatibility results obtained for biodegradable materials using the current 
standards are not the most promising ones. The pH and osmolarity of polymer extracts have 
been suggested to be related to the toxicity of polymers20,22 and dependent on the amounts 
of solubilised monomers and oligomers23. In fact, pH influences cell behaviour and viability 
and acidic ph lower than the physical pH of the cells can cause a toxic response24,25. In 
addition, osmolarity is another factor that can exert an influence on proliferation, morphology 
and cell activity26. We might suggest that the key for overcoming these issues could be the 
control of the kinetics of degradation of the biodegradable polymers. 
 
1.1.1 In Vitro Testing 
The need to restrict animal experimentation to a minimum enhanced the necessity to use in 
vitro systems to select, adequately, potential useful biomaterials and those unsuitable for 
human application. Using cell lines to perform cytotoxicity screening has become routine in 
almost all laboratories around the world. However it must be stressed that in many cases the 
ideal situation is the use of human, non-transformed cells that is, primary isolated cells in 
early passage.10-12,27 Both approaches have advantages and disadvantages thus, many 
authors4,10-12,27,28 defend the use of cell lines at the first stage of screening and the use of 
adequate primary cultures relevant to the purpose for which the potential biomaterial has 
been developed.  
Primary cell cultures are achieved through enzymatic or mechanical disaggregation of a 
piece of tissue or by spontaneous migration from an explant and may be propagated as an 
adherent monolayer or as a cell suspension.29,30 These cells are generally heterogeneous, 
with a low fraction of growing cells but with a variety of cell types representative of the 
tissue.29-31 The major advantage is their ability to proliferate and replicate, although 
specialised cells and functions can be lost with the propagation of the culture.29-31  
---------------------------------------------------------------------------------------------------------------------------------------------------------------  4 ---- 
---------------------------------------------------------------------------------------------------------------------------------------Chapter 1 – Introduction--- 
Cell lines are previously established, and generally have origin in transformed primary 
cultures. While these have limited life, a continuous cell line is immortal and may be derived 
from different species and tissues.30 Comparatively with primary cultures of the same type of 
cells, a cell line presents morphological alterations such as decrease cell size, reduced 
adherence and higher nucleus.11,31,32 The tumour nature of these cells theoretically involves 
the possibility of phenotype and genotype variations.31 The main drawback using cell lines 
can be the extrapolation of results obtained in vitro to in vivo situations where normal cells 
act.4,27,28 Cell lines have however the advantages of being highly sensitive and homogeneous 
allowing for it use for a long time period representing an abundant source of cell material.28,30
Both cell types can be frozen and retrieved intact, even after many years. Within cellular 
phenomena, biocompatibility testing gives high importance to cell death, cell proliferation, cell 
morphology and cell adhesion, which directly correlate with toxicity in vitro.3,9,31
Several methods4,7,13,14,16,27,33,34have been used to quantify cell proliferation mainly based in 
the quantification of total protein7,27,33or DNA4,13,14,16,27,34 and in the measurement of DNA 
synthesis following the incorporation of radiolabelled nucleotides4,16,27,35,36. These molecules 
are taken up into DNA of cells during mitosis allowing for the identification of new cells by 
auto-radiography. The synthesis of DNA can then be followed, through the incorporation of 
labelled bromodeoxyuridine (BrdU)4,16, a pyridine analogue, and 3H- Thymidine27,35,36. In the 
case of BrdU, monoclonal antibodies coupled with a visualization system such as 
peroxidase-antiperoxidase were also used avoiding then the radioactive precursors.37 A 
growth curve can be obtained by counting the number of cells in cultivation at different 
intervals after seeding which allow to extrapolate a cell number from the cytotoxicity test.16  
This usually involved enzymatic treatment to obtain a cell suspension which is then counted. 
Loss of viability constitutes the critical consequence of a toxic biomaterial. A qualitative 
evaluation of cell morphology is often based on the examination by inverted microscopy. 
Typical characteristics of cytotoxic cellular alterations include shrinking of the cell nucleus, 
fragmentation of the cytoplasm, granulation formation, rounding off and cell 
detachment.16,29,32  Furthermore, a reduced biosynthetic activity16 as well as the release of 
cytoplasmic metabolites38 or uptake of non-viable stains39, resulting from cell membrane 
rupture, might be indicators of cell death. Several methodologies, based on these indicators, 
have been used to quantify cell viability. An example of cell stain is neutral red13 which is 
endocytosed by viable cells and internalised inside lysosomes allowing for conclude about 
cell integrity. Contrarily, trypan blue is taken up by cellular proteins within nonviable cells and 
excluded by living cells.13,14,30 The stains can also be measured spectrophotometrically and 
compared with a standard curve for cell quantification.14 A combination of the two principles 
was suggested by Dankberg et al40 using a combination of fluorescein diacetate (FDA) and 
ethidium bromide (EB). FDA is taken up by intact cells and converted by esterases to the 
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polar compound fluorescein, which remains in the cytoplasm giving green fluorescence on 
UV-excitation. EB can only penetrate cells with damaged plasma membranes and binds to 
nuclei acids resulting in an orange-red fluorescence. Others14 have used acridine orange 
(AO) instead of FDA.  
Cell death has also been quantified after contact with biomaterials by a tetrazolium-based 
colorimetric assay which uses a yellow dye, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) reduced, by the mitochondrial succinate dehydrogenase 
of alive cells, into a purple formazan salt.4,16,27,41  
The membrane integrity, therefore cell viability, can also be evaluated by measuring lactate 
dehydrogenase activity (LDH).20,38,42 This cytosolic enzyme has been used for many years to 
measure the cell membrane damage. Indirect measurement of LDH activity, which is present 
in the cytoplasm of intact cells, can occur only if cells are lysed and since LDH activity was 
proved to be directly proportional to the number, of viable cells can be determined.20,38,42
In addition to the evaluation of cell morphology and viability the use of cell dyes, enable cells 
adhesion behaviour to be observed. Cell attachment represents the translation of certain 
physico-chemical events involving the chemical interaction between cells and materials.43 
This is followed by cell adhesion which is the result of biological processes such as the 
production of extracellular matrix proteins and cytoskeleton protein reorganisation amongst 
others.43 Cell adhesion and spreading were shown to be clearly distinguishable biological 
phenomena because substrates that allow cell adhesion do not necessary promote cell 
spreading14. Furthermore, it was previously suggested that surfaces that show good cell 
attachment at early time points do not necessarily promote cell proliferation or 
differentiation.44 After cells contact surfaces, cells will alter their cell membrane and 
morphology to stabilise the cell-material interface.45 Filopodia, finger-like protrusions of 
plasma membrane formed as a consequence of actin assembling in long bundles or 
lamellipodia if assembled in the form of mesh supporting sheet-like protrusions are 
morphological details, characteristic of cell adhesion.43 When cell adhesion was followed by 
progressive flattening of the cells, proliferation occurred.46 Analysis of results should be 
cautious however. In hostile environments, anchorage-dependent cells become round, 
detach from the substratum and die.47 Nonetheless, reduction of cell adhesion may be 
wrongly interpreted since it may not be a toxic effect and has to be distinguished from cell 
death. If certain surfaces aim to be adhesive for cells working as a substrate for cell 
proliferation others will be biocompatible if cells fail to adhere to their surface or to the tissue 
culture polystyrene plates in the presence of their extracts.7,14,16 This allied to a morphological 
evaluation of the cells allow to confirm the reduced cell adhesion as a signal of toxicity.  
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At this point of evaluation of biocompatibility, it is extremely important to proceed mimicking, 
as much as possible, the environment that the implant will face thus using cells related to the 
function for which they were designed.3,13,14
In orthopeadic applications osteoblast adhesion and direct apposition of bone matrix to the 
implant surface are mandatory in the development and maintenance of the bone-implant 
interface. Several studies48-58 involving osteoblast adhesion have been performed in order to 
try to understand the cellular events that occur at the osteoblast-implant interface. 
Surface characteristics of the materials, whether their topography53,56, chemistry56,59-61 or 
surface energy49,52, play an essential part in cell adhesion on biomaterials. Attachment, 
adhesion and spreading belong to the first phase of cell/material interaction and the quality of 
this stage influences the capacity of cells to proliferate and differentiate themselves on 
contact with the implant.43  
Chemical properties such as carboxyl62 and hydroxyl58,63,64  groups can be important in cell 
attachment and growth depending on the type of cell. For instance, Curtis et al63 found that 
the blocking of hydroxyl groups results in lost cell adhesion but Horbett et al65 reported that 
the presence of an excessive number of OH groups has an opposite effect. These studies 
suggest the need of an optimal density for OH groups in order to obtain good cell adhesion. 
In addition others have reported55 that OH groups are responsible for higher surface polarity 
and hydrophilicity of the surface, but a correlation between these two parameters has not 
been determined. Some authors66-68 defend that cell adhesion is generally better on 
hydrophilic surfaces, while other studies50,51,55 showed that osteoblast-like cells do not display 
a consistent trend of behaviour in relation to surface wettability but rather varied as a function 
of particular functional groups. Wettability was also related to protein adsorption. Cell 
attachment was shown69 to be preferred on moderate hydrophilic surfaces and it has been 
suggested that these surfaces permit the adsorption of serum proteins with labile and 
reversible bonds. The moderate degree of wettability of the substrates allows cells to deposit 
their own adhesion proteins, exchanging with the more rapidly adsorbed serum proteins. This 
mechanism was proposed70 to be slower on extremely hydrophobic or hydrophilic surfaces, 
justifying the fact that cells do not adhere and proliferate so well on those surfaces. 
Nonetheless other work with osteoblasts suggested that cell adhesion was greatly influenced 
by the polar interaction energy49,52, which emphasises the role of surface energy in this 
biological process. 
In addition to chemistry, osteoblasts react differently according to surface topography53,56  
and roughness48,54,57,58. Rougher surfaces were shown to reduce proliferation of osteoblast-
like48,54 and human bone derived cells57,71. In addition, the initial adhesion of osteoblast-like 
cells was shown to be greater on polished (smoother) surfaces.54
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A direct relationship between roughness and surface energy of the materials does exist and 
it was demonstrated that the apolar component of surface energy increased significantly with 
roughness.72 Furthermore, it was reported73 that for relatively low surface roughness values, 
cell responses to the surface chemistry are more important than the physical surface. 
Some studies50,55,57,74 demonstrated ultrastructural differences in cell spreading and filopodia 
forming on a surface even if no differences in the percentage of adherent cells were 
observed74.  
Morphological aspects have also been shown to be influenced by different 
chemistries.50,55,56,66 A critical value for the surface energy of the substratum above which cell 
spreading occurs, was previously established.75 Likewise, cytoskeleton organisation and cell 
morphology are regulated by surface wettability49,50. Cell attachment and spreading are 
generally greater on certain moderately hydrophilic surfaces relative to hydrophobic ones49,50.  
Osteoblasts are also shown to recognise substrate morphology and to respond by altering 
their degree of spreading76,77. Several studies54,57 have demonstrated that cell spreading and 
continuous cell layer formation was better on smooth surfaces compared to rough ones. 
However, Bigerelle et al78 suggested that topography below the cell scale favours polygonal 
morphology of osteoblasts although when the topography was considered above the cell 
scale they also appreciate the roughness may explain cells being spread and flattened on 
surfaces considered rough76. 
 
1.1.2 In Vivo Testing 
Several implantation procedures have been suggested in order to obtain the most adequate 
system for each type of material for the evaluation of local toxicity. It is important to evidence 
that besides the materials, there are other issues related with the surgical technique that 
influence quite extensively the host response.15 Thus, although the most currently used 
intramuscular and subcutaneous models represent appropriate choices, new options are 
always under study aiming to reduce as much as possible the interference of other variables 
apart from the implant.19,28,79
Degradable materials, which will stay in the human body long-term, will induce not only local 
but also systemic effects.79-81 The degradation products, their concentration, the changes 
occurred in the materials such as alteration of the shape, roughness as well as for example 
the mechanical irritation of the more degraded materials in the biological tissues, may induce 
local and remote interactions between material/products and the biological system.20,82-84 
Furthermore, the evaluation of the implants in vivo performance can be achieved by means 
of biomechanical testing. After sacrificing the animal, shear strength, bending and tensile 
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tests are commonly performed to compare device characteristics before and after 
implantation.85
An acute phase follows the implantation of any material the severity and extent of which 
depends on several parameters mainly related with the material. If the deleterious action of 
the materials remains, a chronic response persists, leading in many cases to the failure of 
the implant.83,84 Both acute and chronic reactions can persevere for many years.  
The assessment of the type and extension of response that a biomaterial might locally 
induce is based on the histological analysis of the tissues surrounding the implant. Several 
factors have been taken into account within that analysis helping to define the degree of 
toxicity of the implant. The presence and amount of certain types of cells such as neutrophils, 
monocytes, macrophages, eosinophils, lymphocytes, fibroblasts and foreign body giant cells 
at the interface tissue-material are indicative of the response elicited by the implant.79,83,84 
Immuncytochemistry techniques are often used to identify the cells present in the retrieved 
implant as well as in the local tissues and complemented with image analysis systems to 
quantify the number of cells and their distribution related to the implant.79,86 Many of these 
cells when activated, produce hydrolytic enzymes responsible for the lesion of the tissues 
thus, the enzymatic activity in the tissues surrounding the implant can be determined in order 
to identify the presence or not of the toxic stimulus.87,88
Following the implantation of any medical device, the wound healing mechanisms are 
triggered in response to injury and to the presence of a foreign body.89,90 Thus the host 
generate a response aiming to eliminate the cause of injury and to repair the damaged 
tissues. The formation of a fibrous capsule is a common occurrence after the implantation of 
biomaterials but its formation depends on the severity of the response induced by the implant 
and consequently on its properties.20,82-84 Thus, the thickness of the fibrous capsule formed 
around an implant was also suggested20,83,84,89,90 to be a measure of the toxicity of the 
materials studied.  
Because of the interconnection between tissues and organs through blood, the lymphatic 
system and interstitial tissue fluid, exchange of products takes place between the 
implantation site and the rest of the body. Remote site effects are slightly neglected within 
the in vivo biocompatibility evaluation of potential biomaterials. Rather than histological 
analysis, the assessment of systemic effects can be done examining physical symptoms like 
hypokinesia, dyspnea, diarrhea, cyanosis, tremors and, the worst scenario, eventually 
death.79-81,91
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1.2. IMMUNOCOMPATIBILITY 
Many materials are proposed or currently used in a wide range of biomedical applications92-96 
but few are considered ideal and most of them can be hypothesised as foreign by the host 
and prompt a tissue response82,84,97,98. In general these biomaterials do not exhibit 
comparable physical, chemical or biological properties to natural tissues and ultimately, 
these devices can lead to chronic inflammation and foreign body reactions82,98-100. 
To date, a complete understanding of the biological responses to implanted biomaterials is 
still missing. The mechanisms of how a body reacts to implants over the course of time by 
inflammation, wound healing and the foreign body response is not fully understood. Immune 
system cells and chemical mediators are thought to be very important players in those 
reactions and will be present at the implantation site, independently of the function of the 
device. Thus the evaluation of the mechanisms of inflammation, wound healing and foreign 
body reactions may provide useful information about the immunocompatibility of newly 
developed biomaterials. 
The implantation of a biomaterial into human tissues triggers a set of cellular and 
biochemical processes collectively known as inflammation, in response to the injury and to 
the presence of the implant82,101,102. Leukocytes have been identified as the main cell types 
responsible for the adverse reactions implicated in inflammation.99,103,104 Severe and 
persistent leukocyte activation may lead to compromising alterations in the function of an 
implant and eventually to the failure of the device. In addition, there is some controversy 
about which properties of the surface of materials stimulate particular cell/tissue reactions. It 
has been hypothesized that not only the wettability and surface charge of the surface of the 
materials, but also the presence of certain functional groups have importance for the 
adhesion and activation of immunological cells in vitro105-112. Furthermore, the degradation 
rate and mechanisms of degradation in biodegradable devices can also modulate113-116 and 
might allow control of tissue responses in vivo. 
The acute inflammatory response is immediately initiated, leading to exudation of plasma 
proteins and inflammatory cells that migrate to the site of injury117. During this early stage 
several chemical mediators control and determine the extent of the reaction which would 
culminate in the restoration of the tissue and consequently wound healing118. However, it is 
becoming clear that in the presence of an implant the normal healing of injured tissues does 
not necessarily occur via the same mechanisms119. A chronic inflammatory response is often 
instigated and can be maintained or amplified, depending on the material properties, causing 
damage of the host tissues120-122. This process is mainly controlled by chemical mediators 
known as cytokines; these substances are produced by the cells present at the implantation 
site and can act locally or systemically attracting other cells and inducing the production of 
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other cytokines as well as guiding cellular functions.123 The so called cytokine network 
represents a very complex system of many molecules with multiple actions, involving many 
different types of cells and intermediaries124.  
 
1.2.1 Immune System 
Immunity means ability of an organism to resist disease by identifying and destroying foreign 
substances or organisms125,126. Cells and molecules involved in such mechanisms constitute 
the immune system and the response resulting from the introduction of a foreign agent is 
known as the immune response. However, not all immune responses occur to protect the 
host from disease; there are situations, although not the majority, when sickness is caused 
by an immune reaction127-131. These are for example allergic reactions, which occur due to 
the presence of external stimuli or autoimmune diseases such as multiple sclerosis130 or 
rheumatoid arthritis129,131, where an individual reacts against their own tissues. The 
implantation of any medical device can be considered an external invading element that 
might induce an immune response, mostly but not exclusively, dependent on the properties 
of the device itself101,105-107,132-134. 
Central organs of the immune system include the bone marrow and thymus, which are 
involved in generating precursor lymphocytes rather than immune responses126,135. In 
addition to lymphocytes, monocytes and granulocytes derived from precursor stem cells in 
the bone marrow126. The lymph nodes and spleen are known as peripheral organs and have 
as main roles to optimise interaction between antigen presenting cells (APC) and T and B 
lymphocytes135. 
Lymphocytes have receptors for antigen and confer specificity to an immune response. 
These cells express receptors with varying affinity for the antigen in question. Thus, during 
lymphocyte development the cell with the highest affinity for the most abundant antigen will 
have a growth advantage and will preferentially generate progeny of itself135.  
There are two types of lymphocytes, B and T; B cells have their origin in the bone marrow of 
adult mammals, whereas T lymphocytes undergo further maturation in the thymus. B 
lymphocytes migrate directly from marrow to peripheral lymphoid tissue producing antibodies 
and some soluble mediators called cytokines124. On the contrary, T lymphocytes do not 
produce antibody molecules but have surface receptors structurally related to 
Immunoglobulins (Ig)136. 
Once released from the bone marrow and thymus, lymphocytes begin to populate the whole 
lymphoid system. The higher concentration and the degree of accessibility of these cells, 
enables a rapid response to infectious agents.  
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T cells see antigen by recognising peptide fragments complexed with surface Major 
Histocompatibility Complex (MHC) glycoproteins on neighbouring cells. The cell surface 
glycoproteins encoded by genes in the MHC allele, bind fragments of antigen after it has 
been subjected to antigen processing137.  
There are two sub-sets of T cell divided according to their function; T helper (Th) and T 
cytotoxic (Tc) both are involved in cytokine production, but they also have individual actions, 
respectively helping B cells and T cytotoxic cells in the lysis of infected and tumour cells138. 
Surface proteins expressed by the different cells of the immune system, have been given 
standardised names, characterised by the initials CD (Cluster Designation) and a number. 
CD4 and CD8 are specific for the two T cell subsets, but the CD markers can be specific for 
individual populations of cells, or particular phases of cellular differentiation or activation. Th 
cells express CD4 and present antigens in association with MHC class II molecules while Tc 
lymphocytes express CD8 and present antigen using MHC class I proteins139. 
B cells use a different mechanism of antigen presentation; after binding to a cell surface 
antibody their specific antigen is internalised, partially degraded and presented to Th cells in 
association to MHCII molecules140. 
Natural killer (NK) cells are large granular lymphocytes that are cytotoxic in the absence of 
prior stimulation. NK cells represent a first line of defence to infections, tumour growth and 
other pathogenic alterations of tissue homoeostasis possessing receptor molecules which 
allow them to detect some infected host cells, including tumour cells, virus, or intracellular 
bacteria-infected cells138. NK cells do not express antibodies or T cell receptors at their cell 
surface, but produce cytokines and express receptors for immunoglobulins141.  
Phagocytic cells, also part of the immune system, are critical in the defence against bacterial 
and simple eukaryotic pathogens. Mononuclear phagocytes, in particular 
monocytes/macrophages, can recognise bacterial and yeast cell walls through broadly 
specific receptors, usually for carbohydrate structures, being able to take them up by 
phagocytosis142. Besides monocytes/macrophages, mononuclear phagocytic cells also 
include microglial cells in the central nervous system, endothelial cells of vascular sinusoids 
and reticular cells of lymphoid organs, which take up large particulate antigens, pieces of 
tissue, senescent cells and bacteria 138. 
Mononuclear phagocytes have important properties; they express a myeloid receptor (CD14) 
which serves as a recognition molecule for a wide variety of bacterial envelope molecules, 
such as lipopolysaccharides (LPS), which, after interaction lead to macrophage activation143. 
Mononuclear phagocytes can act as APCs for T cells and at the same time can be activated 
by T cell derived cytokines leading to increased phagocytosis and microbicidal activity 
(increased activity of degradative enzymes, prostaglandins, nitrogen and oxygen free radical 
production)144. Furthermore, these cytokines also increase the antigen presenting activity of 
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macrophages, which, in turn, are able to present antigen to T cells. This cycle will continue 
as a positive feedback loop until the antigen is eliminated145.  
Mononuclear phagocytes express receptors for antibodies and complement, which means 
that they bind immune complexes, especially if the antibody involved has complement 
components bound to it, in which case cells endocytose/phagocytose these rapidly146. 
Other APC are the group of dendritic cells; these are of two types and although having 
similar names they have different functions. Cells of the dendritic cell (DC) lineage are bone 
marrow derived but they are also present in the skin where they are known as Langerhan 
Cells (LC)138. These cells efficiently process antigen but cannot present it to T cells. LC pick 
up antigen in the skin and carry it via afferent lymphatic vessels to lymph nodes. Here, the 
tissue dendritic cells or interdigitating cells, may efficiently present antigen if they encounter 
the right T cell. In fact these are the most efficient APC, since far fewer DC are required to 
initiate an immune response than any other APC147.  
Granulocytes constitute another class of immunological cells. There are three types of 
granulocytes: neutrophils, eosinophils and basophils. Neutrophils, also known as 
polymorphonuclear leukocytes, they express receptors for immunoglobulin and complement 
and are involved in the acute inflammatory response148. Eosinophils carry receptors for 
immunoglobulin E (IgE) and are involved in the destruction of IgE coated parasites and 
contribute to the response to allergens149. Basophils are the circulating counterpart of tissue 
mast cells. They express high affinity receptors for IgE and are stimulated to secrete the 
chemicals responsible for immediate hypersensitivity following antigen induced aggregation 
of these receptors149.  
Each type of cell of the immune system experiences a series of processes which involve not 
only other types of cells but also chemical mediators that are enrolled in its regulation. These 
characterize the immune responses. It is possible to make a distinction between innate and 
adaptive immunity respectively as the capacity to respond to foreign agent instinctively or in 
a specific manner. The innate or natural response is present in neonatal animals while in the 
case of adaptive response the immune system requires pre activation and memory towards 
the foreign agent. Natural immunity depends on a variety of immunological effector 
mechanisms which are neither specific nor improved by repeated encounters138. Among 
others, its components are the complement system, acute phase proteins and interferons. In 
turn, the adaptive immunity increases in effectiveness and strength each time the host 
contacts the invaders125,138. This constitutes a useful evolutionary adaptation because it 
improves the efficacy of the innate immune response by focusing the response to the site of 
invasion/infection as well as providing additional effector mechanisms that are unique to 
lymphocytes125,150. The difference between innate and acquired immunity lies in the antigen 
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specificity of lymphocytes125. This property is conferred upon lymphocytes by the expression 
of cell surface receptors that recognise discrete parts of the antigen. 
From a different perspective, it is possible to organize the immune response in a dual system 
known as cell-mediated immunity and humoral immunity. Both systems are adaptive and 
respond specifically to most foreign substances although, depending on the antigen, one 
immune response generally is favoured over the other151. Lymphocytes are involved in both 
types of reactions. T cells are responsible for the cellular immunity because they are directly 
involved in the response, and B lymphocytes are implicated in the humoral response reacting 
with the antigen and producing antigen specific antibodies125,138. An antigen is then defined 
as any substance that can bind to a specific antibody and comprises an enormous range of 
substances from simple chemicals, sugars and small peptides to complex protein complexes 
such as viruses125. 
During an immune response, a complex lattice of interlinked antigens and antibodies, known 
as an immune complex, will present an array of constant regions, which can activate cells 
through the binding of their immunoglobulin receptors. Antibodies can act in different ways; 
by blocking the biological activity of their target molecule e.g. an enzyme binding to its 
receptor; neutralisation, interacting with special receptors on various cells, including 
macrophages, neutrophils, basophils and mast cells allowing them to recognise and respond 
to the antigen; opsonisation, and causing direct lysis by complement which also enhances 
phagocytosis; complement activation125. 
 
1.2.2 Adhesion Molecules 
Cell adhesion molecules (CAMs) play an essential role in adhering circulating leukocytes to 
the vascular endothelium at the sites of inflammation and then their subsequent 
transmigration into adjacent tissues. In the absence of signals to stimulate the expression of 
CAMs, the adhesive forces between endothelium and leukocytes are not enough to attach 
leukocytes.152
The adhesion molecules can be divided into three families of different structural architecture: 
selectins, integrins and certain glycoproteins included in the Ig superfamily153. 
Cytokines have been implicated in the up-regulation of many CAMs, this expression 
increases cell adhesion between leukocytes and endothelium, which may be crucial to the 
regulation of inflammatory processes154. Cytokine-activated endothelial cells also secrete 
chemokines such as interleukin (IL)-8 and monocyte chemoattractant protein (MCP)-1 
required for leukocyte recruitment155. 
Selectins are molecules which mediate leukocytes and platelets to vascular surfaces, they 
are characterised by an extracellular motif involving two domains: a lectin-like domain 
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attached to an epidermal growth factor (EGF) like domain and a variable number of 
complement regulatory protein repeat sequences153,156-158. 
There are three selectins which have been shown159 to be important in the cell to cell 
adhesion process; L-selectins are constitutively expressed on leukocytes while E-selectins 
are present exclusively in endothelial cells, being only expressed following stimulation by 
cytokines. In contrast P-selectins are accumulated pre-formed for rapid release in platelets or 
endothelial cells160.  
Selectins play a critical role in the leukocytes initial attachment and rolling on the vascular 
endothelium prior to integrin action161. Endothelium becomes activated by inflammation-
induced cytokines, in turn resulting in the expression of selectins153. The interaction of P- and 
E- selectins with the carbohydrate ligands on the surface of leukocytes appears to be 
responsible for initiating their rolling on the endothelium153. Although neutrophils and some 
lymphocytes constitutively express L-selectin, it is only after E- and P- selectin expression by 
endothelial cells that the rolling process occurs158,161.  
Integrins are another class of adhesion molecules; they are heterodimers consisting of non-
covalently linked α and β subunits. There are many possible combinations between the 
different known subunits, however, β2, α4β1 and α4β7 integrins are the main intervenients in 
regulating immune cell adhesion to endothelium153.  
Within the β2 integrins, it is possible to find the surface antigen expressed in all leukocytes, 
known as lymphocyte function-related antigen (LFA-1); it is an integrin consisting of a α 
subunit (designated CD11a), and the β2 subunit (designated CD18)152. The α subunit  can 
vary in the heterodimer region, originating two other important adhesion molecules, the Mac-
1 (designated CD11b) and C3b receptor (designated CD11c), both are expressed on 
monocytes/macrophages and granulocytess162 but not on lymphocytes163. CD11a is involved 
in the adhesion of leukocytes to endothelium and Mac-1 plays a key role in the adherence of 
both monocytes and neutrophils to vascular endothelium for subsequent extravasation164,165. 
CD11b/CD18 is also implicated in a variety of cell-cell and cell-substrate interactions such as 
attachment and phagocytosis of particles coated with C3bi by granulocytes and 
macrophages166. 
The α4 subunit-containing integrins have been termed VLA (very late activation) since two of 
them are expressed on lymphocytes about two weeks after antigen stimulation in vitro166. 
VLA-4 (α4β1; CD49d:CD29) expressed in resting lymphocytes and monocytes is probably the 
most important VLA integrin with respect to cell adhesion152.  
The α4β7 integrin, also known as lymphocyte Peyer’s patch adhesion molecule-1 (LPAM-1), 
is expressed on the microvillus tips of lymphocytes mediating the adhesion to the walls of 
inflamed venules153. 
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It is important to emphasise that the adhesion and consequently the cell migration to a site of 
injury via integrins is dependent on the changes which occur in the adhesion molecules 
subunits. Rather than an increase in the amount of expressed CAMs, stimuli like cytokines 
and antigens induce a conformational change of the integrins from a low to a high affinity 
state153. 
In addition to their role in the adhesion of cells to endothelium, integrin receptors on the 
neutrophil cell surface facilitate binding of neutrophils to the extracellular matrix167. 
Membrane proteins belonging to the Ig superfamily are specific cell surface molecules which 
act as counter-ligands for integrins. Those which are expressed on endothelial cells can be 
also designated as Ig-like addressins152.  
Some representative examples of membrane proteins members of the Ig superfamily are: Ig-
α/Ig-β heterodimer, part of B cell receptor, T cell receptor (TCR), T cell accessory proteins 
such as CD2, CD4, CD8, CD28 and the γ, δ, and ε chains of CD3, class I and class II MHC 
molecules, platelet-derived growth factor (PDGF) and various cell-adhesion molecules, 
including vascular cell adhesion molecule-1 (VCAM-1), intracellular adhesion molecule-1 
(ICAM-1), ICAM-2 and LFA-3.124  
 
1.2.3 Cytokines 
Cytokines are local protein mediators involved in almost all important biological processes 
namely, cell growth and activation, inflammation, immunity and differentiation168. Molecularly, 
cytokines are defined as inducible, water soluble, heterogeneous, proteinaceous mediators, 
possessing specific effects in target cells and/or in the mediator-producing cells 
themselves169.  Cytokines exert their effects by binding to specific cell-surface receptors 
which signal to their target cells170. They act at very low concentrations (typically 10-10 to 10-12 
M), are short-lived and may act, either on other cells (paracrine) or on the same cell 
(autocrine), or systemically (endocrine)124. 
The term cytokine encompasses different classes, interleukins which refer to a group of 
cytokines which are typically produced by T lymphocytes and macrophages although other 
leukocytes are also able to secrete them in lower amounts168. Another group of cytokines is 
designated by the generic name of chemokines due to their effects in the chemotaxis of 
leukocytes124.  
However, it is often not clear which molecules should be defined as cytokines, particularly in 
the case of hormones and growth factors (GF), but the pleiotropic nature of cytokines 
enabled the problem to be clarified168. Furthermore, GF tend to be produced constitutively, 
whereas cytokine production is carefully regulated and, unlike hormones, which act long 
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range in an endocrine way, most cytokines act over a short distance in an autocrine or 
paracrine manner.124
The cytokines known collectively as pro-inflammatory cytokines stimulate or accelerate 
inflammation and also regulate inflammatory reactions either directly or by their ability to 
induce the synthesis of cellular adhesion molecules or other cytokines in certain cell types169. 
The major pro-inflammatory cytokines that are responsible for early acute phase responses 
are IL-1α, IL-1β, IL-6, and tumour necrosis factor-α (TNF-α) . Other pro-inflammatory 
mediators include interferon-γ (IFN-γ), transforming growth factor-β (TGF-β), granulocyte and 
macrophage colony stimulating factor (GM-CSF), leukaemia inhibitory factor (LIF), and the 
interleukins IL-8, IL-11, IL-12, IL-17, IL-18169,171. 
IL-1 is a major mediator of inflammation and in general initiates and/or increases a wide 
variety of non-structural, function associated genes characteristically expressed during 
inflammation172. Although secreted by a variety of cells such as activated macrophages from 
different sources (alveolar macrophages, Kupffer cells, adherent spleen and peritoneal 
macrophages), peripheral neutrophil granulocytes, endothelial cells, fibroblasts, smooth 
muscle cells, keratinocytes, langerhans cells of the skin, osteoclasts, astrocytes, epithelial 
cells of the thymus and the cornea, T cells, B cells, and NK-cells, monocytes and tissue 
macrophages are the main source of IL-1124,172,173.  
There are two functionally almost equivalent forms of IL-1, IL-1α and IL-1β that are encoded 
by two different genes174. IL-1β is the predominant form in humans, while IL-1α is found more 
abundantly in mice169,175. Mature forms of IL-1α and IL-1β and also their precursors are 
secreted by murine macrophages after stimulation with bacteria or numerous microbial 
products176. Both forms of IL-1 bind to the same receptor and therefore also show similar if 
not identical biological activities177 with only a few functional differences between the factors 
having been described. 
Within a few minutes of binding to cells, IL-1 induces several biochemical events. This 
cytokine is strongly involved in the proliferation mechanisms of several cells acting as a 
stimulant for NK-cells and fibroblasts and as an inhibitor for endothelial cells. IL-1 causes 
many alterations of endothelial functions in vivo. It promotes thrombotic processes and 
attenuates anticoagulatory mechanisms. IL-1 therefore plays an important role in 
pathological processes such as venous thrombosis, arteriosclerosis, vasculitis, and 
disseminated intravasal coagulation178. Chemotactic properties are also attributed to IL-1; it is 
a strong chemoattractant for leukocytes in particular neutrophils. 
TNF-α, another pro-inflammatory cytokine, is produced by activated mononuclear 
phagocytes, macrophages and lymphocytes as well as many other non-immune cell types179. 
TNF-α is particularly important in organising reversible microenvironments, and its production 
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can induce remarkable cellular changes and tissue remodelling180. Like IL-1, TNF is a potent 
activator of neutrophils, mediating adherence, chemotaxis, degranulation and respiratory 
burst181. However, this cytokine has paradoxical roles in the inflammatory process. While 
inducing death of diseased cells at the site of inflammation, this cytokines stimulates 
fibroblast growth182,183. In the skeletal system, TNF-α stimulates bone and cartilage 
resorption and inhibits proteoglycan and collagen synthesis under some conditions184.  
Together with IL-1, IL-6 is a major physiological mediator of the acute phase reaction, 
inducing hepatic expression of acute phase proteins185,186. It is produced by many different 
cell types but the most important source is mononuclear phagocytic cells187. Macrophages, T 
cells and B lymphocytes, granulocytes, smooth muscle cells, eosinophils, chondrocytes, 
osteoblasts, mast cells, glial cells, and keratinocytes also produce IL-6 after stimulation124,179. 
IL-6 has pleiotropic functions influencing antigen-specific immune responses and 
inflammatory reactions. IL-6 is a B cell differentiation factor in vivo and in vitro and an 
activation factor for T cells188. However, in contrast to those pro-inflammatory effects, IL-6 
also possesses anti-inflammatory functions namely inhibition of IL-1, TNF synthesis189 and 
stimulation of IL-1 receptors antagonist (IL-1ra) production. 
The most important cytokine responsible for cell-mediated immunity is IFN-γ190. The 
expression of IFN-γ was long considered to be restricted to activated T and NK cells191. The 
production of this cytokine requires activation of the cells, which can occur via a combination 
of different types of signals; a specific or non-specific ligand interaction with a T cell receptor, 
their contact with accessory cells through adhesion molecules, and by a combination of 
cytokines192. Although initially considered to have antiviral functions, it has become clear that 
IFN-γ has a broader role191. Compared to other interferons, IFN-γ growth inhibitory activities 
are more pronounced and its main biological activity appears to be immunomodulatory in 
contrast to the other interferons, which are mainly antiviral. 
As the majority of cytokines, IFN-γ is seen as a pro-inflammatory cytokine with a pleiotropic 
nature mainly to increase TNF activity and nitric oxide (NO) secretion193 and to activate the 
pathways that lead to cytotoxic T cells194. IFN-γ exerts important activities on both 
monocytes/macrophages and lymphocytes, which generally result in macrophage activation 
and T cell differentiation towards a TH-1 type of immune response194. In addition, it can 
destroy blood vessels but also induce several angiogenic factors. IFN-γ inhibits the 
proliferation of endothelial cells and the synthesis of collagens by myofibroblasts, thus 
functioning as an inhibitor of capillary growth mediated by myofibroblasts and fibroblast 
growth factor (FGF) and PDGF. 
Besides IFN-γ, another significant lymphocyte-derived interleukin is IL-2, which is produced 
mainly by Th cells, expressing the surface antigen CD4, following activation by mitogen or 
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allogen. Several secondary signals are required for maximal expression of IL-2 and resting 
cells do not produce IL-2.179,195 IL-2 induces proliferation of T lymphocytes however, this only 
occurs when IL-2 and IL-2 receptors (IL-2r) are simultaneously produced and expressed. 
Therefore, IL-2 is an antigen-specific proliferation factor for T cells ensuring that only the T 
cells specific for the antigen provoking the immune response become proliferative179. Due to 
its effects on T cells and B cells, IL-2 is a central regulator of immune responses.  
Anti-inflammatory cytokines, contrarily to pro-inflammatory ones, are generally considered as 
possessing immunoregulatory and inhibitory properties. These mediators act mainly by the 
inhibition of the production of pro-inflammatory cytokines or by counteracting the many 
biological effects of pro-inflammatory mediators in different ways169. The main anti-
inflammatory cytokines include124: IL-4, IL-10 and IL-13 but other anti-inflammatory mediators 
include IL-16, IFN-α, TGF-β, IL-1ra, granulocyte colony stimulating factor (G-CSF), as well as 
soluble receptors for TNF or IL-6. Although IL-4, IL-10 and IL-13 are considered anti-
inflammatory cytokines due to their ability to suppress production of IL-1, TNF and 
chemokines, they are potent activators of B lymphocytes169. 
IL-4 is produced mainly by a subpopulation of activated T cells (Th2) which are the 
biologically most active helper cells for B cells124,196. It promotes the proliferation and 
differentiation of activated B cells197, and the expression of low affinity IgE receptors in 
resting B cells198. This cytokine can promote their capacity to respond to other B cell stimuli 
and to present antigens for T cells. This may be one way to promote the clonal expansion of 
specific B cells and the immune system may thus be able to respond to very low 
concentrations of antigens.199
The anti-inflammatory properties of IL-4 appear to be mediated at multiple levels, directly 
suppressing the production of pro-inflammatory cytokines200,201, as well as antagonising the 
pro-inflammatory effects of IFN-γ on several functions202,203. 
IL-10 is secreted by both Th1 and Th2 cells204, the major source in humans are monocytes 
and B cells179 having the macrophage as it’s main target. IL-10 suppresses cytokine 
production by macrophages, thus indirectly reducing cytokine production by Th1 cells179. 
Furthermore it down-regulates the expression of MHC class II molecules in antigen-
presenting cells179,205. 
IL-13 is homologous to IL-4 and shares a large amount of its biological activities on 
mononuclear phagocytic cells, endothelial cells and B cells206. This cytokine is however, 
more widely produced than IL-4 including by Th1 lymphocytes being readily identified in 
allergic inflammatory tissue207.  
Chemotactic cytokines are a superfamily of low molecular weight proteins that facilitate the 
passage of leukocytes from the circulation into the tissues and are generally identified as 
chemokines.208 These molecules are capable of inducing chemotaxis in a variety of cells 
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including neutrophils, monocytes, lymphocytes, eosinophils, fibroblasts and keratinocytes179. 
Despite being considered mainly as a chemotactic molecule their role is much more complex 
and it goes from recruiting and activating leukocytes to homeostatic functions179,209. For 
example, they can have direct effects on T cell differentiation or indirectly by changing APC 
trafficking or cytokine production210. 
It was demonstrated211 that the expression of chemotactic cytokines are both cell and 
stimulus specific, which suggests that the recruitment of cells to a site of inflammation is 
dependent upon the expression of specific cytokines for both the induction and maintenance 
of the lesion. 
Four chemokine subfamilies are known208: 1) The C-X-C (α chemokines which includes IL-8 
(CXCL8), melanoma growth stimulator (GRO-α) and epithelial neutrophil activating peptide 
78 (ENA 78) which primarily target neutrophils. 2) The C-C (β) chemokines such as RANTES 
(regulated upon activation normal T cell expressed and secreted), MCP-1 and  MIP-1α 
(macrophage inflammatory protein 1α), which recruits T cells and monocytes. 3) The “C” 
subfamily, which includes lymphocyte-specific chemotactic peptide XCL1. 4). The CX3C 
subfamily with only one member, CX3CL1 (fractalkine).179
IL-8, a potent neutrophil chemoattractant, is the classic chemokine example. It induces 
adherence to vascular endothelium and extravasation of neutrophils into tissues where they 
become activated and degranulate causing tissue damage179. In addition, it is a potent 
inducer of monocyte/macrophage activation, which produces IL-8 in response to IL-1 and 
TNF212. 
MIP-1 is a LPS inducible, heparin-binding protein made up of two peptides (MIP-1α and MIP-
1β). It possesses chemotactic activity for macrophages213 and can augment the inflammatory 
effect of these cells in chronic inflammation214. 
MCP-1, expressed in macrophages, has similar chemotactic activity and is induced by IL-1 
and LPS stimulation of peripheral mononuclear lymphocytes215,216. 
Cytokine GFs are produced by a variety of cells, including those typically involved in 
inflammatory processes, such as macrophages, lymphocytes, endothelial cells, platelets and 
fibroblasts217. These cytokines are powerful activators of the production of collagen and other 
extracellular matrix components, often in an autocrine manner217. 
Colony stimulating factors (CSF) are examples of cytokines with direct effects on cell 
proliferation in particular the stimulation of growth of colonies of cells from bone marrow 
precursors218. CSF-1, also referred as macrophage colony stimulating factor (M-CSF), 
promotes the growth of macrophages, while GM-CSF promotes the growth of both 
granulocytes and macrophages218,219. CSF-1 appears to be an important signal in inducing 
monocytes to mature into marcrophages220. 
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TGF-β is a member of one of the most complex groups of cytokine superfamilies, consisting 
of various TGF-β isoforms and other family members, for example, Activin A and bone 
morphogenic proteins (BMP)221. This family of cytokines is produced primarily by 
chondrocytes, osteocytes, fibroblasts, platelets, monocytes and some T cells179. It has both 
stimulatory and inhibitory effects on different cell types222. 
 
1.2.4 Cytokines Regulation 
The same cytokine may act pleiotropically, having different effects on different target cells or 
sometimes even on the same cell, while others can act synergistically and/or antagonistically 
for the same result171. The effect of a cytokine depends on the context in which it is working, 
since it is unlikely that cells in a particular inflammatory situation are exposed to only a single 
cytokine or only one inflammatory mediator or even one cell type223. 
The first cells to appear in a site of inflammation are neutrophils. Neutrophil numbers reach 
peak levels approximately 24 hours after injury102. Their migration is stimulated by various 
chemotactic factors and cytokines, including complement factors, IL-1, TNF-α, TGF-β, and 
chemokines such as IL-8 and MCP-1, and also by bacterial LPS224,225. IL-8 and IL-1 besides 
being a chemoattractant for neutrophils, respectively induce degranulation and activate the 
oxidative metabolism of those cells, causing tissue damage.179 In addition, pro-inflammatory 
cytokines such as GM-CSF and TNF-α modulate NADPH oxidase activity inducing the 
release of large quantities of superoxide anion (O2.-)226 in a phenomenon known as the 
respiratory burst. Regulation of this free radical production is critical to kill pathogens without 
inducing tissue injury226.  
Monocytes enter inflammatory sites where they develop into macrophages under the 
influence of a number of inflammatory mediators derived from other migrating cells 
(lymphocytes, macrophages and granulocytes) as well as from the affected tissue and 
endothelial cells themselves227. These are the cells that essentially control and regulate the 
wound healing process and wounds cannot heal without the participation of these cells as 
shown by experiments involving depletion of wound macrophages228,229.  
Monocytes are recruited following interaction with chemotactic peptides such as bacterial 
peptides, complement fragment C5a, leukotriene B4, fibronectin and fragments of basement 
membrane proteins230. Chemokines such as MCP-1,2 and 3, MIP-1 and 2 and RANTES also 
contribute to the recruitment of circulating monocytes within tissues.227  The profile of 
cytokines secreted by activated and resident tissue macrophages is different231, which allows 
for the modulation of most of the macrophage functions and cell surface marker expressions. 
Some cytokines (IL-3, GM-CSF, IFN-γ) can up-regulate the production of other cytokines by 
macrophages while IL-4, IL-10, IL-13 and TGF-β can inhibit that secretion169. TNF-α, IFN-α, 
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IFN-β and IFN-γ and also bacterial endotoxins, viruses, mitogens, and antigens induce the 
synthesis of IL-1176,179. In human monocytes, bacterial LPS induce approximately ten fold 
more mRNA and the respective proteins for IL-1β than for IL-1α.175 IL-1 can also induce the 
synthesis of GM-CSF by peripheral blood lymphocytes and synergises with that cytokine in 
the induction of M-CSF232. In Infection, besides IL-1, TNF-α, IL-12 and IL-18 production is 
stimulated by LPS.  IL-12 is generally considered the major inducer of IFN-γ production by T 
and NK cells191,233. Pro-inflammatory IFN-γ stimulates the bactericidal activity of phagocytic 
cells and, therefore, boosts the innate response190. In monocytes and macrophages besides 
the secretion of TNF-α, IFN-β, IL-1α and β234-236  IFN-γ induces the transcription of genes 
encoding G-CSF and M-CSF and also stimulates the release of reactive oxygen species 
(ROS)193. In addition to those stimulatory effects, IFN-γ can exert some inhibitory activity on 
the production of other inflammatory mediators such as IL-1, IL-2, IL-8, IL-10 and MCP-1, in 
human monocytes237-240. Bacterial endotoxins together with IL-1, TNF, PDGF, and Oncostatin 
M also represent physiological stimuli for the synthesis of IL-6241. The synthesis of IL-6 in 
human alveolar macrophages is however inhibited by IL-4, which prevents the production of 
IL-1, TNF-α and prostaglandins in response to activation of the cells by bacterial endotoxins 
or IFN-γ242 Furthermore, IL-4 induces the formation of foreign body giant cells (FBGC) from 
human monocyte-derived macrophages in vitro which can in turn be reinforced by the action 
of GM-CSF and IL-3243. 
The expression of certain cell surface markers have been often addressed244,245  as an index 
of cellular immune function and suppression and shown246-252 to be influenced by cytokines 
action. Inflammatory mediators such as TNF-α248, IL-1α251, IL-4249, IL-10250 and 
prostaglandins246 are known to regulate MHC-II expression. IFN-γ also regulates the 
expression of MHC class II genes and is the only interferon that stimulates the expression of 
these proteins. Due to a direct correlation with depressed MHC-II expression and defective 
antigen presentation248, a monocyte population with up-regulated MHC-II expression is 
important for certain healing processes. IL-4 down-regulates the expression of CD14 in 
normal human monocytes but strongly increases the expression of CD23, another monocytic 
antigen247.  
IL-1 and TNF-α are also responsible for increasing the expression of adhesion molecules252 
which allow leukocytes to adhere to endothelium prior to their extravasation into tissues. IL-1 
promotes the adhesion of neutrophils, monocytes, T cells and B cells by enhancing the 
expression of ICAM-1 and endothelial leukocyte adhesion molecule (ELAM)179. Lymphocytes 
use LFA-1 and VLA-4 to respectively bind ICAM-1 and VCAM-1.253 In turn, neutrophils 
appear to use both LFA-1 and Mac-1 to attach to ICAM-1 expressing cells153. ICAM-1 is 
primarily recognised by β2 integrins while the VLA-4 molecules interact with VCAM-1153. 
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Finally, the LPAM-1 integrins recognise the mucosal addressin cell molecule-1 (MAdCAM-
1)153. In addition, the transmigration through the intercellular junction of endothelial cells 
appears to require the expression of platelet/endothelial cell adhesion molecule-1 (PECAM-
1) another molecule belonging to the Ig superfamily254. 
Lymphocytes are, together with neutrophils, monocytes and macrophages also involved in 
the inflammatory process. Appropriate Th cell development is essential for an effective 
adaptive immune response. It is now established that soon after microbial invasion, 
macrophages promptly secrete considerable amounts of IL-12, which triggers the 
differentiation of T cells towards a Th1 type response255. Although the understanding of 
immune regulation is incomplete it is known that CD4+ helper T cells are capable of 
differentiating from an initial common state (Th0) into 2 apparently distinct types called Th1 
and Th2, which differ in their cytokine secretion179,256,257. Th0 are responsible for the secretion 
of IFN-γ, IL-2, IL-3, IL-4, GM-CSF, IL-5, IL-10 and TGF-β. After differentiation IL-2, IL-3 and 
GM-CSF continue to be produced by both subsets while IFN-γis only secreted by Th1 and IL-
4, IL-5, IL-10 and TGF-β by Th2. In addition two other cytokines, LT-β and IL-6, are produced 
respectively by Th1 and Th2 cells. 
The balance between Th1 and Th2 represents a switch, which can be used to influence the 
immune response in one or other direction. The commitment of Th0 cells to become Th1 or 
Th2 is influenced by cytokines secreted by the 2 subtypes themselves and by macrophages, 
NK cells and mast cells.258  
The Th1 pathway is essentially cell mediated immunity, with the activation of macrophages, 
NK cells, cytotoxic T cells and a prolonged inflammatory response. A main biological activity 
of IL-1 is the stimulation of Th cells, which are induced to secrete IL-2 and to express IL-2 
receptors179. In the presence of IL-2, IL-6 induces the differentiation of mature and immature 
T cells into cytotoxic T cells259. The expression of the IL-2 receptor of monocytes is 
modulated by IL-5 and IL-6 and induced by IFN-γ, so that these cells become tumour-
cytotoxic260. IFN-γ thus influences cell-mediated mechanisms of cytotoxicity modulating T cell 
growth and functional differentiation. It is a growth-promoting factor for T lymphocytes and 
improves the response of these cells to mitogens or GF. In addition, IFN-γ acts synergistically 
with IL-1 and IL-2261 and appears to be required for the expression of IL-2 receptors on the 
cell surface of T lymphocytes262.   
The TH2 pathway is essentially a humoral pathway, with the production of cytokines, which 
promote B cell growth (like IL-4, IL-6) and the production of IgG1 (IL-4), IgA (IL-5) and IgE 
(IL-4) in mice.263 It also stimulates effectors, which use these antibody isotypes; eosinophils 
(via IL-5) and mast cells (IL-4). IL-4 plays a pivotal role within this pathway. In activated B 
cells, IL-4 stimulates the synthesis of IgG1 and IgE and inhibits the synthesis of IgM264. This 
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isotype switching induced by IL-4 in B cells is antagonised by IFN-γ179. IL-2 promotes the 
proliferation of activated B cells but this requires the presence of additional factors, for 
example, IL-10265. IL-6 is capable of inducing the final maturation of B cells into 
immunoglobulin-secreting plasma cells if the cells have been pre-activated by IL-4. The 
growth of B cells induced by IL-4 is however, directly inhibited by the synergistic action of 
IFN-γ, TNF-α and TNF-β .266  IL-3 also inhibits the proliferation of human B cells stimulated by 
IL-2 by antagonising the IL-2-induced effects in B cells and by causing a slow decrease of 
the expression of IL-2 receptors267. In contrast, IFN-γ and Anti-Ig co-stimulate the proliferation 
of human B cells although not of murine B cells. 
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Figure 1.1. A schematic representation of some of the biological elements involved in the cytokine 
network. 
 
Macrophages also control the degradation of the extracellular matrix and regulate 
remodelling of the wound matrix by secreting several neutral proteinases such as elastase, 
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collagenase and plasminogen activators.268 Fragments of extracellular matrix and fibrin 
degradation products can be phagocytosed and degraded, which together with the cleavage 
of plasminogen into plasmin, results in the onset of important inflammatory processes 
involving not only activation of fibrinolysis, but also the complement, kinin and coagulation 
cascades. Macrophages also secrete GF such as TGF-β and PDGF, which have been 
shown to stimulate the growth of fibroblasts. TGF-β appears to be the major factor 
responsible for the formation of granulation tissue and the synthesis of proteins of the 
extracellular matrix179, which have lead to it being attributed as a wound hormone. TGF-β1 
and TGF-β2 inhibit IL-1 mediated proliferation of lymphocytes and at the same time decrease 
the secretion of inflammatory proteins such as neutral proteases. Therefore IL-1 activity 
antagonises the effects of TGF-β on the extracellular matrix269. The complexity of the wound 
healing process is illustrated by the observation that manipulation of the ratios of TGF-β 
superfamily members, particularly the ratio of TGF-β-1 relative to TGF-β-3, reduces scarring 
and fibrosis270. Re-epithelialization is mediated by chemotactic and mitogenic GF of the EGF 
family of GF.  
The mechanism of inflammation seems rather straightforward, but how the immune system 
regulates the type of response to a given challenge is still unclear. Different types of 
challenges require very different protective mechanisms to be activated, an inadequate 
response can fail to protect the host against an organism or even cause damage to the host 
directly. Systemic actions can be critical and not only cells and chemical modulators at the 
site of inflammatory are involved in the process. Cells such as monocytes/macrophages and 
endothelial cells also contribute to bone remodelling by either contact with osteogenic cells or 
by the release of soluble factors namely cytokines and GF.271
In the skeletal system, TNF-α stimulates bone and cartilage resorption and inhibits 
proteoglycan and collagen synthesis under some conditions184. IL-1 induces the expression 
of a large variety of cytokines. LIF and IL-6 are two of those molecules which are known to 
stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage272 but are 
also potent anti-apoptotic agents of osteoblasts273. In bone, the major sources of IL-6 are 
osteoblastic cells and not osteoclasts274 however the main activity of that cytokine involves 
osteoclastogenesis and bone resorption275. Prostaglandin E2 (PGE2) is also directly related to 
IL-6 expression276. 
The production of IL-1, TNF-α and TGF-α is influenced by prostaglandins, in particular it’s 
ability to stimulate bone resorption which is mediated by increased PGE2 synthesis277. Large 
amounts of PGE2 are produced in cells stimulated with IL-1278. In fact many of the biological 
activities of IL-1 are due to an increase of PGE2 production169. In vitro, PGE2 and 
glucocorticoids inhibit the synthesis of IL-1. The PGE2-mediated inhibition of IL-1 synthesis, 
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like the inhibition of IL-1 synthesis caused by IFN-α and IFN-γ, is mediated by an increase of 
intracellular cAMP levels.  
The effects of TNF-α, IL-1, IL-6 and PGE2 are therefore interconnected; IL-6 stimulates 
osteoclasts formation inducing the release of IL-1279 and mediates the stimulatory effects of 
TNF280 while PGE2 together with IL-6 activate osteoclasts in a paracrine way. Those 
cytokines act synergistically in the stimulation of osteoclast differentiation acting in the 
stromal cells or directly on osteoclasts and their precursors. 
 
1.2.5. Foreign Body Reaction to Implanted Materials 
The implantation of a biomaterial initiates a cascade of events, generally described as a 
foreign body reaction, which varies in time and in the inflammatory mediators involved101,106. 
The duration and intensity of the response depends on several elements including the extent 
of the injury caused by the implantation procedure, factors related with the host281,282 and  
numerous properties of the implant such as chemical composition, surface free energy, 
surface charge, roughness, size and shape106,108-112,283.  
The significant properties of biomaterials have been the focus of much research, probably 
because they constitute the controllable variables133,284-287 in the development of potential 
biomaterials. The emergence of biodegradable materials introduced more complexity to the 
biological response. Together with the foreign body reaction the material is degrading, which 
may lead to changes in shape, surface roughness, release of degradation products287-289 and 
formation of particulates290,291 therefore, from the host perspective, potentially new elements 
to respond to. 
Histological analysis enables the degree and extent of the foreign-body reaction to be 
determined. Fibrous capsule formation around biomaterial implants is considered a normal 
response292. The thickness of the capsule is between 20 and 30 µm and is reported to be the 
ideal situation for biocompatibility293. Materials that induce a thin-walled capsule containing 
quiescent fibroblasts and a small number of macrophages were considered 
biocompatible294,295. Imai et al296 reported that the threshold capsule thickness should not 
exceed 200-250µm for an implanted hydrogel. In addition, Marchant et al297 have observed 
that the total collagen content was about 0.23-0.27mg/mg tissue dry weight in 21 days post-
implantation of an hydrogel.  
 However, it must be clarified that the biocompatibility of any material includes 
biofunctionality1. Therefore, even if by inducing an inflammatory response the function for 
which the device was designed is not compromised and there are no sequels associated with 
the implantation of the device, it must be seen as biocompatible. For example, because 
collagenous encapsulation may impede the biofunctionality of implantable drug delivery 
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systems, in this particular application the objectives are a reduction of the capsular thickness 
and an enhancement of angiogenesis around such devices298. Contrarily, in the case of 
devices where diffusion is important such as sustained-release systems299 and implantable 
bioartificial organs300, encapsulation by a fibrotic capsule can be a considerable impediment 
to device function301. 
Wound healing is a very complex process that emerges after tissue injury with the aim to 
seal and make stable an area of damage302.  This response involves a series of distinct 
stages which can overlap in terms of time303. Dysfunctions in any of these phases can induce 
disorders in the healing process, thus, the nature and severity of the injury are dependant on 
the normal course of the reparative process304. If the injury is minimal the repair process 
takes place in a short time, since the complete repair of the tissues might be accomplished 
by the regeneration of parenchymal cells only2. However, with more extensive wounds, the 
inflammation is more severe and the repair process involves scar tissue formation and 
possibly the loss of functions304. It is under this situation, where the inflammatory reaction is 
more complex, due to the persistent presence of the causing agent and with few 
mechanisms to deal with it, that the implant devices might be considered2. 
The phases of normal wound healing follow an orderly sequence of events that are 
characterized and regulated by the chronologic appearance of a number of different cell 
types303. Once these cells undergo activation i.e. phenotypic alterations of cellular, 
biochemical, and functional properties, thrombin inside the plasma clot induces platelets to 
degranulate releasing the contents of their alpha-granules which, in turn, lead to the 
expression of new cell surface antigens, increased cytotoxicity, increased production and 
release of cytokines118,305. These, together with other factors activate cells, which then 
mediate subsequent phases of the wound healing process. 
The first cells arriving to the site of injury are neutrophils, reaching a peak after 24 hours, 
being removed by tissue macrophages when they are no longer needed106. Monocytes 
appear approximately 24 hours after injury reaching a maximum number 48 hours post-injury 
and fibroblasts migrate into the wound from day 3 onwards. Since monocytes mature into 
macrophages they can be considered an essential source of cytokines, which then drive 
repair processes. A variety of chemokines are also responsible for the spatial and temporal 
infiltration of leukocyte subsets and therefore control the integration of inflammatory and 
reparative processes during wound repair101.  
However, any type of disorder or tissue injury inevitably involves an acute phase reaction. 
Acute inflammation is the generic term used to label the complex process of endocrine and 
metabolic or neurological changes observed in an organism, either locally or systemically, a 
short time after injuries, infections, immunological and inflammatory reactions306. Thus, any 
type of disorder or tissue injury inevitably involves an acute phase reaction.  
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Many infections, especially where small wounds are the route of entry, are eliminated by the 
combination of complement and recruitment of phagocytes, which flow from the acute 
inflammatory response117. In fact, the acute reaction is initiated and mediated by many 
cytokines and by different types of cells, like PMN, fibroblasts, endothelial cells, monocytes 
and lymphocytes148. The development and control of the reaction occurs through the 
interaction of the numerous cascades of cytokines within the different tissues. 
Locally, the acute phase is characterised by an increase in blood flow to the site of injury, 
enhanced vascular permeability, and the well-organized and directional influx and selective 
accumulation of different leukocytes from the peripheral blood at the site of 
injury/implantation148,307. In particular, the number of circulating neutrophils and monocytes 
increases. Neutrophils are highly destructive cells capable of mounting a rapid, non-specific 
phagocytic response, while monocytes mature into macrophages, which are responsible for 
the removal of necrotic tissue, the phagocytosis of foreign materials and the release of 
growth factors306. 
A short-time after implantation, the device has many proteins adsorbed onto its surface308-310. 
Some of these proteins such as IgG, fibronectin, complement C3 fragments work as 
opsonins308,310. Neutrophils and macrophages bind to the implant surface through receptors 
for those proteins, which results in cell attachment, activation, secretion of reactive oxygen 
species and the release of proteolytic enzymes101,311. These cells will attempt to phagocytose 
implants, if successful implant particulates may be a subsequent product, if the implant is too 
large frustrated phagocytosis will occur. Either process can release these powerful 
destructive species mediators stimulating further inflammation121,307,312,313. The presence of a 
device can induce a massive and excessive activation of leukocytes, sustaining an 
inflammatory response.  
In addition to local activities, some systemic effects are typical of this type of reaction. Fever 
is a very common sign, but also cellular and biochemical changes occur in the liver with the 
synthesis of the so called acute phase proteins117. 
When an immune stimulus persists for a prolonged period of time, beyond that in which the 
immune system would normally have eliminated the antigen125 a chronic inflammation 
process takes place. 
Following neutrophils, other cell types like monocyte/macrophages and particularly 
lymphocytes (specific subsets of T-cells and B-cells) and plasma cells migrate to the site of 
injury106,122. These cells involve antigen-specific and more tightly regulated immune 
responses and once activated they also produce protective and inflammatory molecules. 
Another important characteristic of chronic inflammation is the development of blood vessels 
and production of connective tissue2. 
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Once again the implant is determinant for the progress and resolution of the reaction. If the 
foreign body continues to resist, the host defence becomes more aggressive and a special 
type of inflammatory tissue is formed. Macrophages fuse forming FBGC, fibroblasts 
proliferate, collagen and proteoglycans are synthesised and angiogenesis take place to form 
the so called granulation tissue2. 
Regardless of the intensity of the inflammatory process a reparative phase, aiming to repair 
damaged tissues, is always present. The first step of the reparative phase involves the 
activation of the intrinsic part of the blood coagulation cascade. This starts when the injury 
takes place due to ruptures of the blood vessels which instigate the contact of plasma with 
tissue and basal membranes of cells and the exposure of sub-endothelial collagen to 
platelets101. The formation of a fibrin gel serves to fix plasma proteins and blood cells, which 
leads to haemostasis, and acts as a scaffolding matrix that can be populated subsequently 
by inflammatory cells such as neutrophils, monocytes, and macrophages as well as 
fibroblasts and endothelial cells. Thus, inadequate clot formation is associated with abnormal 
wound healing2.  
Fibroblasts and endothelial cells are the primary proliferating cells arriving, as the number of 
neutrophils decreases and the number of macrophages and fibroblasts in the wound area 
increases101,106,122. Fibroblasts replicate in response to cytokines and growth factors present 
in the surrounding tissues, which were released during the earlier phases of wound healing, 
and stored in the fibrin clot, which is invaded by these cells. Fibroblasts deposit the collagen 
that forms part of the substance of granulation tissue106,314. 
The formation of new blood vessels is initiated by endothelial cell migration and into the 
healing wound. The formation of new blood vessels within the wounded area is essential for 
normal fibroblast and leukocyte function, thus the process is maintained as long as required 
by various angiogenic factors122. 
The final phase is characterized by the gradual replacement of granulation tissue by fibrous 
connective tissue, a process that also requires locally acting cytokines. Collagen is 
synthesised and the closure of the wound and formation of the scar is accompanied by a 
decrease in cellularity, including the disappearance of typical myofibroblasts2.  
The presence of an implant also has a role in the disruption of the normal sequence of 
events of the reparative phase. Angiogenesis is restricted, due to the inability of capillaries to 
migrate through the device, as well as the pattern of collagen deposition being different, 
either would most likely result in slowing down the repair process and prolonging 
inflammation2. Furthermore, the presence of considerable amounts of granulation tissue may 
be responsible for an adjustment of the mechanisms of repair and their replacement by 
extensive scar tissue lacking specialised functions, instead of the ideally minimal fibrous 
encapsulation of the implant292,315
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1.2.6 Hypersensitivity to metals 
As it was mentioned before, besides helpful immune reactions, there is another type of 
immune response that has harmful consequences for the host normally described as 
hypersensitivity. So far, hypersensitivity reactions were sub-divided into four types, three 
mediated by antibodies and one mediated by T cells125,149,316. 
Type I hypersensitivity reactions are the most currently described because these correspond 
to the rapid allergic reaction. The symptoms resulting from exposure depend upon the site of 
contact. Mast cells and basophils have a high density of antigen specific receptors and 
become activated after the contact between those receptors and the allergen. This induces 
rapid cell degranulation releasing primary inflammatory mediators stored in the granules. The 
mediators initiate a sequence of events characteristic of acute inflammation. Furthermore, 
cell activation also induces the production of secondary mediators such as prostaglandins, 
leukotrienes, cytokines and enzymes125,149. 
The second class of destructive reactions - type II, is caused by specific antibody binding to 
cells or tissue antigens. The antibodies directly or indirectly cause cell destruction, through 
the recruitment of complement. Usually the target cells are foreign to the host, but they might 
not be, as in the case of autoimmune diseases, which mean that this type of hypersensitivity 
reaction is only found in blood transfusion recipients and patients with certain autoimmune 
diseases. 
The type III hypersensitivity reaction has much in common with the type I response. It is also 
mediated by antigen-antibody immune complexes although with a different antibody and 
consequently without the involvement of mast cells. These complexes deposited at various 
sites triggering neutrophils to release their granule contents with consequent damage to the 
surrounding tissues. 
Finally the type IV reaction also called delayed type hypersensitivity, which is the only class 
of hypersensitive reactions to be triggered by antigen-specific T cells. In this situation, the 
antigen is picked up by an antigen presenting cell, typically dendritic cells, processed and 
presented in association with MHCII molecules to Th lymphocytes. Therefore, T cells become 
activated producing cytokines such as chemokines (chemoattractant for macrophages, other 
T cells and to a lesser extent, neutrophils) as well as TNF-β and IFN-γ. The consequences 
are a cellular infiltrate in which mononuclear cells tend to predominate. 
One of the major problems of the currently used metallic biomaterials, is organometallic 
complexes, possibly being the result of the reaction of the corrosion products, which are 
considered to be antigens/allergens 91 and the metallic ions with the proteins of the 
host317,318. Metals accepted as sensitizers are nickel319,320, beryllium321, cobalt318,322 and 
chromium318,323 and occasional responses have been reported to tantalum324, titanium325 and 
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vanadium326. The most common metal sensitizer in humans is nickel followed by cobalt and 
chromium319,320,327. Although little is known about the mechanisms of interaction and the 
dynamics of the metallic products in vivo, there are many immunologic type responses 
reported and associated with cardiovascular328,329, orthopaedic319,325,326, plastic surgical330 
and dental implants331,332. These reactions are generally associated with the hypersensitivity 
type IV response320,321,326,327, most likely mediated by wear debris products and leading to 
specific responses such as severe dermatitis, urticaria and/or vasculitis 320,324,327. 
Furthermore, other effects such as metabolic alterations, alterations in host/invader 
interactions, formation of lymphocyte toxins, and initiation and/or promotion of chemical 
carcinogenesis may come together with the direct immune response122,292,333,334. 
 
1.2.7 Cytokines in Orthopaedics 
The challenge in the development of new devices for orthopaedics is to insure long term 
stability, anchorage and function. Loosening of joint prosthesis resulting in failure is a major 
concern in the biomaterials field for orthopaedic applications335,336, with revision surgery 
occurring at early or later stages of implantation depending on the cause of failure. A key 
factor is believed to be the generation of wear particles and the biological response to them 
in periprosthetic tissues337. Those reactions modulate the formation and resorption of 
mesenchymal tissue and eventually lead to some of the pathological findings in failed total 
joint replacements including membrane formation, periprosthetic osteolysis and implant 
loosening338-340.  
The adverse effect was suggested to depend more on the particulate nature of the material 
than it’s chemical biocompatibility341. For example, both the size and volume (or number) of 
polyethylene particles are critical factors in macrophage activation and particles in the 
phagocytosable size range of 0.3-10µm appear to be the most biologically active342. A similar 
result was found for a given mass of polymethylmethacrylate (PMMA) bone cement; smaller 
particles (less than 20µm) resulted in more inflammation than larger particles (50-350µm)343 
and irregularly shaped particles produced a greater response than spherical particles. This is 
consistent with the fact that macrophages will tend to digest smaller particles344 and form 
multinuclear giant cells to surround larger objects345 although the differences in duration of 
their response also may have to be partly related with the material properties345.  Large 
particles were shown to induce a more intense increase in the white blood-cell count and in 
the production of PGE2343 but other work346 indicates that most of the particles in implant 
membranes are smaller than the resolution of the light microscope. The concentration of 
polyethylene particles accumulated in the tissue has been concluded by some research to be 
the most critical factor in the pathogenesis of osteolysis347. 
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Thus, there is not yet any general understanding of the mechanisms by which particulate 
materials exert a harmful effect greater than that of the whole material. Hydroxyapatite (HA) 
products, well tolerated in bulk form, have been used widely in clinical medicine. However, 
porous HA blocks were reported348 to have an unacceptably high failure rate in clinical 
applications. TGF-β1 concentration was found to decrease by the addition of HA particles in 
vitro but that variance was dependent on particle size349. In addition that effect was also 
suggested to be mediated by the increased synthesis of PGE2277,349. 
There have been many studies on tissue at the bone/cement-material interface339,350-352 and 
attention has been focused in analysing the retrieved specimen to measure the material 
degradation from the real environment and to perform biological studies on the tissues. In 
some of the studies the tissue was found to be fibrous granulation tissue350,351 with wear 
particles being released into surrounding tissue. These particles can initiate chronic 
inflammation with a significant number of activated macrophages and FBGC aiming to 
eliminate the debris353. Therefore, implant-derived wear particles are thought to induce 
cytokines and prostaglandins which are the primary cause of osteolysis354-356. In fact, 
retrospective studies on failed implants suggest that periprosthetic osteolysis is mediated by 
activated macrophages and consequently by the released cytokines357. Other works350,352,358 
have revealed that several cytokines are produced, which suggests a critical role for 
cytokines in bone destruction and total hip arthroplasty (THA) loosening.  
Demonstration of the production of bone resorptive cytokines in response to wear debris 
does not, however, demonstrate that bone resorption is only increased by this mechanism, 
since wear particles also induce production of factors that inhibit bone resorption like IL-4 
and IL-10 359. IFN-γ for example is involved in the processes of bone growth and inhibits bone 
resorption probably by partial inhibition of the formation of osteoclasts. At the same time, 
IFN-γ synergises with LPS in the induction of NO production. 
Particulate wear debris has been shown to alter the function of a variety of cell types within 
the periprosthetic space including macrophages, fibroblasts and osteoblasts, and either 
directly or indirectly osteoclasts360-362. Particulate debris induces monocyte/macrophage 
activation by multiple signalling pathways363,364. The interaction between particulates and cell 
membranes increases cytokine release without requiring phagocytosis363. In addition, the 
selective opsonisation of orthopaedic implant wear particles by human serum proteins was 
also shown to influence monocyte/macrophage activation364. 
Strong evidence has been shown362,365,366 for  the major role of increased recruitment of 
osteoclast precursors namely macrophages, and their subsequent role in wear particle-
induced osteolysis, while osteoclast activation and survival appears to play minor roles. In 
addition, a synergistic effect of cell activation and wear particles on O2- production by 
activated macrophages and osteoclasts, suggested O2- involvement in mediating 
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osteolysis367. Osteoclasts are capable of producing ROS which were suggested to play a role 
in normal bone resorption at osteoclast-bone interface368. Low-levels of ROS play a role in 
the differentiation of pre-osteoclasts thus, if produced by macrophages or osteoclasts in 
response to cytokines and wear debris, can increase osteoclast formation367,369.  
Furthermore, EGF and TGF-α370, mainly responsible for wound healing, can induce bone 
resorption partly due to their ability to increase the proliferation and fusion of osteoclast 
precursors, leading to an increase in the number of osteoclasts 371,372.  
NO seems to play a role in stimulating resorption of bone by macrophages and 
osteoclasts373-376. Analysis of revision tissue has identified the presence of functional 
inducible NO synthase in activated macrophages and endothelial cells containing metal, 
polyethylene and polymethylmethacrylate (bone-cement) particles377,378 . Nonetheless, the 
effect of biomaterials on macrophage production of ROS and reactive nitrogen species is 
largely unexplored. Those species are known to damage extracellular matrix and to increase 
their degradation by proteases379,380, but they also elicit an increase in cytokine production at 
the implant-bone interface381. During inflammation, ROS have been reported382 to activate 
collagenase and initiate bone resorption, another finding to support their role in osteolytic 
processes that cause aseptic loosening.  
Macrophages respond to wear particles by releasing the pro-inflammatory cytokines IL-1, IL-
6, TNF-α, as well as other bone-resorptive fibroblast-derived mediators such as PGE2 and 
matrix metalloproteinases383-386. Cemented prostheses showed higher incidence of severe 
osteolysis, and higher level of cytokines387. It has also been reported388 that bone resorption 
occurred as a result of the macrophage inflammatory response to particulate polyethylene. 
Local bone-resorbing agents like IL-1α389,390, IL-1β389,391,392, TNF-α389-391 and LPS389,390,392 
greatly induced IL-6 mRNA expression in both cell line and primary osteoblast cells. 
In combination with TNF-α, IL-1 appears to be involved in the generation of lytic bone 
lesions393. IL-1 activates osteoclasts and therefore suppresses the formation of new bone.  
Osteoblasts are exposed to the cytokines released in the periprosthetic space. TNF-α394,395 
and PGE2394,396 have demonstrated negative impact on a variety of osteoblast functions such 
as suppressing procollagen α1 mRNA expression394-396 and subsequent reduction of type I 
collagen synthesis396. TNF-α induces the release of IL-6397, IL-8, MCP-1 and TGF-β. 
Secreted IL-6 together with PGE2 activates osteoclasts. In addition, a direct effect of wear 
debris on osteoblasts showed increased production of IL-6 and PGE2 and a direct influence 
in bone collagen mRNA expression and on the biosynthesis of bone collagen. 
Lukacs et al398 reported MCP-1 and MIP-1 production by fibroblasts in inflammatory 
granuloma and these chemokines were also found in membranes retrieved from total joint 
arthroplasty399. Considering that fibroblasts are a source of C-C chemokines, they can act as 
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chemoattractants for inflammatory cells in response to wear debris. Fibroblasts may also 
play an important role in osteolysis by increasing the synthesis of metalloproteinases and the 
secretion of certain mediators that suppress the expression of collagen. 
In some cases of aseptic loosening, T lymphocytes were shown to be present, together with 
debris-containing macrophages, which suggest a sensitivity reaction to those particulates376. 
The recruitment of T lymphocytes to tissue interface membranes of aseptic loosened devices 
was confirmed by another work although those cells were not participating in hypersensitivity 
responses.385 Furthermore, it was found that, in mice400 there is a lymphocyte-independent 
pathway of macrophage activation in response to particulate polymethylmethacrylate. This 
suggests that the foreign-body response to particulate orthopaedic biomaterials is 
macrophage dependant and that lymphocytes are not essential to this response, although 
they may modulate it. 
Bone resorption results in further loosening of the prosthesis, changes in stress, frictional 
wear, release of more wear debris and recruitment of more macrophages. Bone death and 
proliferation of macrophages, thus appear to be the cause for pain and loosening of 
prosthesis. 
Because many promising materials and designs have failed in clinical use an understanding 
of the mechanisms involved in osteolysis is crucial to the development of new methods to 
prevent implant loosening. Extensive theoretical and experimental testing is mandatory 
before introducing new materials and implants in a clinical application. To date, many 
different materials have been tried in order to reduce wear and the generation of 
macrophage stimulating submicron sized particles, or to provide more biocompatible 
components. Therefore, several studies401-404 have been carried out with potential 
biomaterials in order to try to understand which conditions can modulate inflammatory cell 
activity in response to the implanted material. By testing the cells that give rise to particular 
tissues rather than the tissue itself, the biological effects of biomaterials on the soft tissue 
can be elucidated. 
Immediately following implantation, proteins adsorb onto the surface of the device therefore, 
the effect of the type and amount of proteins as well as the dynamics of adsorption on 
cytokine production has been in focus401,405. A hypothesis of controlling the inflammatory 
response of implanted devices has emerged. Natural and synthetic polymers, with variable 
and selective protein adsorption, have been used to coat other materials expecting to 
passivate within certain limits those materials402. The surface chemistry of a biomaterial 
implant can determine the degree of monocyte and macrophage adhesion and consequently 
the types and levels of secreted cytokines401,402. Therefore, the surface chemistry of the 
material directly and/or indirectly dictates monocyte adhesion and macrophage activation 
and fusion by determining the type, amount and conformation of adsorbed proteins. 
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Brodbeck et al404 showed that hydrophilic and anionic surfaces promote an anti-inflammatory 
type of response in vitro404 and decreased rates of monocyte/macrophage adhesion and 
fusion in vivo404 proving that biomaterial adherent cells undergo biomaterial dependent 
responses, sometimes affecting the surrounding implant environment. 
However, there are still some reservations in drawing conclusions, not only because the in 
vitro studies can be considered limited due to the lack independent and dependant variables 
or to simplistic conditions which do not represent the in vivo environment, but also because 
some results may be contradictory171,172. For example, polymers that supported the highest 
number of adherent monocytes also elicited the lowest levels of pro-inflammatory cytokines 
secretion402. Conversely, chitosan based hydrogels were found to inhibit the adhesion of 
macrophages, maintaining their viability without significantly affecting the production of IL-6 
and TNF-α403. However, cytokines in vivo rarely, if ever, act alone. 
Another concern involves the secretion profile of macrophages which is dependent on their 
stage of differentiation and on environmental stimuli231. Human macrophages obtained from 
various anatomical sites in the absence or presence of an inflammatory reaction also show 
differences in their spontaneous and stimulated release patterns406,407. Differentiation of 
monocytes in vitro in the presence of various stimuli, like bacterial antigens, lymphokines and 
monokines alter their subsequent secretory pattern upon stimulation with membrane-
activating agents408. 
 
1.2.8. Immunoreactivity to Natural Origin versus Synthetic Biodegradable Systems 
Currently used biodegradable materials for biomedical applications are mainly synthetic92-
96,286,409. Natural origin biodegradable polymers such as polypeptides410-413, 
polysaccharides414-418 and bacterial polyesters419,420 have been proposed as an alternative.  
Unpredictable adverse reactions to some commonly used traditional implants have been 
reported during the years82,84,97,98,421. Nevertheless, polylactides and it’s derivatives are the 
most commonly used synthetic biodegradable materials and they are widely accepted as 
biocompatible422-425. In the first phases of polylactide degradation in vivo, only hydrolysis 
takes place. The final products of the disintegration have to be removed by cells, which 
would normally be involved in inflammation. In fact, both clinical applications82,84,97 and 
animal studies113,114,426 have suggested that degradation products directly and indirectly affect 
tissue remodelling, respectively by interaction with the cells responsible for the formation of 
de novo tissue and through the induction of inflammatory cytokines released by activated 
macrophages. Therefore, the influence of the degradation time was addressed with long-
term in vivo studies, but the results were not conclusive demonstrating acute to mild 
inflammation depending on the material113,290,427. Long-term evaluation of implanted PLLA 
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screws and plates84 showed that some patients presented intermittent swelling at the site of 
implantation which was classified, after investigation of the nature of the tissue explanted, as 
a non-specific foreign body reaction to the degraded PLLA material. Furthermore, remnants 
of degraded PLLA were surrounded by a dense fibrous capsule and internalization of crystal-
like PLLA material in the cytoplasm of various cells was also noted84. A comparable result 
was observed in another study82 which applied  poly glycolic acid (PGA) and lactide-glycolide 
copolymers. Only 7.9% of patients developed complications, identified as a non-bacterial 
inflammatory response which was typical of a non-specific foreign-body reaction. A more 
serious complication was detected four months after osteosynthesis of medial malleolar 
fractures with PGA Biofix® implants99. Lymphocytes were the main type of cell found in the 
retrieved cell suspension with a low number of mononuclear phagocytes, which suggested a 
lymphocyte-mediated immunological reaction against the implant.  
Some studies comparing non-degradable and biodegradable materials103,290,428,429 reported a 
less favourable host reaction when degradable materials were used, although the differences 
become less noticeable for longer times of implantation.290 Furthermore, the expression of 
MHC II has been reported in response to several materials, independently of being 
biodegradable, such as poly(L-lactide acid)430, hydroxyapatite-coated prostheses431, 
polymethylsiloxane432 and titanium433. 
Many uncertainties are still present but factors have been implicated in the occurrence and 
intensity of an inflammatory response against biodegradable implants. The difference in the 
rate of degradation and subsequently the difference in the kinetics of the release of the 
degradation products, such as monomers, oligomers and finally fragments have been 
considered of major importance.  The issue is that the velocity of degradation might be too 
fast allowing the inflammation process to take over, thus compromising the role of the 
device434,435. The inflammatory cell reaction has been reported to be more intense for 
polymers that deteriorate rapidly103,114,116.  However, a too slow or hardly detectable 
degradation can also be undesired for some applications such as the use of biodegradables 
to support osteosynthesis. Pistner et al436, showed that although the polylactides presented 
moderate inflammation, characterised by macrophages and giant cells only during the first 
few weeks of implantation, some of those polymers did not present an adequate degradation 
rate for the proposed function.  
Degradable glasses were found to stimulate an inflammatory response in soft tissue100 which 
was clearly associated with its degradation rate. No chronic inflammation was observed after 
implantation of a slowly degrading glass, while the fastest degradation rate leads to tissue 
damage and necrosis. The high numbers of mast cells in fibrous tissue at an implant site was 
suggested to be linked with allergic reactions to the presence of glass.  
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The degradation process seems in turn to be influenced/controlled by other variables. It has 
been suggested that geometry and dimension of an implant influence biodegradation. 
Typically, implantation of a porous material does not induce a dense fibrous capsule102,437and 
enables a better vascular invasion of the polymer bulk298,438,439. 
Several studies104,440-444 have highlighted other extrinsic and intrinsic factors with influence in 
the biodegradation of biomaterials and consequently in the tissue response. Among them it is 
possible to refer to pH440 and the type of electrolytes of the degradation media 104,442, the 
external stress/strain applied442, the temperature441,443, free radicals104,444. It has been 
suggested that the results of biocompatibility studies must be aware of species 
differences445,446 and the site of implantation447,448 of the models in use.  
With the emergence of natural origin materials, the research approach assumed that a 
combination of synthetic macromolecules with natural macromolecules might yield 
materials133,449-453 whose properties would combine the advantages of both. In fact, collagen-
p(Hema) hydrogels were found to be well-tolerated when subcutaneously implanted in rats449 
overcoming the problem of enzymatic resistance and inertness. Histopathological data 
indicated that the tissue reaction at the implant site progressed from an initial acute 
inflammatory response characterized by the presence of eosinophils and polymorphs to a 
chronic response marked by few macrophages, foreign body giant cells and fibroblasts. An 
artificial connective tissue matrix constructed from the association between elastin or elastin-
solubilised peptides and type I + III collagens was investigated454. Biocompatibility studies in 
rabbit indicated that the material is totally integrated into the surrounding tissue after a 
moderate inflammatory response. 
Grimandi et al455 proposed to develop an injectable bone substitute for percutaneous 
orthopaedic surgery composed of methylhydroxypropylcellulose and biphasic calcium 
phosphate, which showed preliminary encouraging results in vivo. The inflammatory process 
was shown to be resolved after 15 days of subcutaneous implantation and at the same time 
a decrease of calcium phosphate granules and extracellular matrix formation was observed. 
An hylan gel, an insoluble form of hyaluronic acid, was presented456 as an effective 
alternative for soft tissue augmentation, due to its unique properties and it’s capacity of not 
eliciting inflammatory reactions.  
Natural materials have been proposed for biomedical applications mainly due to their 
similarities with the biological components of the host. However, there are some issues 
which should be considered439,457,458; Animal origin biomaterials may have a further problem 
when compared to synthetic materials. Specific immune stimulatory effects leading to 
humoral immune responses have been reported 439,457 and associated with contaminating 
proteins from the source organism of the implanted material which accentuates the need to 
use highly purified grades of natural origin materials. With the growing use of collagen-based 
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biomaterials, questions have been raised regarding the immunogenicity of this protein in 
humans459.  Furthermore, most natural origin polymers are generally degraded in biological 
systems by hydrolysis followed by oxidation or enzymatically442,460,461 contrarily, the majority 
of biodegradable synthetic polymers which are not subjected to the action of enzymes and 
are hydrolysed by the action of water or serum442.  
Natural origin materials are subjected to strong physiological reactions and their degradation 
in vivo will depend on the enzyme concentration within each living tissue. The enzyme 
concentration or other physiological conditions can determine the degradation rate, however, 
conclusions in terms of inflammation are not straightforward. Alginates for example are not 
subjected to enzymatic degradation when implanted in mammals, therefore presenting a 
limited and uncontrolled hydrolytic degradation in vivo462. On the other hand, chitosan is 
highly sensitive to enzymatic degradation in particular to lysozyme action463,464, a neutrophilic 
enzyme released to the tissues after activation. Chitosan was found to be uniformly 
degraded in vitro by enzymatic degradation464 but the extensive in vivo cellular response 
suggested that other degradation mechanisms as well as other factors were involved in that 
response464,465. However, other works with chitosan materials466-468 revealed a mild tissue 
reaction with vascularisation of the implant, involving neutrophils which resolved with 
increasing implantation time and changed to a fibroblastic population.  
Starch-based materials, other natural-origin polymers, have been shown to be degraded by 
α-amylase and phagocytosed by macrophages446,469 showing an excellent tissue reaction 
when implanted both in rat and mice446,470. In works by other groups21,471 starch-based 
materials implanted in rabbits and goats performed well and without adverse reactions. The 
host response to cross-linked high amylose starch (Contramid®) was found to be in 
accordance with the main phases of the inflammatory and foreign body responses to injuries 
caused by implanted devices2,102,106,307. After 4 months only a small residual scar was 
apparent macroscopically and it was even related with a less severe early reaction than a 
skin incision and closure with suture material sham446.  
Kohane et al345,472 proposed novel lipid-protein-sugar particles to be used as drug delivery 
systems. It was suggested that the particles would be biocompatible due to the natural 
compounds345 together with expected faster degradation rate when compared with other 
polymeric delivery systems423,473. Their residue would not be expected to remain within the 
tissues, inducing the formation of FBGC. In fact the evaluation of the in vivo tissue response 
of two tyrosine-derived polymers (poly(DTE carbonate), poly(DTE adipate) in comparison to 
PLLA474 showed that the response to PLLA fluctuated as a function of the degree of 
degradation and that the natural origin materials did not exhibit significant inflammation. In 
addition, they degraded faster, probably due to enzymatic action, allowing tissue ingrowth 
into the implant while no comparative ingrowth of tissue was seen for PLLA. 
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Polyhydroxybutyrate (PHB), a polymer made by microorganisms under conditions of nitrogen 
deficiency, has been proposed as a biodegradable implant material on the basis of its known 
degradation characteristics in certain biological environments419. Monofilaments of PHB have 
been studied in vitro and in vivo up to 180 days475 demonstrating that these materials are not 
biodegradable, although susceptibility to degradation may be increased by exposure to 
gamma radiation. Another work476 showed that the slow degradation rate can be modified by 
using a filler reinforcement and by changing the initial molecular weight of the polymer. This 
approach allows these materials to induce a bone tissue adaptation response with no 
evidence of an undesirable chronic inflammatory response after implantation up to 12 
months476. 
The degradation of collagen-based materials is usually controlled using chemical 
crosslinkers such as glutaraldehyde, formaldehyde or hexamethylene diisothiocyanate, 
which also involve the potential toxicity of leaching of unreacted chemical, which will 
contribute to increase the duration and intensity of the inflammatory response477. Due to the 
toxicity problem of the crosslinking agents, other less toxic and more biocompatible478-480 
materials are being looked for.  Some of them have been found to elicit significantly less 
inflammation480 than the control collagen fibres crosslinked with the currently used agents. 
The subcutaneous implantation of glutaraldehyde-crosslinked dermal sheep collagen 
(GDSC) showed an increase in infiltration of neutrophils with a deviant morphology when 
comparing with hexamethylene diisothiocyanate-crosslinked dermal sheep collagen 
(HDSC)481. Furthermore, a high incidence of calcification was observed, which may explain 
the minor ingrowth of giant cells and fibroblasts, and the poor formation of new rat collagen. 
Acyl azide-crosslinked dermal sheep collagen (AaDSC) first induced an increased infiltration 
of macrophages, and then of giant cells, both with high lipid formation. Other authors482 
defend that collagen crosslinking preserves material integrity for a longer time, additionally 
decreasing tissue responses at late time intervals, probably by reducing matrix 
biodegradability and antigenicity. Dermal sheep collagen (DSC) materials crosslinked with 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride and N-hydroxysuccinimide 
(ENDSC) induced the same mild cellular reaction as HDSC; whereas, similar to AaDSC, the 
degradation rate was slow and an optimal rat collagen matrix was formed. 
Following implantation, blood proteins immediately adsorb to the surface of the implants. 
Physico-chemical properties of the implant therefore regulate that adsorption and 
consequently cell adhesion. Previously, implants with increased water and carboxylic group 
content have been shown to inhibit macrophage adhesion and multinucleation, probably 
because hydrophobic interactions participate in cell-matrix interactions483,484. Additionally, an 
inhibitory effect of carboxyl groups on macrophage spreading has been reported485. 
Glycosaminoglycans (GAGs) are highly negatively charged polysaccharides due to the 
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presence of sulphate and carboxylic groups, which may contribute to  the reduced foreign 
body reaction found in the presence of those materials486. 
Anionic collagen membranes, negatively charged at physiological pH, presented advantages 
over other collagen materials also crosslinked with glutaraldehyde487. Besides the controlled 
biodegradability, the inflammatory response progressed from an intense acute response after 
3 days of implantation (polymorphonuclear cells and lymphocytes) to a moderate reaction 
characterised by the presence of mononuclear cells with low activity after 60 days487. 
In recent years hyaluronic acid has been used for many clinical purposes and the search for 
new derivates continues. The esterification of hyaluronic acid with alcohols leads to the 
preparation of semi-synthetic insoluble polymers (Hyaff) with different physico-chemical 
properties allowing  modulation of its biological properties488. In fact, fibronectin, collagen and 
fibrin were shown to react readily with these polymers in vitro489 therefore modulating the cell 
response. In vivo tests in rats were performed488 with several Hyaff esters which induced 
different tissue reactions. Cell exudates revealed a poor polymorphonuclear infiltration for all 
the materials but the most hydrophilic material show an almost exclusive monocyte and 
macrophage population around it that was responsible for it’s resorption. 
In general, foreign body reactions towards implants, manifested by the presence of giant 
cells are frequently observed106,314,481 and if the duration and extension of the reaction does 
not compromise the role of the device it can be considered harmless. However, specific 
immune reactions have been observed with some natural origin materials. Calcium alginate 
dressings have beneficial effects on wound healing by providing a moist wound environment, 
favourable for cell regeneration490. The commercially available dressings may enhance 
wound healing through mechanisms that induce the stimulation of monocytes to produce pro-
inflammatory cytokines491. Although this may be advantageous due to the stimulation of 
cellular activity at the chronic wound site and thereby enhancing the healing process492 it can 
promote unresolved chronic foreign-body reaction493. Novel freeze-dried alginate gel 
dressing low in calcium ions demonstrated the improvements, showing reduced cytotoxicity 
and significantly reduced foreign-body reaction when compared to commercially available 
calcium alginate dressings494,495. 
Though the numerous collagen-based devices are reliable and effective, it has long been 
recognised that some subjects may develop immunity to the collagen or other components in 
them. Some studies demonstrated that bovine collagen implants have weak antigenic activity 
and that the immune responses to this implant are typically localized reactions459,496. 
However, early clinical studies with injectable collagens497-499 verified that approximately 3% 
of the population develops hypersensitivity reactions. Lymphocytes were observed at the 
implantation site of collagenous matrices486,500,501. Studies with T-cell deficient rats500 showed 
that T cells play a major role in the formation of giant cell and the phagocytosing activity of 
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macrophages and giant cells during the tissue response to HDSC. This means that the tissue 
reaction to biomaterials might be modulated by controlling T-cell activation in the case of 
unwanted or secondary burst reactions, or in the case of too-fast degradation of biomaterials.  
Hung et al79 showed that SACCHACHITIN, a chitin derivative accelerates the wound healing 
of skin, but also induces acute local inflammatory allergic effects when its suspension was 
injected subcutaneously in rats. This study also reinforced the chemotactic effect of chitin on 
inflammatory cells suggested before502 although concluding it as a positive effect since the 
onset of acute inflammation wound facilitate early angiogenesis and faster tissue formation 
and wound healing79. 
 
 
This introduction was structured to support the description and discussion of the work 
performed during the PhD. The work was sub-divided in two main areas: i) the evaluation of 
the biocompatibility of starch-based polymers and composites in terms of cytotoxicity and 
cytocompatibility, considering a potential orthopaedic application and, ii) the assessment of 
the immunocompatibility of starch-based polymers and composites both in vitro and in vivo.  
Therefore, the initial three chapters (chapter 2 to 4) will focus on the in vitro tests performed 
both with extracts (indirect contact) and with the materials in study (direct contact) using a 
mouse-fibroblast cell line (L929) and a human-osteoblast cell line (SaOs-2). The intent was 
in an initial stage, to screen the novel starch-based biomaterials for cytotoxicity and in a 
subsequent phase to test, in vitro, their potential to be used in orthopaedic applications.  
The remaining chapters of this thesis (chapter 5 to 7) report on the implementation of in vitro 
models with different types of immune system cells aiming to predict the real implantation 
conditions where inflammatory reaction might dictate the success of the implant. Particular 
emphasis was given to specific elements such as cell adhesion molecules and cytokines, 
which play a pivotal role in inflammation. The correlation between the in vitro and in vivo 
situation was also established with the implantation of starch-based materials and 
composites (chapter 8).  
 
Please note that this introduction is based on the following publications: 
 
 A. P. Marques, J. A. Hunt, R. L. Reis, Natural origin degradable materials: the barrier or 
the passage through the immune system?, in: Biodegradable Systems for Tissue 
Engineering and Regenerative Medicine, Ed: R. L. Reis and J. San Roman, CRC Press, 
Boca Raton, USA (2004), 355-375. 
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 A. P. Marques, J. A. Hunt, R. L. Reis, Mediation of the cytokine network in the 
implantation of orthopaedic devices, in: Biodegradable Systems for Tissue Engineering 
and Regenerative Medicine, Ed: R. L. Reis and J. San Roman, CRC Press, Boca Raton, 
USA (2004), 377-397. 
 G. A. Silva, A. P. Marques, M. E. Gomes, O. P. Coutinho, R. L. Reis, Cytotoxicity 
screening of biodegradable polymeric systems, in: Biodegradable Systems for Tissue 
Engineering and Regenerative Medicine, Ed: R. L. Reis and J. San Roman, CRC Press, 
Boca Raton, USA (2004), invited chapter, 339-353. 
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CHAPTER 2 
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Marques, A. P.1,2, Reis, R. L.1,2 and Hunt, J. A.3 
1 3B’s Research Group – Biomaterials, Biodegradables, Biomimetics, University of Minho, 
Campus de Gualtar, 4710-057 Braga, Portugal  
2 Department of Polymer Engineering, University of Minho, Campus de Azurém, 4810-058 
Guimarães, Portugal 
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ABSTRACT 
Studies with biodegradable starch-based polymers have recently demonstrated that these 
materials have a range of properties, which make them suitable for use in several biomedical 
applications, ranging from bone plates and screws to drug delivery carriers and tissue 
engineering scaffolds. 
The aim of this study was to screen the cytotoxicity and evaluate starch-based polymers and 
composites as potential biomaterials. The biocompatibility of two different blends of corn-
starch, starch/ethylene vinyl alcohol (SEVA-C) and starch/cellulose acetate (SCA) and their 
respective composites with hydroxyapatite (HA) was assessed by cytotoxicity and cell 
adhesion tests. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) 
assay was performed with the extracts of the materials in order to evaluate the short-term 
effect of the degradation products. The cell morphology of L929 mouse fibroblast cell line 
was also analysed after direct contact with polymers and composites for different time 
periods and the number of cells adhered to the surface of the polymers was determined by 
quantification of the cytosolic lactate dehydrogenase (LDH) activity. 
Both types of starch-based polymers exhibit a cytocompatibility that might allow for their use 
as biomaterials. SEVA-C blends were found to be the less cytotoxic for the tested cell line, 
although cells adhere better to SCA surface. The cytotoxicity test also revealed that SCA and 
SEVA-C composites have a similar response to the one obtained for SCA polymer. Scanning 
electron microscopy (SEM) analysis showed that cells were much more spread on the SCA 
polymer and LDH measurements showed a higher number of cells on this surface. 
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2.1 INTRODUCTION 
Biodegradable starch-based polymers have recently been proposed as having great potential 
for several applications in the biomedical field such as bone replacement implants1, bone 
cements2, drug delivery systems3 and tissue engineering scaffolds4. The development of new 
processing techniques5 and the reinforcement with various fillers results in materials with 
mechanical properties matching those of bone6. However, other conditions should be met for 
a material to be considered suitable for any biomedical use. 
The performance of a medical device is controlled by two sets of characteristics, those which 
determine the ability of a device to perform the appropriate and specific function and those 
which determine the compatibility of the material within the body - biofunctionality and 
biocompatibility7. As such, the approach in the assessment of material biocompatibility 
encompasses the evaluation of the effects of physiological environments on materials and of 
the materials effects on the environment8. 
The evaluation of the in vitro cytotoxicity of a biomaterial is the initial step on a 
biocompatibility study, and is usually performed using immortalised cell lines9,10 being often a 
qualitative analysis, based on the morphological examination of cell damage and growth 
when in direct11,12 or indirect contact13,14 with the materials.  
In the present study, the biocompatibility of starch-based polymers was qualitatively and 
quantitatively evaluated. Cytotoxicity tests with the extract of the materials were performed in 
order to evaluate the presence and or release of toxic leachables and degradation products. 
Cell material interactions on the surface of the polymers were observed by scanning electron 
microscopy (SEM) and related to the materials formulations. Lactate dehydrogenase (LDH) 
was quantified in order to calculate the number of cells attached to the surface of the 
materials. 
This cytosolic enzyme has been used for many years to measure the loss of cellular 
membrane integrity15,16. Indirect measurement of LDH activity, which is present in the 
cytoplasm of intact cells, can occur only if cells are lysed. Since LDH activity was proved to 
be directly proportional to the cell number17, a new experimental procedure was developed to 
suite the enzyme activity measurement test for quantification of the cells adhered on 
materials. 
 
2.2 MATERIALS AND METHODS 
2.2.1 Tested Materials 
The studied materials were: i) a 50/50 (Wt %) blend of corn starch and ethylene vinyl alcohol 
(SEVA-C, Novamont, Italy), ii) SEVA-C reinforced with 30% (wt) of hydroxyapatite (HA, 
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Plasma Biotal, UK), iii) a 50/50 (Wt %) blend of corn starch and cellulose acetate (SCA, 
Novamont, Italy) and iv) SCA reinforced with 30% (wt) of hydroxyapatite. In the composites 
the average size of 90% of the HA particles was found to be below 6.5 µm (laser 
granulometry analysis). 
All the materials, both the polymers and the composites were processed into dumb-bell 
shaped ASTM tensile samples (2x4mm cross section) by injection moulding. The samples 
were then cut into appropriate sizes for the different tests. The samples were sterilised by 
ethylene oxide (EtO) in conditions that have been described previously2. 
 
2.2.2 MTT Test 
SEVA-C, SCA and the respective HA reinforced composites were incubated in 20 ml of 
culture medium (2.5 cm2/ml)18 for 24 hours at 37°C with constant shaking. That is an advised 
procedure for biomaterials extraction in order to obtain the major toxic leachables and 
simulate better the short-term effect of the degradation products under conditions similar to 
those of human body, a dynamic environment. The extract was then filtrated (0.45µm pore 
size) to eliminate the possible presence of solid particles of the material. Serial dilutions were 
made in growth medium (1:1, 1:3, ratios of extract to medium). 
L929 cultured cells were resuspended in culture medium at a density of 3.3x104 cells/ml and 
plated (200µl/well) into 96-well micrometer plates at 6.6x103 cells/well. The plates were 
incubated, for 24h, at 37°C in a humidified atmosphere of 5% CO2 in air. After that, the 
medium was replaced by the previous prepared extract dilutions, using culture medium by 
itself as a control. After 72h incubation the cell culture was treated with 50µl/well of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) (1mg/ml in medium 199 without 
phenol red, Sigma, St. Louis, USA) and incubated for further 4h at 37°C in a humidified 
atmosphere of 5% of CO2 in air. At this stage the MTT was removed and 100µl/well of 
isopropanol (BDH, Poole, England) was added in order to dissolve the formazan crystals. 
The plates were placed in the incubator for 10 minutes and then in a cold room for 15 
minutes before the absorbance measurements. The optical density (OD) was read on a 
multiwell microplate reader (EL 312e Biokinetics reader, Biotek Instruments) at 570nm. 
All materials extracts were tested in 24 replicates for each extract concentration for a 
minimum of three separate experiments with comparable results. 
 
2.2.3 Direct Contact Assay 
In order to characterise, morphologically, the cell behaviour when in the presence of the 
tested materials19, 5ml of L929 mouse fibroblasts cell suspension, in fresh culture medium 
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(3.3 x 104 cells/ml), were added to ethylene oxide sterilised materials which had been 
attached centrally in 6-well plates by silastic adhesive (Silastic, Dow Corning, UK). The area 
occupied by the test sample corresponds to 14% of the area of each well, which means that 
cells were cultured at a ratio of 2.3x103 cells/cm2. Dishes with and without adhesive were 
used as control. The plates were incubated for 1,2 and 7 days in a humidified atmosphere of 
5% CO2 at 37°C, without refreshing the culture medium. After each time period, the cells 
were fixed with methanol for 3 minutes, stained with 0.4% methylene blue for 10 minutes and 
examined by inverted microscope. 
 
2.2.4 Preparation of cell-material surfaces for SEM observation 
Cells were grown as described before for the direct contact assay. After each time period, 
the cells were washed with phosphate buffer saline (PBS) solution and fixed in 
glutaraldehyde 2.5% in 0.1M of PBS for 30 minutes at 4°C. After the fixation, the cells were 
washed twice, 15 minutes each, with phosphate buffer and then dehydrated in ethanol 
solutions 50%, 70%, 90%, and 100%, twice and during 15 minutes for each concentration. 
The materials with the adherent cells were kept in 100% ethanol until being subjected to 
critical point drying (CPD) to avoid water contamination. The samples were then gold coated 
by ion sputtering (BIO-RAD Microscience Division, Watford, England) and examined by SEM 
using a JEOL JSM-35C equipment. 
 
2.2.5 LDH Quantification 
L929 mouse fibroblasts were grown as described before in 6-well plates in contact with 
SEVA-C and SCA for 1,2 and 7 days without refreshing the culture medium. After each time 
period the plates were incubated at -70°C for approximately 30 minutes followed by thawing 
at 37°C for 15 minutes. The freeze and thaw cycle was repeated 3 times and then the plates 
were centrifuged at 250 x g for 4 minutes to eliminate any contaminant particles resulting 
from cell lysis. Supernatant aliquots of each well (50µl) were transferred to a new 96-well 
plate and the LDH quantified using an enzymatic kit (Promega, CytoTox96TM, UK). The 
absorbance was recorded on a multiwell microplate reader (EL 312e Biokinetics reader, 
Biotek Instruments) at 490nm within 1 hour. At each time period a pre-determined number of 
cells was seeded in the same plate as the material in order to prepare a calibration curve.  
The materials were assayed in triplicate for a minimum of four separate experiments with 
comparable results. For each material, a well without any material was used as negative 
control. 
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2.3. RESULTS  
2.3.1 Cytotoxicity Assessment 
The MTT test results are presented in figure 2.1. It was observed that in spite of the 
decrease in the percentage of viable cells with an increase in the extract concentration, none 
of the tested materials showed complete cytotoxicity for the L929 fibroblasts. These results 
are not typical for biodegradable polymers, as their degradation tends to induce a complete 
cytotoxic behaviour, especially when they induce a strong pH drop (as for instance for 
polylactides). Consequently, the obtained results are a good indication when thinking on the 
future clinical application of the studied polymers. For SEVA-C, it was observed a slightly 
higher degree of cytotoxicity for the polymer reinforced with 30% of HA, while for SCA and its 
composite the opposite result was observed. The SCA polymer demonstrated an increased 
cytotoxic effect when compared with SCA reinforced with 30% of HA. The difference 
between SCA and SCA reinforced with 30% of HA was not as great as for SEVA-C and 
SEVA-C with 30% of HA. Both the SCA polymer and composite present a value of 
cytotoxicity between the value of SEVA-C and composite but nearest to the one obtained for 
SEVA-C with 30% of HA.  
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Figure 2.1. Percentage of viable cells, compared to control, after 72 hours of growth with extracts of 
SEVA-C, SCA and their composites. 
 
2.3.2 Cell Morphology Evaluation 
These tests were carried out for SEVA-C, SEVA-C+30%HA (Fig. 2.2). No significant 
morphologic changes were observed in the cells in contact with any of the tested materials 
for all the studied time periods. A confluent monolayer was present for the two polymers after 
7 days of contact, even though SEVA-C composite presented a slightly higher degree of 
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cytotoxicity than the unreinforced SEVA-C. After 7 days of contact an almost confluent 
monolayer was observed, there was a delayed proliferation of the cells but they maintained 
good morphology. 
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Figure 2.2. Methylene blue stained L929 fibroblasts after different time periods in contact with SEVA-
C (B,C,D) polymers and reinforced with 30% of HA (F,G,H). M-material; A,E-Controls (Tissue culture 
polystyrene) without adhesive; B,F-One day of contact; A,E,C,G-Two days of contact; D,H-Seven days 
of contact (inverted microscope, original magnification x 2.5). 
 
SEM observation complemented the previous data since it was possible to see cells adhered 
on the surface of the polymers. On SEVA-C and SCA, cells cover most of the surface after 7 
days of growth (Fig. 2.3). 
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Figure 2.3. SEM micrograph showing the L929 fibroblasts adhesion to the surface of SEVA-C (A,B) 
and SCA (C,D) polymers. A,C-One Day of growth; B,D-Seven days of growth. 
 
Due to the considerable difference between the materials surfaces, such as chemistry, 
roughness and wettability, the cell adhesion behaviour was also different. On the SCA 
surface the adherent cells dispersed in a more irregular way than in the SEVA-C surface. 
Some cells in the SEVA-C surface were not spread, they were round and sometimes 
connected with other cells instead of being connected to the materials surface. On the 
contrary, on the SCA surface the cells were well spread and connected to the materials 
surface by the extensive lamellipodium observed. It seems that SCA polymers present a 
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better surface for cells to adhere and also a relevant topography with preferential cell 
adhesion in specific areas. 
 
2.3.3 LDH – Cell Adhesion and Proliferation Quantification 
As it can be seen in the figure 2.4, significant cellular adhesion and proliferation was found 
for both starch-based polymers, SEVA-C and SCA. At the first and second days of growth, 
the number of adhered cells remains the same, but after seven days of growth, the number 
of cells on the surface of the materials is already greater than the number of cultured cells. 
However, the number of cells adherent to the SCA surface is higher than the number of cells 
on the SEVA-C. 
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Figure 2.4. Number of cells adherent to the materials against culture time periods.  
 
On the other hand, the total number of quantified cells in each well is not coincident with the 
number of seeded cells. This result is not unexpected since the tested materials present a 
certain degree of cytotoxicity, expected for any type of biodegradable polymer, due to the 
release of toxic materials (plasticizers, low molecular weight chains) during their degradation. 
However, they clearly pass any standard screening test needed for them to be considered as 
biomaterials. 
 
2.4. DISCUSSION 
The short-term effect of leachables from starch-based polymers was quantified by exposing 
L929 cell to the degradation products released by those materials after immersion in culture 
medium. The differences in cytotoxicity (Fig. 2.1), between SEVA-C polymers and 
composites, can be explained by some thermal degradation of the polymeric chains that 
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occurred during the preparation of the composites. During the processing, the polymers with 
reinforcement are subjected to more severe thermal and shear cycles (extrusion 
compounding and injection moulding) that always provoke some thermal degradation (due to 
viscous heat dissipation), generating low molecular weight fragments20. These fragments are 
easily leached to the solution during the extract preparation and consequently the 
concentration of degradation products for the same extraction period is higher for the 
reinforced polymers. Also it has been reported there is a preferential attack by the 
degradation fluids at the polymer/reinforcement interface21. This higher degradation rate may 
explain the obtained cytotoxicity data (Fig. 2.1 and 2.2). The same type of behaviour would 
be predicted for SCA polymers and their composites. However, the opposite was observed 
and this kind of behaviour could be due to the pre-purification stage (in water) performed for 
these materials. During this procedure the low molecular weight chains that were originated 
by some thermal degradation during processing, are leached out to the solution and the 
cellular response to the polymer and composite become more similar. 
Cell adhesion and proliferation of different types of cells onto various surfaces depends on 
polymer surface characteristics like wettability22,23, surface charge24 and surface free energy 
and topography25. It has been reported there is a favoured cell attachment on moderate 
hydrophilic surfaces, which permits the adsorption of serum proteins with labile and 
reversible bonds22. The moderate degree of wettability of the substrates allows cells to 
deposit their own adhesion proteins, exchanging with the more rapidly adsorbed serum 
proteins. This mechanism is believed to be slower on extremely hydrophobic or hydrophilic 
surfaces, which is probably one reason that may contribute for cells do not adhere and 
proliferate so well on them26. 
The difference in cell adhesion, observed by SEM, for SEVA-C and SCA polymers may be 
attributed to the differences in their surface properties. The results are in agreement with the 
previous mentioned studies. In fact, SCA was found to be more hydrophilic than SEVA-C27, 
which was also moderately hydrophilic. 
However, other factors can affect cellular adhesion. Hydrophilicity, on its own is neither 
necessary or sufficient for cell adhesion. Chemical properties such as carboxyl28 and 
hydroxyl29,30 groups can be important in cell attachment and growth depending on the type of 
cell. Curtis et al30 found that the blocking of hydroxyl groups results in lost cell adhesion but 
Horbett et al31 reported that the presence of an excessive number of hydroxyl groups has an 
opposite effect. These studies suggest the need of an optimal density for hydroxyl groups to 
obtain good cell adhesion. 
The topography of the materials is another parameter to consider when discussing cell 
adhesion. Surface-morphological studies on the roughness of biomaterials surface have 
been performed and showed an affinity of different types of cells for roughened surfaces32,33. 
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In fact the higher water-uptake capability of SCA materials and its higher degradation rate34 
generate a rougher surface (as compared to SEVA-C) for cells to adhere. The more 
degraded and consequently rougher surface of SCA promoted a non-standard cellular 
adhesion (Fig. 2.3). The LDH quantification demonstrated that the SCA surface is the one to 
which cells adhere in higher numbers. These results can be pertinent considering that the 
cytotoxicity tests showed that SCA is the material with a slightly higher degree of cytotoxicity. 
However, as it was discussed, there is not only one factor to consider on its own, from the 
standpoint of material science, on cellular adhesion. 
 
2.5. CONCLUSIONS 
The short-term effect of the degradation products revealed that SEVA-C was the less toxic 
biomaterial and that its reinforcement with 30% HA induced higher percentage of cell dead 
due to the leaching of low molecular weight chains formed during processing (thermal 
degradation) and to the faster degradation rate of the composite. Despite the less promising 
results in terms of extract cytotoxicity, when L929 were seeded onto the materials, only a 
slight delaying on cell proliferation was observed in the presence of SEVA-C+30%HA but 
only for early culture times. The quantification of the number of cells adhered to SEVA-C and 
SCA did not shown a significant difference comparatively to TCPS.  
Considering the overall behaviour of SEVA-C, SCA and their composites, it can be expected 
that their cytocompatibility will allow for their use in the future in applications such as bone 
replacement/fixation and/or tissue engineering scaffolding. 
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ABSTRACT 
The cytotoxicity of starch-based polymers was investigated using different methodologies. 
Poly-L-lactic acid (PLLA) was used as a control for comparison purposes. Extracts of four 
different starch-based blends (corn starch and ethylene vinyl alcohol (SEVA-C), corn starch 
and cellulose acetate (SCA), corn starch and polycaprolactone (SPCL) and starch and poly-
lactic acid (SPLA70) were prepared in culture medium and their toxicity was analysed. 
Osteoblast-like cells (SaOs-2) were incubated with the extracts and cell viability was 
assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) test 
and a lactate dehydrogenase (LDH) assay. In addition DNA and total protein were quantified 
in order to evaluate cell proliferation. Cells were also cultured in direct contact with the 
polymers for 3 and 7 days and observed at light and scanning electron microscopy (SEM). 
LDH and DNA quantification revealed to be the most sensitive tests to assess respectively 
cell viability and cell proliferation after incubation with starch-based materials and PLLA. SCA 
was the starch blend with higher cytotoxicity index although similar to PLLA polymer. Cell 
adhesion tests confirmed the worst performance of the blend of starch with cellulose acetate 
but also showed that SPCL does not perform as well as it could be expected. All the other 
materials were shown to present a comparable behaviour in terms of cell adhesion showing 
slight differences in morphology that seem to disappear for longer culture times. 
The results of this study suggest that not only the extract of the materials but also their three-
dimensional form has to be biologically tested in order to analyse material-associated 
parameters that are not possible to consider within the degradation extract. In this study, the 
majority of the starch-based biomaterials presented very promising results in terms of 
cytotoxicity, comparable to the currently used biodegradable PLLA which might lead the 
biocompatibility evaluation of those novel biomaterials to other studies. 
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3.1 INTRODUCTION 
Biocompatibility assessment comprehends several hierarchical stages each one of them 
aiming to evaluate the effect of different characteristics/properties of newly developed 
biomaterials on the biological system. The emergence of novel biomaterials, in particular 
biodegradables, demands an adaptation of the existing test systems in accordance to their 
new properties. Several variables have emerged when evaluating the biocompatibility of 
those materials. The possible effects of the metabolites resulting from the degradation, the 
local and remote interactions of cells with those products and the rate and mechanism of 
degradation have been the focus of some studies.1-4
The toxic effect of the proposed biomaterials on cells is considered one of the most important 
issues to be evaluated. Toxicity involves the disturbance of cellular homeostasis5 therefore 
affecting cellular functions that can be very subtle or lead to a multiplicity of biochemical 
changes. Within cellular phenomena high importance is given to cell death, cell proliferation, 
cell morphology and cell adhesion, which directly correlate with toxicity in vitro5-7. Loss of 
viability constitutes the critical consequence generated by a toxic biomaterial. A reduced 
biosynthetic activity8 as well as the release of cytoplasmic metabolites9 or uptake of non-
viable stains10, resulting from cell membrane rupture, might be indicators of cell death. In 
hostile environments, anchorage-dependent cells become round, detach from the substratum 
and die11. The evaluation of cell morphology is therefore a rather simple and reliable tool to 
predict and identify loss of cellular viability. Another sign of toxicity is a reduced proliferation 
rate. Several methods8,12 have been used to quantify cell proliferation mainly based in the 
quantification of total protein or DNA and in the measurement of DNA synthesis following the 
incorporation of radiolabelled molecules. 
Considering cell adhesion, it is important to emphasize that a reduced cell adhesion might 
not be indicative of cell death and consequently cannot be interpreted as a toxic effect5. In 
fact, if using anchorage-dependent cells, representative of the environment that the implant 
will face, cell adhesion is required and its absence would be considered an indication of poor 
biocompatibility. This should be allied to a morphological evaluation of the cells which would 
allow to confirm the eventual reduced cell adhesion as a signal of toxicity. 
Several biodegradable polymers have been proposed for a wide range of biomedical 
applications2,3,13-18. Some of them were considered to induce an appropriated biological 
response in vitro15,16,18 and in vivo2,16 while others provoked a negative biological effect 
3,13,14,17,19. However those materials do not exhibit comparable physical, chemical or biological 
properties to natural tissues therefore, the search for novel materials which resemble living 
systems constitutes one of the major challenges for biomaterials scientists. Natural origin 
materials, due to their structural similarities to components in host tissues, their possibility of 
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being enzymatically degraded in  biological systems allowing for a better control of the 
degradation rate along with other properties, have been presented as potential solutions for 
the lack of biocompatibility of currently used devices20-24. Starch-based materials have 
revealed promising properties envisaging their use in a wide range of biomedical 
applications25-28. Therefore the aim of the present work was to evaluate the cytotoxicity of 
several starch-based materials (commercial environmentally applications grade) and the 
most currently used biodegradable material, poly-L-Lactic acid (PLLA, medical grade) in 
order to compare the performance of the different polymers. Cell viability and cell 
proliferation were the two parameters chosen to assess the cytotoxicity of the extracts of the 
materials and each one of the variables was quantified using two different techniques. Cells 
were also cultured in direct contact with the materials in study in order to compare the cell 
behaviour with the cytotoxicity results trying to identify potential additional negative effects of 
the surface of the materials. 
 
3.2 MATERIALS AND METHODS 
3.2.1 Tested Materials 
The materials studied were: i) a 50/50 (wt %) blend of corn starch and ethylene vinyl alcohol 
(SEVA-C), ii) a 50/50 (wt %) blend of corn starch and cellulose acetate (SCA), iii) a 30/70 (wt 
%) blend of corn starch and polycaprolactone (SPCL) and iv) a 30/70 (wt %) blend of corn 
starch and poly-lactic acid (SPLA70). 
Poly-L-Lactide (Purac biochem bv, The Netherlands), being the gold standard for 
biodegradables in biomedical applications, was used as a biodegradable control material and 
latex rubber as a positive control. 
All the materials, except latex, were processed into circular samples (∅ 1cm) by injection 
moulding and sterilised by ethylene oxide (EtO) under the conditions previously described25.  
 
3.2.2 Cell Culture 
A human osteosarcoma cell line SaOs-2, an immortalized cell line with an osteoblastic 
phenotype, was obtained from European Collection of Cell Cultures (ECCC, UK). The cells 
were cultured in Medium 199 without phenol red (DMGibco BRL, Life Technologies, USA) 
supplemented with 10% of heat-inactivated fetal bovine serum (FBS; Biochrom AG, 
Germany), 100000 U/ml penicillin-G, 100 µg/ml streptomycin and 25µg/ml amphotericin B 
(Sigma Chemical Co, USA) and 20 mM Hepes (Sigma Chemical Co, USA) in a humidified 
atmosphere with 5% CO2 and at 37°C. 
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In preparation for the MTT, Total Protein and LDH quantification tests cells were 
resuspended in culture medium at a density of 6.6x104 cells/ml and seeded (200µl/well) in 
96-well plates. For the DNA quantification, cells were resuspended in culture medium at a 
density of 2.4x105 cells/ml and seeded (1ml/well) in 24-well plates.  
All the plates were then incubated for 48h at 37°C in a humidified atmosphere of 5% CO2 in 
order to establish a 90-100% confluence monolayer. 
 
3.2.3 Extract Preparation 
Materials (3cm2/ml) were incubated in 10 ml of culture medium for 24 hours at 37°C with 
constant shaking (60rpm) in order to simulate better the short-term effect of the degradation 
products under conditions similar to those of human body, a dynamic environment. The 
extract was then filtrated (0.45µm pore size) to eliminate the possible presence of solid 
particles of the material and serial dilutions (25, 50 and 75%) in culture medium were 
prepared. 
 
3.2.4 MTT Assay 
Culture medium was replaced by the extracts of the materials (150µl/well) after cells reached 
the confluent monolayer and plates were incubated for 72 hours. 
After incubation medium was removed, each well was treated with 50µl/well of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) (1mg/ml in medium 199 without 
phenol red, Sigma, St. Louis, USA) and plates incubated for further 4h at 37°C in a 
humidified atmosphere of 5% of CO2. At this stage the MTT was removed and 100µl/well of 
isopropanol (Merck, Germany) was added in order to dissolve the formazan crystals. The 
plates were placed in the incubator for 15 minutes and then in a cold room for 15 minutes 
before the absorbance measurements. The optical density (OD) was read on a multiwell 
microplate reader (Molecular Devices SPECTRAMax Plus 340PC, USA) at 570nm. 
 
3.2.5 LDH Quantification 
Plates were treated with the extracts of the different materials as described for MTT test, but 
reserving replicates to determine total and extracellular lactate dehydrogenase (LDH). After 
the 72h of incubation 50µl of 10mM HEPES solution were added to each well. The solution of 
the wells reserved to determine extracellular LDH was transferred to new 96-well plates. The 
lysis of the cells adhered to the initial 96-well plates was promoted by 3 consecutive cycles of 
-80°C for 10 minutes and 37°C for 5 minutes and the suspension removed to another 96-well 
plates to quantify total LDH. Both for extracellular and total LDH quantification, 10µl of each 
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sample were incubated with 50µl of pyruvate (9.76mM pyruvate in 81.3mM Tris/203.3mM 
NaCl, pH 7.2) and the reaction was started with 125µl of NADH (0.244mM NADH in 81.3mM 
Tris/203.3mM NaCl, pH 7.2). Blank was read using 50µl of 81.3mM Tris/203.3mM NaCl, pH 
7.2 instead of pyruvate. The LDH activity was followed through the rate of oxidation of NADH 
to NAD+ for 150 seconds at 340nm (Molecular Devices SPECTRAMax Plus 340PC, USA) 
and the Vmax (OD340nmx10-3/min) determined. 
 
3.2.6 DNA Quantification 
After reaching confluence, the culture medium was replaced by serial dilutions of the extract 
(600µl/well) of each material. Culture medium without any extract was used as control. After 
72h, the extracts were removed, 200µl of trypsin-EDTA solution added to each well for 5 
minutes and replaced by 1ml of phosphate buffer saline (PBS, Sigma Chemical Co, USA) 
solution 0.01M. The solution was homogenised with a micropipette in order to remove all the 
cells still adhered and transferred to new test tubes. Tubes were centrifuged for 10 minutes 
at 2500 rpm and 4°C, the supernatants rejected and the pellets resuspended in 5ml of 
Proteinase K solution previously prepared with 2,5ml NaCl 4M, 20ml EDTA 500mM, 5ml Tris 
2M, pH=8.0, 25ml SDS 10% (w/v) and 525µl of Proteinase K (10mg/ml). Tubes were 
incubated overnight at 37°C. Following incubation 1.5ml of water plus 1.5ml of NaCl were 
added to each tube. These were mixed for 30 seconds and centrifuged for 3 minutes at 4000 
rpm and 4°C. Supernatants were transferred to new tubes, 6ml of 70% ethanol (v/v) was add 
and the mixtures homogenised until DNA precipitate. Tubes were let to stabilise for 1 hour, 
the supernatants despised and the precipitated transferred to eppendorfs to which 200µl of 
70% ethanol (v/v) and 150µl of Tris-HCl 10mM/EDTA 1mM were added. 
The DNA concentration was determined reading the optical density at 260nm, using the 
same equipment referred to before. 
 
3.2.7 Total Protein Quantification 
As for the DNA quantification, after reaching confluence the culture medium was replaced by 
serial dilutions of the extract (150µl/well) of each material. Culture medium without any 
extract was used as control. In the end of the incubation time (72h) the extracts were 
removed, cells were washed with 0.1M PBS and let in 100µl of PBS 0.1M. From this point 
on, the BCA Protein Assay kit (Pierce Chemical Co, USA) was used. This system utilises 
bicinchoninic acid (BCA) as the detection reagent for Cu+1, which is formed when Cu+2 is 
reduced by protein in an alkaline environment. The purple coloured reaction product is 
formed by the chelation of two molecules of BCA with one cuprous ion (Cu+1). This water-
---------------------------------------------------------------------------------------------------------------------------------------------------------------  85 ---- 
-----------------------Chapter 3 - Effect of starch-based biomaterials on the in vitro proliferation and viability of osteoblast-like cells--- 
 
soluble complex exhibits a strong absorbance at 562nm that is linear with increasing protein 
concentration. 
 
3.2.8 Direct Contact Assay 
The materials were placed in contact with cells during different time periods in order to 
identify morphological changes resulting from this contact and to see how cells were adhered 
and spread on the material.  
In this assay cells were trypsinised (0.25% trypsin/EDTA solution, Sigma Chemical Co, USA) 
from a culture flask and 1.5 ml of cell suspension, in fresh culture medium (3,3 x 10-4 
cells/ml) were seeded onto the materials. Three samples, per material, per time of growth, 
were studied and tissue culture polystyrene wells were used as control. The 24-well plates 
were incubated for 3 and 7 days. Culture medium was changed on the third day and after 
each pre-determined time of culture the cells were washed with PBS 0.1M, fixed with 2.5% 
glutaraldehyde (BDH, UK) solution in PBS for 30 minutes at 4°C, washed and kept in PBS at 
4°C until being stained or prepared for scanning electron microscopy (SEM) observation. 
The surface of the materials was therefore stained with a 0.4% methylene blue solution in 
water for 1 minute and examined in a stereomicroscope Zeiss KL 1500 (Zeiss, Germany). 
For SEM, samples were dehydrated in graded ethanol solutions (70%, 90%, and 100%) 
twice, 15 minutes each and let to dry overnight. Samples were gold sputter coated in a 
Sputter Jeol JFC 1100 and observed on a Leica Cambridge S360 SEM equipment (Leica 
Cambridge, UK). 
 
3.2.9 Statistical Analysis 
All materials extracts were tested in 12 (Total protein and MTT tests) and 6 (Total DNA and 
LDH tests) replicates for each extract concentration for a minimum of three separate 
experiments with comparable results. 
All data was averaged and standard deviation is reported as a measure of sample deviation. 
The data for the neat extracts was statistically compared by a one way ANOVA analysis 
using a Tukey test29. If probability values were less than 0.05 (p<0.05), differences observed 
for the two materials were considered statistically significant. 
 
3.3. RESULTS 
MTT and LDH quantification were used to measure cell viability while cell proliferation was 
assessed by DNA and total protein quantification. These methodologies were applied after 
culturing an osteoblast-like cell line with the extracts of biodegradable polymers. Before each 
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test, cells were seeded in different densities and allowed to adhere overnight to confirm that 
each one of the parameters was linearly correlated with cell number and to define the cell 
seeding concentration. 
 
3.3.1 Cell Viability 
The MTT assay revealed that the extracts of all the materials in study affected the viability of 
osteoblast-like cells. This was expectable due to the biodegradable nature of the polymers. It 
was possible to observe (Fig. 3.1) that the extract of the polymer of starch with cellulose 
acetate induced the highest percentage of cell death (about 75%). While in the presence of 
the extracts of all the other materials the number of viable cells was comparable to the 
number of viable cells in the negative control (tissue culture polystyrene -TCPS), in the case 
of SCA its behaviour was closer to the positive control (latex). In fact, the percentage of cell 
death in the presence of the extracts of starch-based materials (except SCA) and PLLA was 
around 30%, which can be considered a good result for this type of polymeric biomaterials. 
The statistical analysis of the results obtained for the neat extract confirmed that the effect of 
SCA extracts was significantly different from all the other materials. In addition, only the 
extract of SEVA-C was found to be significantly different from the extract of SPLA70 which 
suggests that the extract of SEVA-C was the less toxic (31% of cell death) and that SPLA70 
was the material with second highest index of cytotoxicity (36% of cell death). 
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Figure 3.1. Effect of the concentrations of the extract of several starch-based polymers on cell viability 
when compared with controls and reference materials. The results obtained in the presence of neat 
extract of SCA were found to be significantly different from the results obtained in the presence of all 
the other materials. In addition, when comparing SEVA-C and SPLA70, their effect on cell viability was 
found to be significantly different. 
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It is known that the intracellular LDH is proportional to the number of cells9. This parameter 
was determined subtracting the extracellular LDH to the total LDH, in order to obtain the 
number of viable cells and compare the results with those obtained in the MTT test.  In fact, 
although with some differences, the same tendency was observed with the LDH 
quantification experiment. The incubation of osteoblast-like cells with the extracts of the 
polymers induced a decrease in the number of viable cells (Fig 3.2). Once again, the extract 
of SCA induced highest percentage of cell death (about 46%). However, this was a less 
pronounced reduction, in comparison with the result obtained for MTT quantification. 
The statistical analysis of the results however, evidenced significant differences between the 
materials. While the SCA effect was found to be significantly different from all the other 
polymers with the MTT test, the LDH quantification showed that SCA and PLLA induced a 
similar outcome. Furthermore, PLLA was also found to provoke significant and more cell 
death (about 44%) than SPCL (about 24%) and SEVA-C (about 35%). Interestingly, the 
toxicity of SPLA70 (about 34%) was shown to be significantly higher than the toxicity of 
SPCL and lower than SCA (about 46%) but not different from SEVA-C and PLLA. It is 
important to remind herein that SPCL and SPLA70 have both 30% of starch and 70% of PLA 
or PCL. 
Thus, based on the LDH quantification, PLLA could be considered to be the material with 
higher index of cytotoxicity after SCA, and SPCL the less harmful. The toxicity index of SCA 
can be explained due to the release of low molecular weight chains released to the extraction 
medium, which are responsible for a pH drop therefore inducing cell death. 
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Figure 3.2. Effect of the concentrations of the extract of several starch-based polymers on the 
intracellular LDH activity when compared with controls and reference materials. The results obtained 
in the presence of neat extract of SEVA-C were found to be significantly different from the results 
obtained in the presence of SCA and PLLA. Furthermore, SPCL was found to induce a significant 
different behaviour when comparing to SCA, PLLA and SPLA70. SCA and SPLA70 were also found to 
be different. 
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3.3.2 Cell Proliferation 
The proliferation of osteoblast-like cells evaluated after incubation with the extracts of the 
degradable materials in study showed that their degradation products affect that cellular 
parameter (Fig. 3.3). The quantification of DNA showed that SEVA-C and SPCL were the 
two polymers which had less effect on cell proliferation, respectively 26% and 28% of growth 
inhibition, presenting a result close to the negative control. Again, these results are quite 
promising for biodegradable polymers. Furthermore the statistical comparison of the results 
obtained with the neat extract of those two materials and each one of the other polymers 
showed that the reduction in cell proliferation was significantly different. The blend of starch 
with poly-lactic acid followed SPCL in terms of percentage of inhibition of cell proliferation 
(about 31%). PLLA was the material which provoked the second highest reduction in cell 
proliferation (about 35%) and SCA was again the material with the most negative properties 
inducing around 57% of inhibition of osteoblast-like cells proliferation. As mentioned before, 
the presence of low molecular weight chains in the SCA extract affected the cellular 
metabolism inducing, in some cases, cell dead and delaying proliferation of the less affected 
cells. 
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Figure 3.3. Effect of the concentrations of the extract of several starch-based polymers on the 
quantified total DNA when compared with controls and reference materials. Only in the presence of 
SEVA-C and SPCL neat extracts the effect in cell proliferation was found to be similar to negative 
control. 
 
The quantification of total protein confirmed the majority of the results obtained with the DNA 
methodology (Fig. 3.4). Again the results obtained with the extracts of SEVA-C and SPCL 
revealed to be comparable to those obtained for the negative control and significantly 
different from all the other materials. While those two polymers induced about 43% of 
inhibition in cell proliferation, SCA and PLLA which results were not statistically different, 
provoked an inhibition closer to the positive control and of about 63%. The amount of total 
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protein measured after incubation with the extract of SPLA70 did not show any effect with 
increasing concentration of extract. In fact, the cell proliferation was affected for the 25% 
extract concentration, with a decrease of about 17% in cell proliferation, but did not change 
for higher concentrations of extract. This might be an indicator that the incorporation of starch 
into the poly-lactic acid positively influences cell response. 
Therefore, SCA together with PLLA were shown to negatively affect the proliferation of 
osteoblast-like cells in higher extent while SEVA-C and SPCL presented a comparable 
performance to TCPS. 
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Figure 3.4. Effect of the concentrations of the extract of several starch-based polymers on the amount 
of total protein, as compared to controls and reference materials. The amount of protein and 
consequently the effect on cell proliferation was found not to be different between neat extracts of 
SEVA-C and SPCL, the less toxic, and SCA and PLLA the more harmful. 
 
3.3.3 Cell Adhesion 
The presence of a substrate to adhere constitutes an important variable in understanding the 
biocompatibility of newly developed biomaterials. Despite good cell behaviour in the 
presence of biomaterials extracts, it might be possible that, when in direct contact with the 
materials, the surface properties are not the most suitable for an optimal cell response. 
Osteoblast-like cells were therefore cultured in direct contact with the polymers in study and 
cell morphology was analysed after 3 and 7 days. Considering the cell viability and 
proliferation analysis performed with the extracts of the materials, SEVA-C and SPCL were 
expected to be the best surfaces for cell adhesion. Figure 3.5 A and B show cells adhered to 
the surface of SEVA-C respectively after 3 and 7 days of culture. Cells present the typical 
morphology of osteoblastic cells; a polygonal shape with cytoplasm extensions looking for 
adhesion points on the surface of the materials. SEVA-C appears to present appropriate 
physico-chemical properties for SaOs-2 to adhere and proliferate since the surface of the 
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sample after 7 days of culture was almost fully covered. However, and contrarily to what was 
expected, cells adherent to SPCL did not show the characteristic morphology of osteoblast-
like cells (Fig. 3.6 C and D). Although spread, cells did not seem to be strongly adhered 
which may prevent an adequate long-term cell response (Fig. 3.5A). In addition, the 
proliferation rate of these cells did not seem to be comparable to cells adhered to SEVA-C 
since SPCL surface area occupied by cells, after 7 days of culture, was less significant (Fig. 
3.6D). 
Like for SPCL, the extract of SPLA70 did not significantly affect the behaviour of SaOs-2 but 
its adhesion performance on the surface of that polymer was not as good as it could be 
expected in particular for earlier times of culture (Fig. 3.6E). Some of the adherent cells 
presented the typical morphology of osteoblast-like cells but there were a great number of 
cells that seemed flatten and not so well adherent the surface (Fig. 3.5B). Despite this, after 
7 days of culture an almost confluent layer of cells was covering the surface of SPLA70 (Fig. 
3.6F) showing that cell proliferation is not affected by the surface of this polymer.  
Comparing SPLA70 with PLLA, the extract of PLLA showed a more damaging effect on cell 
viability and proliferation. However, the surface of the material was found to induce good 
adhesion behaviour (Fig. 3.6 G and H). Cells presented a morphology representative of an 
ideal adjustment to the surface with strong adhesion. Cell proliferation, like for SPLA70, did 
not seem to be affected also resulting in an almost fully covered surface after 7 days of 
culture (Fig. 3.6H). 
Again, the worst results for SCA extracts were confirmed by the adhesion tests (Fig. 3.6 I 
and J). Cells on the surface of starch with cellulose acetate presented a round morphology 
and did not proliferate for longer culture times.    
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Figure 3.5. Scanning electron micrograph showing SaOs-2 cultured on the surface of SPCL for 3 days 
(A) and SPLA70 for 1 day (B). Bar represents 20µm. 
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Figure 3.6. Optical micrographs showing SaOs-2 cultured on the surface of biodegradable polymers 
for 3 and 7 days and stained with methylene blue. A, B - SEVA-C; C, D - SPCL; E, F - SPLA; G, H - 
PLLA; I, J – SCA. A, C, E, G, I – 3 days of culture; B, D, F, H, J – 7 days of culture.  Small squares on 
the upper corner represent an area of the micrograph at higher magnification. Bar represents 100µm. 
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3.4. DISCUSSION 
The present study represents a multi-endpoint approach which provides information about 
different cellular functions. The aim was to use four alternative methods determine the 
cytotoxicity of the degradation products of biodegradable biomaterials at different levels. As 
typically toxic substances do not act at one specific level but affect several cellular functions8, 
we determined how toxic leachables acted at cellular and sub-cellular levels the measuring 
the activity of mitochondrial and cytoplasmic enzymes and quantifying DNA and total protein 
content. 
Some discussion23,30-32 arises when comparing different methodologies to determine cell 
cytotoxicity, but statistically significant correlation between assay techniques were also 
reported33,34. Some authors32,34 defend that the measurement of an intracellular parameter 
such as DNA content may be a more sensitive tool for the estimation of the cytotoxic 
potential of a test material. Furthermore, MacNair et al31 demonstrated that LDH assay is 
inferior in terms of sensitivity since it represents a terminal event while the measurement of 
total cell protein content was presented as a more sensitive index of cytotoxicity.  
In this work, however, when comparing the results obtained for MTT and LDH we could 
suggest that intracellular LDH is a more sensitive index of toxicity. In the LDH quantification 
assay higher levels of than originally thought (after the MTT test) of statistically different 
toxicity levels were found for the majority of the materials. As some of these materials were 
considered, after the MTT test, to have a similar toxic behaviour these results are clearly 
indicative of the higher sensitivity of the LDH technique.  
Analysing the results of DNA and total protein quantification our findings are in accordance 
with the literature. The DNA measurement proved to be more sensitive than the 
determination of total protein. 
Based in the obtained results, we may also speculate that proliferating cells may be more 
sensitive than the resting cells to a toxic challenge therefore the cytotoxicity trend be different 
for some materials when comparing the methodologies used to evaluate cell viability and cell 
proliferation.  
A great challenge in the development of novel biomaterials is to support the interpretation of 
the cytotoxicity results in the characteristics of the materials. In particular, degradable 
polymers display variable behaviour in biological systems, depending on various properties 
such as molecular weight1, hydrophobicity35, distribution of charge22, residual monomer36 and 
pH of the degradation products3. Therefore, these factors, combined with the degradation 
kinetics, are important in determining the toxicity of potential biomaterials. The pH and 
osmolarity of polymer extracts have been suggested to be related to the toxicity of 
polymers4,37 and dependent on the amounts of solubilised monomers and oligomers38. In 
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fact, pH influences cell behaviour and viability and acidic ph lower than the physical pH of the 
cells can cause a toxic response33,39 and osmolarity is a factor that can exert an influence on 
proliferation, morphology and cell activity36. 
From the toxicity data in this work it appears that the material with higher index of cytotoxicity 
is SCA. This is the material with higher capability to uptake water therefore with higher 
predisposition for degradation. I addition SCA is a non-miscible blend  which affects the 
kinetics of degradation releasing higher amounts of low molecular weight chains to the 
extraction medium at early stages of immersion. In fact, the extraction medium (culture 
medium with phenol red) showed a slight change of colour indicative of acidification; thus it is 
possible that the low molecular weight chains released to the medium are responsible for the 
pH decrease and consequently for the cytotoxicity. 
The pH of the extraction medium does not seem to be responsible for the degree of toxicity 
observed for the other materials. Although not as obvious as for SCA, there are some 
differences between the materials, in terms of cytotoxicity, that might be attributed to the 
degradation products of the polymers. In fact, Ignatius et al12 reported studies in buffer 
solutions where PLLA toxicity was attributed to the degradation products themselves. In 
another work4 the low pH of the water incubated PLA specimens was attributed to their 
degradation and the resulting concentration of lactic acid in the exposure medium. It can be 
speculated that since the pH of the extraction medium does not change, the toxicity 
presented by the PLLA extracts, mainly affecting cell proliferation is due to the interaction of 
the cells with the products of degradation. Previous works with starch-based biomaterials40-42, 
in particular with SEVA-C and SCA extracts incubated with other type of cells, have shown 
promising results. Thus the cytotoxicity of SCA can be attributed to the high amount of low 
molecular weight chains and processing additives, which can be removed by an additional 
processing stage.42      
Cytotoxicity tests with extracts are usually defined as indirect contact tests. In our groups we 
defend that these should be complemented with direct contact tests since materials may 
display differences in cytotoxicity depending on cell-material contact arrangements. Cell-
material contact can in a way reduce the sensitivity of an in vitro system but also influence 
cell viability, probably due to chemical interactions18,43. The shape44 and surface texture43,45 
of an implant are other important factors, determining the tissue response although a 
conclusive mechanism is not yet established.  
Cell adhesion experiments performed in this work demonstrate that besides the extracts of 
the materials the three-dimensional forms of the polymers have to be tested as the results of 
cell behaviour may drastically change. This was the case of the blend of starch with 
polycaprolactone (SPCL) which did not present significant toxicity but when in direct contact 
with the materials showed reduced cell adhesion and delayed proliferation rate. Contrarily, 
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SCA confirmed to be the less suitable surface for cell adhesion as was expected by the 
cytotoxicity test. However, other studies46,47 with SPCL and SCA showed that these two 
materials processed under different conditions and shapes aiming for example tissue 
engineering purposes, support cell adhesion. 
The different percentages of starch and the miscibility and the starch-based blends might 
also have some influence in the biological performance of those biomaterials. SEVA and 
SCA, both with 50% of starch could be expected to induce a similar behaviour however, SCA 
is a non-miscible blend which can contribute to a completely different surface in terms of 
starch and synthetic component exposure and consequently cell adhesion. In addition the 
two starch blends with 30% of starch SPCL and SPLA70 also presented very distinct cell 
adhesion results. This might indicate that in this case the synthetic component rules cell 
adhesion and proliferation and we can speculate that increasing the percentage of starch in 
the blend with polycaprolactone would improve those actions.  
Thus specific surface properties have pivotal role on cell adhesion behaviour. Studies with 
pure PCL showed that it has an hydrophilic surface and osteoblast-like cells appear to prefer 
more hydrophobic surfaces35. Contrarily, Yang et al18 reported less adhesion and 
differentiation of bone-marrow stromal cells onto hydrophobic surfaces due to less adsorption 
of fibronectin. The starch-based blend SPCL is more hydrophobic than the other materials 
which are in accordance with Yang et al18. However, other authors48 suggest that some 
chemical groups have more significant role in cell adhesion than the general surface 
properties. For example, the oxygen content of SEVA-C, lower than SPCL and SCA49, seems 
to be the most suitable for the adhesion of SaOs-2 under the studied conditions. 
 
3.5 CONCLUSIONS 
The data generated by this battery of assays allow for a response on the cytotoxic potential 
of materials or devices with a higher grade of certainty. In addition it also provides the 
guaranty that if the leachables from the materials interfere with one test system the results 
are not misinterpreted. 
It was also possible to prove that not only the extract of the materials but also their three-
dimensional form has to be biologically tested in order to analyse material-associated 
parameters that are not possible to consider within the degradation extract.  
Therefore, both direct and indirect tests allowed to determine that SCA induced significant 
cytotoxicity and did not present the ideal surface properties for osteoblast-like cells adhesion 
and proliferation. Contrarily, SPCL extract was not deleterious for cells but did not support 
their proliferation. Comparatively to the gold standard biodegradable biomaterial, SEVA-C 
and SPCL showed a better behaviour than PLLA in terms of cytotoxicity. The adhesion and 
proliferation of osteoblast-like cells on SEVA-C and SPLA70 was however, comparable to 
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PLLA which indicates the good potential of the majority of the starch-based biomaterials 
tested for bone related applications.  
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CHAPTER 4 
HYDROXYAPATITE REINFORCEMENT OF DIFFERENT STARCH-BASED POLYMERS 
AFFECTS OSTEOBLAST-LIKE CELLS ADHESION/SPREADING AND PROLIFERATION 
Marques, A. P.1,2 and Reis, R. L.1,2 
1 3B’s Research Group – Biomaterials, Biodegradables, Biomimetics, University of Minho, 
Campus de Gualtar, 4710-057 Braga, Portugal  
2 Department of Polymer Engineering, University of Minho, Campus de Azurém, 4810-058 
Guimarães, Portugal 
 
ABSTRACT 
The aim of this study was to determine which, from a range of the starch-based biomaterials, 
would be more suitable to be used in orthopaedic applications. This included blends of corn 
starch and ethylene vinyl alcohol (SEVA-C), corn starch and cellulose acetate (SCA), corn 
starch and polycaprolactone (SPCL) and its composites with increasing percentages of 
hydroxyapatite (HA). The polymers and composites were cultured in direct contact with 
osteoblast-like cells (SaOs-2) and the effect of the incorporation and of increasing 
percentages of the ceramic in osteoblast adhesion/proliferation has been assessed. In the 
evaluation of cell adhesion and proliferation rate, two variables were considered; cells 
adhered to the bottom of the tissue culture polystyrene (TCPS) wells and cells adhered to the 
surface of the materials, in order to distinguish respectively: i) the effect of possible 
degradation products released from the materials to the culture medium and ii) of the surface 
properties on the osteoblast-like cells. In addition, the morphology of cells adherent to the 
surface of the starch-based polymers was analysed and correlated with their topography and 
with other chemical properties previously evaluated. 
The proliferation rate was found to differ from blend to blend as well as with the time of 
culture and with the presence of HA depending on the material. SEVA-C and respective 
composites systematically presented the higher number of cells comparatively to the other 
two blends. SPCL composites were found to be less suitable for cell proliferation. The 
amount of cells quantified after 7 days of culture, both on the surface and on the wells 
showed a delay in the proliferation of the cells on SPCL composites surfaces as compared to 
other materials and to TCPS. SCA composites however, did support cell adhesion but also 
induce a slight level of toxicity which results in delayed proliferation on the cells adhered to 
the wells. 
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Cell morphology on the surface of the materials was also, in almost every case, found to be 
appropriate. In fact, cells were well adhered and spread on the majority of the surfaces. 
Thus, starch-based biomaterials can be seen as good substrates for osteoblast-adhesion 
and proliferation which demonstrates their potential for their use in orthopaedic applications 
and as bone tissue engineering scaffolds. 
 
4.1. INTRODUCTION 
The evaluation of the biocompatibility of newly developed biomaterials involves numerous 
steps aiming to assess its safety and suitability for a proposed application. Following the 
early screening stage where cytotoxicity is evaluated, other concerns, directly correlated with 
the future application of the materials, arise. Studies start to be performed using in vitro 
culture of cells that will face the implant1. For example, the evaluation of biomaterials 
proposed for orthopaedic applications has been performed using osteoblast-like cells2-4 
and/or primary cultures of osteoblasts2,5-7. These are cultured in direct contact with the 
materials to be tested providing a rapid, sensitive and cost-effective in vitro evaluation, 
relevant to the function of the device. One of the most important parameters to evaluate is 
cell adhesion. While for some applications, such as hemocompatibility8, a reduced cell 
adhesion is desired, for others, such as orthopaedics7,9,10, enhanced cell adhesion and 
proliferation is required. Following adhesion, cells can experience activation which might be 
evidenced through a variety of processes including spreading, migration, proliferation and 
biosynthetic activity. Although the precise mechanisms of integrin-related events have not yet 
been fully elucidated, those processes have been correlated with changes in cell survival, 
cell proliferation and cellular differentiation.11-13 Cell spreading involves complex cytoskeleton 
reorganisation and is an essential function of cell that had become adherent to a surface. 
Proliferation follows cell spreading and it is central for materials designed to be integrated 
into host tissues. Osseointegration for example is critical in orthopaedic applications.14
Cell adhesion and consequent states depend not only on the cell type15,16 but also on the 
physical and chemical properties of the material surface13,17,18. Firstly these properties control 
the layer of proteins primarily adsorbed to the material which interact with the integrins, cell-
membrane proteins that determine the adhesion and migration behaviour as well as cell 
morphology19,20. Although the protein layer adsorbed to the surface of the materials is known 
to mediate that cell-material interaction, protein adsorption appears neither to be related to a 
specific site of the substrate nor to induce specific orientation of the ligand. Proteins regulate 
early events, however they probably also initiate signalling cascades which regulate long-
term events such as protein production.12
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Previous works18,21-23 have demonstrated that surface topography and surface chemistry play 
important roles in cell orientation. Therefore, not only cell adhesion, proliferation and 
differentiation, but also cell morphology, give information about the appropriateness of newly 
developed biomaterials for a specific application and can be modulated by controlling the 
surface of the materials. 
In the present study, starch-based blends with different synthetic components previously 
proposed to be used in a wide range of biomedical applications24-27, were reinforced with 
increasing percentages of hydroxyapatite (HA) in order to evaluate the effect of the presence 
and amount of the ceramic in the behavior of osteoblast-like cells in terms of cell 
adhesion/morphology and proliferation. Hydroxyapatite is a bioactive material known to 
promote the differentiation of osteoblastic cells in vitro28-30. Moreover, it was suggested31 that 
the proteins adsorbed to the surface of HA induced a specific spreading behavior therefore 
affecting subsequent proliferation and differentiation.  
 
4.2. MATERIALS AND METHODS 
4.2.1 Materials 
The materials studied were: i) a 50/50 (wt %) blend of corn starch and ethylene vinyl alcohol 
(SEVA-C), ii) SEVA-C reinforced with 10%, 20% and 30% (wt) of hydroxyapatite (HA, 
Plasma Biotal, UK), iii) a 50/50 (wt %) blend of corn starch and cellulose acetate (SCA), iv) 
SCA reinforced with 10%, 20% and 30% (wt) of hydroxyapatite, v) a 30/70 (wt %) blend of 
corn starch and polycaprolactone (SPCL) and vi) SPCL reinforced with 10%, 20% and 30% 
(wt) of hydroxyapatite. In the composites the average size of 90% of the HA particles was 
found to be below 6.5 µm (laser granulometry analysis). 
All the materials were processed into circular samples (∅ 1cm) by injection moulding and 
sterilised by ethylene oxide under the conditions previously described24. 
 
4.2.2 Cell Culture 
A human osteosarcoma cell line SaOs-2, an immortalized cell line with an osteoblastic 
phenotype, was obtained from European Collection of Cell Cultures (ECCC, UK). The cells 
were cultured in DMEM (Gibco BRL, Life Technologies, USA) supplemented with 10% of 
heat-inactivated fetal bovine serum (FBS; Biochrom AG, Germany), 100000 U/ml penicillin-
G, 100 µg/ml streptomycin and 25µg/ml amphotericin B (Sigma Chemical Co, USA) and 20 
mM Hepes (Sigma Chemical Co, USA) in a humidified atmosphere with 5% CO2 and at 
37°C. 
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Cells were trypsinised (0.25% trypsin/EDTA solution, Sigma Chemical Co, USA) from a 
culture flask and 1.5 ml of cell suspension, in fresh culture medium (3,3 x 10-4 cells/ml) were 
seeded onto the materials. Three samples per material per time of growth were studied and 
tissue culture polystyrene (TCPS) wells were used as control. The 24-well plates were 
incubated for 1, 3 and 7 days. Culture medium was not changed until the end of the 
experiment. 
 
4.2.3 Microscopy Analysis 
After each time of culture the cells were washed with a 0.1M phosphate buffered saline 
(PBS, Sigma Chemical Co, USA) solution fixed with 2.5% glutaraldehyde (BDH, UK) solution 
in PBS for 30 minutes at 4°C, washed and kept in PBS at 4°C until being stained or prepared 
for scanning electron microscopy (SEM) observation. 
The surface of the materials was therefore stained with a 0.4% methylene blue solution in 
water for 1 minute and examined in a stereomicroscope Zeiss KL 1500 (Zeiss, Germany). 
For SEM, samples were dehydrated in graded ethanol solutions (70%, 90%, and 100%) 
twice, 15 minutes each and let to dry overnight. Samples were gold sputter coated in a 
Sputter Jeol JFC 1100 and observed on a Leica Cambridge S360 (Leica Cambridge, UK). 
 
4.2.4 Total Protein Quantification 
In the end of the incubation time the culture medium was removed, cells were washed with 
0.1M PBS. Materials were transferred to new 24-well plates and 100l and 500l of 0.1M 
PBS were add to each well, respectively of the initial and new culture plates. From this point 
on, the BCA Protein Assay kit (Pierce Chemical Co, USA) was used. This system utilises 
bicinchoninic acid (BCA) as the detection reagent for Cu+1, which is formed when Cu+2 is 
reduced by protein in an alkaline environment. The purple coloured reaction product is 
formed by the chelation of two molecules of BCA with one cuprous ion (Cu+1). This water-
soluble complex exhibits a strong absorbance at 562nm that is linear with increasing protein 
concentration. At the end of the assay, 100l of each sample from TCPS wells and materials 
were transferred to 96-well plates where a standard curve was prepared and the absorbance 
read in a multi-well plate reader (SpectraMax 340PC). 
 
4.2.5 Statistical Analysis 
The total protein was quantified in four separate experiments, each one carried out with four 
replicates for each material. 
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All data was averaged and standard deviation is reported as a measure of sample deviation. 
The data for the neat extracts was statistically compared by a one way ANOVA analysis 
using a Tukey test32. If probability values were less than 0.05 (p<0.05), differences observed 
for the two materials were considered statistically significant. 
 
4.3. RESULTS 
4.3.1 Cell adhesion/proliferation quantification 
Previously to the establishment of the protocol, serial concentrations of cells were cultured in 
order to prove its proportionality with the total protein amount and also to define the initial 
amount of seeded cells.   
The results obtained in the total protein quantification assay were presented as the amount 
of protein measured from cells adhered to the materials (Fig. 4.1 A, C, E) and from cells 
adhered to the bottom of the TCPS wells used (Fig. 4.1 B, D, F). The aim was to distinguish 
the effects of the surface of the polymers studied and of possible toxic degradation products 
that would affect not only cells on the surface but also the cells adhered to the well. In the 
majority of the cases the obtained results were quite good and not typical for other types of 
biodegradable polymers. 
 
4.3.1.1. SEVA-C and Composites 
It was observed that osteoblast-like cells have a preference for the polymer and composites 
with a matrix of starch and ethylene vinyl alcohol (Fig. 4.1A). After one day of culture the 
amount of cells adhered to those materials was higher than the number of cells present in 
the control TCPS. In fact this difference was found to be statistically different. However, after 
3 days the proliferation rate of cells in the control material allowed to reach numbers 
comparable to the ones observed for cells adhered to SEVA-C and composites. An 
exception was observed for SEVA-C+20%HA, which seemed to delay cell proliferation in 
such an extent that the amount of total protein after 3 days on that materials was statistically 
lower than on the TCPS. After 7 days of culture and as expected, the number of cells on the 
surface of SEVA-C and composites was found to be statistically lower than on the control. 
From day 3 to day 7 however, cells on those starch-based biomaterials proliferate at a 
considerable rate, and although SEVA-C +20% of HA seemed to be the less appropriated for 
cell growth, it was not found to induce a statistically different result from SEVA-C or the other 
composites with 10% and 30% of HA. Therefore, the reinforcement with HA did not seem to 
have a significant direct effect in the adhesion/proliferation of osteoblast-like cells on the 
surface of starch-ethylene vinyl alcohol blend, for these times of culture. 
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Considering the effect of the presence of SEVA-C and its composites in the metabolism of 
cells adherent to the bottom of the wells, there were no statistically significant differences 
between these materials for any of the times of culture (Fig. 4.1B). The amount of total 
protein was lower than the one measured for cells on the surface of those materials except 
for SEVA-C+10%HA and SEVA-C+20%HA which were comparable. This might be explained 
by a stronger effect of the surface properties of these materials in contrast with the effect of 
possible degradation products. For 1 and 3 days the number of adhered cells in the wells in 
the presence of SEVA-C and composites was found to be statistically lower when comparing 
to the results obtained for SCA+20%HA. Therefore, higher adhesion to the bottom of the 
well, comparatively to SEVA-C and composites, was observed for other starch-based 
materials; at the same time a higher number of cells was observed on the surface of SEVA-C 
and its composites. In addition, after 7 days the number of cells in the wells the presence of 
SEVA-C composites is higher than in the presence of SCA composites, statistically 
significant comparatively with SCA+30%HA. We might speculate that at early culture times 
osteoblast-like cells consider the surface of SEVA-C and its composites “friendly” enough to 
adhere/proliferate instead of migrating to the TCPS and a possible equilibrium starts to be 
established for longer culture times. 
 
4.3.1.2. SPCL and Composites 
The results obtained for SPCL and its composites were considerably different to what was 
observed for the blend of starch-ethylene vinyl alcohol. The number of cells quantified on the 
surface of SPCL and respective composites was statistically lower comparatively with SEVA-
C and its composites at day 1. Interestingly, for this same time of culture the amount of total 
protein obtained from cells adhered to SPCL and its composites was comparable to the 
value obtained for control (TCPS) (Fig. 4.1C). At day 3 however, the proliferation rate in the 
TCPS had prevailed inclusively being statistically higher than on the surface of SPCL and 
SPCL+20%HA. Furthermore the number of cells on the surface of SPCL was also found to 
be statistically lower comparatively to SEVA-C and SEVA-C+10%HA for the same time of 
culture. As observed for the materials of starch-ethylene vinyl alcohol, after 7 days of culture 
the number of cells quantified for the TCPS was statistically higher than for SPCL and 
composites. 
Contrarily to what was observed for the starch-ethylene vinyl alcohol blend, the 
reinforcement of SPCL had a quite strong effect on osteoblast-like cell behaviour in particular 
for longer times of culture. At day 7 SPCL composites were no longer suitable for cell 
proliferation presenting a number of adherent cells statistically lower than the unreinforced 
polymer (SPCL) and SEVA-C and its composites with 10% and 30%HA.  
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The measurement performed in the wells where osteoblast-like cells were cultured with the 
blend of starch-polycaprolactone, showed completely distinct results. Comparing the values 
obtained for the different materials of the two blends at each time of culture, only in the 
presence of SEVA-C the cell number was found statistically lower than in the presence of 
SPCL+30%HA (Fig. 4.1D). For 1 days however, the number of cells in the wells in the 
presence of SPCL, SPCL+10%HA and SPCL+30%HA was found to be statistically lower 
comparatively to SCA+20%HA. After 7 days this difference was again noted between SPCL 
and SCA+30%HA. Contrarily, at the same time of culture in the wells in contact with 
SPCL+20%HA and SPCL+30%HA the number of cells was statistically higher than in contact 
with SCA+10%HA.  
Apparently the effect of the degradation products of the starch-ethylene vinyl alcohol and 
starch-polycaprolactone blends was not significant and no correlation could be made. 
Nonetheless, and contrarily to what was found for SEVA-C and respective composites, the 
amount of total protein in the wells was higher than on the surface of SPCL and respective 
composites for all the times of culture. Thus, the surface of these starch-based biomaterials 
does not seem to be preferred over the TCPS wells. Taking into account that after 7 days of 
culture SPCL composites did not support a higher number of cells than after 3 days, it would 
be expected that the number of cells on the wells, where those materials were present, 
would be higher. However the obtained values were comparable to those measured in the 
presence of the unreinforced polymer (SPCL) which demonstrates that the properties of the 
surface of the SPCL composites are in fact ruling and delaying osteoblast-like proliferation on 
its surfaces.  
 
4.3.1.3. SCA and Composites 
The number of cells quantified on the surface of SCA and respective composites, as 
observed for the blend of starch-polycaprolactone, was statistically lower comparatively with 
SEVA-C and its composites at day 1. At this time of culture no difference was observed 
comparing to the control TCPS although after 3 days the amount of protein in the starch-
cellulose acetate materials, except SCA+10%HA, was already significantly lower. At the end 
of the assay, SCA and its composites presented a significantly lower adhesion/proliferation 
on their surfaces comparatively to TCPS. In the third day of culture, no significant differences 
were observed between the amount of cells quantified on the surface of SCA and its 
composites and on the surface of the other materials. Differences occurred at day 7 with 
differences between SEVA-C and respective composites and SCA+30%HA and between 
SPCL+10% and SPCL+20%HA and SCA+20%HA, which were found to be the SCA 
composites respectively with lower and higher number of cells at this time point. 
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As for the starch-ethylene vinyl alcohol blend, the reinforcement of SCA with HA did not have 
a significant effect on osteoblast-like cells adhesion although SCA+30%HA presented the 
lowest amount of total protein.  
Contrarily to the other two starch-based blends the degradation products of SCA composites 
had an effect on cell adhesion and proliferation on the wells of the materials. After 7 days of 
culture for increasing percentages the number of total protein decreased and for the 
unreinforced material the number of cells was higher in the wells and not on the surface of 
the materials. Thus, in the case of SCA and composites the reinforcement of the polymer 
could be favourable for cell adhesion if the effect of the degradation rate and consequently of 
the degradation products did not mask the effect of the surface properties. Comparatively to 
the polymer without HA, we would say that the surface properties of the composites are more 
favourable for osteoblast-like cells adhesion and proliferation since the amount on their 
surfaces is comparable even in the presence of proliferation delaying molecules. 
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Figure 4.1. Amount of total protein quantified in osteoblast-like cells (SaOs-2) cultured in direct 
contact with SEVA-C and its composites (A, B), SPCL and composites (C, D) and SCA and its 
composites (E, F) for 1, 3 and 7 days. Total protein was quantified on the materials (A, C, E) and wells 
(B, D, F). Data represents mean ± standard deviation, n≥3. *Indicates significant difference when 
comparing with TCPS (Control). +Indicates significant difference when comparing with SEVA-C and 
SEVA-C composites. ¤Indicates significant difference when comparing with SEVA-C. #Indicates 
significant difference when comparing with SPCL. $Indicates significant difference when comparing 
with SPCL composites. xIndicates significant difference when comparing with 
SCA+20%HA. ºIndicates significant difference when comparing with SCA+30%HA. 
Indicates significant difference between the connected bars. 
 
4.3.2 Surface topography 
The morphology of the materials analysed by SEM, showed that SEVA-C possesses a quite 
irregular surface with some areas of intense irregularities (Fig. 4.2A). At higher magnification 
it was possible to note that SEVA-C surface is highly asymmetrical with some areas rougher 
than others although this blend has been reported33 to be an inter-penetrating network (IPN). 
After the incorporation of 10% of HA, the surface of the material has become uniform 
although the presence of HA particles seemed to introduce a rough character to this 
composite (Fig. 4.2B). The SEVA-C composite with 20% of HA showed again a rather 
inhomogeneous surface (Fig. 4.2C) that even seemed to have, in comparison with the 
composite with 10%HA, some smoother areas. The increasing in the percentage of HA 
incorporated from 20% to 30% did not show significant changes in surface topography (Fig. 
4.2D). In fact HA particles are dispersed all over the surface and we might speculate that the 
difference between those two composites would be the amount of HA granules on the 
surface. Thus the topography/morphology of the surfaces of the polymers and composites of 
starch with ethylene vinyl alcohol has changed with the incorporation of HA. 
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Figure 4.2. Scanning electron micrograph showing the surface topography of (A) SEVA-C, (B) SEVA-
C+10%HA, (C) SEVA-C+20%HA, (D) SEVA-C+30%HA; Original magnification x 350. Small squares 
on the upper corner represent an area of the micrograph at higher magnification (x 1000). Bar = 100 
µm. 
 
 
 
100 µm 100 µm
100 µm 100 µm
DC 
BA  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Scanning electron micrograph showing the surface topography of (A) SPCL, (B) 
SPCL+10%HA, (C) SPCL+20%HA, (D) SPCL+30%HA. Original magnification x 350. Small squares 
on the upper corner represent an area of the micrograph at higher magnification (x 1000). Bar = 100 
µm. 
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Contrarily to the surfaces of SEVA-C and composites, SPCL and SPCL reinforced with HA 
presented smoother surfaces (Fig. 4.3). In addition, the reinforcement of the SPCL polymer 
with HA may have introduced some roughness the surfaces of the composites, in particular 
to SPCL+30%HA. These differences are not notorious and HA particles were not clearly 
observed on the surface of SPCL composites.  
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Figure 4.4. Scanning electron micrograph showing the surface topography of (A) SCA, (B) 
SCA+10%HA, (C) SCA+20%HA, (D) SCA+30%HA. Original magnification x 350. Small squares on 
the upper corner represent an area of the micrograph at higher magnification (x 1000). Bar = 100 µm. 
 
The morphology of the surface of SCA was not comparable to any of the other starch-based 
biomaterials (Fig. 4.4A). This material was quite rough and the reinforcement of SCA with HA 
has resulted, in this blend in a notorious way, in rougher surfaces for increasing percentages 
of ceramic. Since SCA is the more immiscible blend, the HA particles were visibly present in 
the surface and in great amounts for SCA+30%HA (Fig. 4.4D).   
 
4.3.3 Cell adhesion/morphology 
The adherence of osteoblast-like cells on the surface of starch-based materials was 
assessed after methylene blue staining. Cells were adhered all over the surface of SEVA-C 
and composites after 1 and 3 days of culture (Fig. 4.5 A, C, E, G) presenting the typical 
polygonal shape of osteoblastic cells, therefore showing the suitability of the substrates for 
adherence.  
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Figure 4.5. Optical micrograph of osteoblast-like cells (SaOs-2) stained with methylene blue cultured 
on SEVA-C and its composites for 3 and 7 days. Bar = 100µm 
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The morphology of the cells was analysed in detail by SEM which allowed to see that cells 
have different morphologies when adhered to SEVA-C comparatively to its composites (Fig. 
4.6). After 3 days of culture there were some completely spread cells with extended 
lamelipodia to the material but also some cells still starting to flatten (Fig. 4.6A). These cells 
presented filopodia towards the material with some of them already showing lamelipodia. In 
the case of SEVA-C composites cells were much more spread, highly connected with the 
surface (Fig. 4.6B). Only few cells were showing filopodia and in the direction of HA particles. 
However, no significant differences were observed for different percentages of 
reinforcement. After 7 days of culture, as it was demonstrated by total protein quantification, 
cells proliferated well on the surface of those materials. In fact some areas of the samples 
were covered with a monolayer of cells (Fig. 4.5 B, D, F, H), again indicating that SEVA-C 
and respective composites possess appropriated properties for osteoblast-like cells 
adhesion. The SEM observation of these surfaces after 7 days of culture proved that cells 
were completely spread on the surface forming a monolayer. On SEVA-C it was however still 
possible to distinguish the cell contours while in the case of composites cells were 
interconnected being impossible to delineate each one of them. 
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Figure 4.6. Scanning electron micrograph of osteoblast-like cells (SaOs-2) on (A) SEVA-C and (B) 
SEVA-C+20%HA after 3 days of culture. Bar = 20µm. 
 
The adhesion of osteoblast-like cells on SPCL and respective composites was, at early times 
of culture and in terms of cell distribution and morphology, similar to what was observed for 
SEVA-C and SEVA-C composites. Cells seemed to show the typical osteoblastic morphology 
although this was more obvious for SPCL composites with 20% and 30% of HA (Fig. 4.7 A, 
C, E, G). SEM evaluation of cell morphology showed that cells on the surface of SPCL and 
SPCL+10%HA were spread on the surface and merging other cells in the periphery (Fig. 4.8 
A, B). These observations were not exactly the same for cells adhered to the surface of 
SPCL+20%HA and SPCL+30%HA. Cells were also spread, in a higher extent on 
SPCL+20%HA, but it was possible to distinguish independent cells. Thus increasing 
-------------------------------------------------------------------------------------------------------------------------------------------------------------  111 ---- 
----Chapter 4 - Hydroxyapatite reinforcement of different starch-based polymers affects osteoblast-like cells adhesion/spreading and proliferation--- 
 
percentages of HA did not seem to favour cell spreading and proliferation on the surface of 
SPCL materials. 
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Figure 4.7. Optical micrograph of osteoblast-like cells (SaOs-2) stained with methylene blue cultured 
on SPCL and its composites for 3 and 7 days. Bar = 100µm 
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After 7 days of culture, the results obtained for total protein quantification were proved once 
again. SPCL composites were found not to be the ideal substrate for cell proliferation (Fig. 
4.7 D, F, H). Cells were starting to form agglomerates in certain areas of the surface of the 
composites contrarily to what was observed on the surface of the unreinforced SPCL, which 
showed cells all over the surface (Fig. 4.7 B). In fact the SEM observation showed that the 
cells on the surface of SPCL materials were starting to retract after 7 days of culture. The 
majority of the cells was not spread starting to extend filopodia, which seems to be an 
attempt to remain attached to the surfaces. Thus, although the surface properties of SPCL 
and its composites were suitable for initial cell attachment and adhesion, it was found that for 
increasing times of culture and consequent changes on the surface characteristics as time 
goes by may render those surfaces improper (less adequate) for osteoblast-like proliferation.  
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Figure 4.8. Scanning electron micrograph of osteoblast-like cells (SaOs-2) on (A) SPCL, (B) 
SPCL+10%HA, (C) SPCL+20%HA and (D) SPCL+30%HA after 3 days of culture. Bar = 20µm. 
 
Comparatively to the other blends, the starch-cellulose acetate did not support so well 
osteoblast-like cell attachment and adhesion. For all the times of culture cells did not present 
the characteristic morphology of osteoblasts and were preferential adhered to some areas of 
the surface instead of being all over it (Fig. 4.9). In addition, the differences between SCA 
and its composites did not seem to be significant.  
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Figure 4.9. Optical micrograph of osteoblast-like cells (SaOs-2) stained with methylene blue cultured 
on SCA and its composites for 3 and 7 days. Bar = 100µm 
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The detailed observation of cell morphology confirmed that although adhered to the SCA and 
respective composites using cytoplasm extensions, the majority of the cells were not spread 
and its nucleus was prominent and easily identifiable (Fig. 4.10). The amount of spread 
osteoblasts, comparatively to round cells, on the surface of SCA was still considerable after 7 
days (Fig. 4.10A) which may constitute a good sign in terms of suitability of this material for 
cell adhesion and proliferation. However, for higher percentages of HA, the amount of spread 
cells decreases (Fig. 4.10 B, C, D). Thus contrarily to what should be expected, in the 
presence of HA, the morphology of osteoblasts on the surface of SCA composites did not 
seem to be ideal for cell proliferation.    
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Figure 4.10. Scanning electron micrograph of osteoblast-like cells (SaOs-2) on (A) SCA, (B) 
SCA+10%HA, (C) SCA+20%HA and (D) SCA+30%HA after 7 days of culture. Bar = 20µm 
 
4.4. DISCUSSION 
Surface characteristics of the materials, whether their topography23,30, chemistry21,30,34,35 or 
surface energy29,36, play an essential part in osteoblasts adhesion to biomaterials. 
Attachment, adhesion and spreading belong to the first phase of cell/material interaction and 
the quality of this stage influence the capacity of cells to proliferate and differentiate itself on 
contact with the implant.12  
Cell attachment represents the translation of certain physico-chemical events involving the 
chemical interaction between cells and materials.12 This is followed by cell adhesion which is 
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the result of biological processes such as production of extracellular matrix proteins, 
cytoskeleton proteins reorganisation among others.12 Cell adhesion and spreading were 
shown to be clearly distinguishable biological phenomena because substrates that allow cell 
adhesion do not necessary promote cell spreading37. Furthermore, it was previously 
suggested38 that surfaces that show good cell attachment at early time points do not 
necessarily promote cell proliferation or differentiation.  
This study was performed in order to determine which of the starch-based biomaterials would 
be more suitable for the development of biomedical device for orthopaedic applications and 
bone tissue engineering scaffolding. The effect of the incorporation and of increasing 
percentages of a ceramic in osteoblast adhesion/proliferation was also assessed for the 
three starch-based materials. The experiment was set in order to distinguish the effect of the 
surface properties on the adhesion/proliferation rate of osteoblast-like cells from possible 
degradation products released from the materials to the culture medium. Furthermore, cell 
morphology was also analysed and correlated with the topography of the surface of the 
materials. 
Cell growth capacity has been shown be influenced by different chemistries of the 
materials.21,30,34,35 For example, hydroxyl groups are known to enhance cell adhesion and 
growth39,40. These groups are responsible for higher surface polarity and hydrophilicity of the 
surface13. However, a correlation between these two parameters has not been a consensus. 
Some authors15,41,42 defend that cell adhesion is generally better on hydrophilic surface. 
However, other studies11,13,28 showed that osteoblast-like cells do not display a consistent 
trend of behaviour in relation to surface wettability but rather varied as a function of particular 
functional groups. Studies29,36 with osteoblasts suggested that cell adhesion was greatly 
influenced by the polar interaction energy, which emphasises the role of surface energy in 
this biological process. 
Due to their starch component, the materials in study have high number of hydroxyl groups 
on their surfaces. In addition SCA is the more hydrophilic material and possesses higher 
content of oxygen43. Thus it would be expected, based on this properties, that the blend of 
starch with cellulose acetate would have higher number of cells adhered to its surface. 
However, SEVA-C with the lowest oxygen content and a less hydrophilic43 surface than SCA 
presented higher cell adhesion and a regular proliferation rate. SCA is a non miscible blend 
and due to its higher water uptake capability and degradation rate experiences more and 
more rapidly changes on its surface which definitely determine and influence cell behaviour. 
In addition to chemistry, osteoblasts react differently according to surface topography23,30  
and roughness4,22,40,44. Rougher surfaces were shown to reduce proliferation of osteoblast-
like4,44 and human bone derived cells22,45. In addition, the initial adhesion of osteoblast-like 
cells was shown to be greater on polished (smoother) surfaces.4
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A direct relationship exists between roughness and surface energy of the materials and it 
was demonstrated that the apolar component of surface energy increased significantly with 
roughness.46 Furthermore, it was reported47 that for relatively low surface roughness values, 
cell responses to the surface chemistry are more important than the physical surface. 
In terms of topography, starch-based biomaterials presented different surfaces apparently 
showing irregularities that might influence cells adhesion. SPCL polymer seems to have the 
smoother surface48. Therefore, the wettability and roughness of SPCL would indicate that this 
material did not present the best properties for cell adhesion. However, cells adhered to its 
surface similarly to SEVA-C which might suggest that roughness plays a more important role 
than wettability in cell adhesion to SPCL. In addition, the oxygen content of SPCL is similar 
to SCA43 and we could suggest that it also has a role in osteoblast-like cells adhesion to 
SPCL. 
After cells contact surfaces they will alter their cell membrane and its morphology to stabilise 
the cell-material interface49. When cell adhesion was followed by progressive flattening of the 
cells, proliferation occurred50. 
Some studies11,13,22,51 demonstrated ultrastructural differences in cell spreading and filopodia 
forming in dependence on a surface even if no differences in the percentage of adherent 
cells were observed51. Filopodia, finger-like protrusions of plasma membrane formed as a 
consequence of actin assembling in long bundles or lamellipodia if assembled in the form of 
mesh supporting sheet-like protrusions are morphological details, characteristic of cell 
adhesion.12  
Morphological aspects, like cell adhesion and proliferation, have also been shown to be 
influenced by different chemistries of the materials.11,13,15,30 A critical value for the surface 
energy of the substratum above which cell spreading occurs, was previously established.20 
Likewise, cytoskeleton organisation and cell morphology are regulated by surface 
wettability11,36. Cell attachment and spreading are generally greater on certain moderately 
hydrophilic surfaces relative to hydrophobic ones11,36.  
Surface wettability of starch-based materials definitely influences cell morphology. SEVA-C 
materials with intermediate hydrophilicity has shown highly spread osteoblast-like cells on its 
surface while cells on the surface of SCA, the most hydrophilic material, were adhered but 
not flat or spread. Interestingly enough, the hydrophobic surface of SPCL material supported 
cell adhesion and spreading for early but not for longer culture times. Osteoblasts are also 
shown to recognise substrate morphology and to respond by altering their spreading 
degree52,53. Several studies4,22 have demonstrated that cell spreading and continuous cell 
layer formation was better on smooth surfaces compared to rough ones. However, Bigerelle 
et al54 suggested that topography below the cell scale favours polygonal morphology of 
osteoblasts although when the topography was considered above the cell scale they also 
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appreciate the roughness which may explain cells being  spread and flattened on surfaces 
considered rough52. Morphologically, cell layer organisation was also modified by the 
roughness of the underlying substrates22. Our results are, in some extent, in accordance with 
these observations; the rougher material, SCA, showed the lower osteoblast flattening 
degree. However, on the smoother surface (SPCL) cells were very spread at short culture 
times but the surface was not able to support a cell layer.  
As the surface characteristics determine how proteins adsorb to the surface55,56 and more 
particularly determine the orientation of those adsorbed molecules17,57 proteins constitute 
another variable in the cell attachment/adhesion process. Fibronectin (Fn) and vitronectin 
(Vn) have been shown to be involved in osteoblast adhesion in vitro22,58-60 although they 
preferentially adhere to Fn59-61. However, the surface charge or the material might counteract 
this response60. Fn undergoes greater conformational change when adsorbed onto 
hydrophobic surfaces than on hydrophilic ones while the conformational changes on 
adsorption of Vn is substrate independent56-58. In addition, in vitro cell attachment was shown 
to be primarily mediated by Vn due to its ability to adsorb to the substrate in competition to 
other serum proteins.19,58,62 Attachment to TCPS in vitro also depends on Vn adsorption.62
A previous study33 with starch-based polymers and protein adsorption from serum showed 
that vitronectin is the protein that adsorbs in higher amount to those materials. Furthermore, 
SPCL was the material with higher amount of adsorbed Vn in comparison with SEVA-C and 
SCA33. Thus, it is likely that this protein plays a major role in the initial cell attachment to 
SPCL. The surface properties determine that initially Vn, when adsorbed onto this polymer 
will adopt a conformation that is ideal for cell attachment which becomes less favourable or 
desorbs from the surface with increasing periods of culture.  
Bone has been shown to mechanically react to an HA surface in vivo14. However, the in vitro 
attachment and growth of osteoblast cells on HA ceramics or other biodegradable polymer 
reinforced with it has been reported3,9 to be significantly low compared to a range of 
orthopaedic biomaterials.  
When osteoblasts were cultured with HA particles, the cell population was significantly 
decreased63. Fine particles of HA, normally a non-toxic material were shown to cause cell 
damage in vitro64, which depend on the direct contact between cells and particles resulting in 
cell membrane damage. On the other hand, the test material may have a low level of toxicity 
which, although not sufficient to kill cells, may inhibit normal cell function. The intracellular 
dissolution of calcium-containing crystals was also proved to greatly influence cell 
behaviour65,66 Osteoblasts have been implicated in calcium-phosphate degradation2,67,68 
which lead to a significantly inhibition growth. The explanation suggests that the presence of 
HA particles and its intracellular solubilisation could adversely affect homeostatic 
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mechanisms and mechanical regulators of DNA synthesis can be modified without any 
expression of cytotoxic effect2. 
In another study69, the degradation of hydroxyapatite powders was also associated with poor 
cellular response but in this case the effect was attributed to an increase in the amount of 
impurity ions released. High phosphate ions concentration released from ceramics has also 
been suggested as being inhibitory to cell activity5. 
Previous short and long-term studies70-72 with SEVA-C-based HA composites and different 
types of cell lines have shown promising results which were confirmed in this study. The 
release of HA particles during the experiment may only constitute an explanation for SCA 
composites since it was only with these materials that the proliferation rate on TCPS was 
kept or reduced and only for longer times of culture. In fact SCA is the material with higher 
water uptake capability and a higher access to the inner HA particles within the composite 
and a higher susceptibility to hydrolysis at the interface polymer-HA comparatively to the bulk 
of the material. The easier access to those interfaces facilitates the degradation of the 
material with the release of not only HA particles but also low molecular weight chains 
responsible for a pH drop. Thus, for the periods of time tested the amount of released HA 
particles may induce some inhibitory activity on the osteoblasts. 
Furthermore, the surface properties of SPCL composites were shown to be inappropriate for 
cell proliferation. In this particular case, HA particles itself do not seem to be responsible for 
this behaviour. In turn, the incorporation of the ceramic seemed to have affected the surface 
properties in such way that between 3 and 7 days osteoblast decreased its proliferation rate. 
The composition and topography of HA composites influenced the morphology of cells, 
showing that cell spreading was more pronounced on exposed HA regions of the 
composite73. In addition, human osteoblasts showed propensity for spreading at early time 
points on surfaces containing exposed HA particles73.  
A slow rate of osteoblast-like proliferation on HA as well as weak affinity of fibronectin to that 
ceramic has been previously reported74 and associated with the physicochemical 
characteristic of the material. In another study31, vitronectin and fibronectin were not only 
found to adsorb to HA but also to participate in the osteoblast spreading on that material. 
In this work one could confirm that, in comparison to unreinforced polymer, starch-based 
composites induced more pronounced cell spreading. The miscibility character of each one 
of the starch-based blends also determines the exposure of the HA particles within the 
samples. Thus, SCA as the more immiscible blend and the more hydrophilic material, 
presented higher amount of HA on its surface and higher access to the HA particles in the 
bulk of the composite, was expected to show higher spreading of osteoblasts. However, the 
spreading of osteoblasts on SCA composites was not as notorious as on SEVA-C and SPCL 
composites. 
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4.5 CONCLUSIONS 
The results reported in this study indicate that the physico-chemical properties of starch-
based biomaterials influenced adhesion, proliferation and morphology/spreading of 
osteoblast-like cells. Depending on the starch blend, thus on its synthetic component and the 
properties that it confers to the surface, cells proliferate at different rates. Furthermore, the 
incorporation of hydroxyapatite also had different effects according to the polymer matrix 
used. In the case of SCA it seemed to change its degradation behaviour and consequently 
the degradation products released to the culture medium which delayed cell proliferation. In 
the case of SPCL, the incorporation of HA induced changes in the surface properties that 
induced cell detaching for longer culture times. Different percentages of HA did not seem to 
change significantly osteoblast-like cell behaviour. 
Overall results indicate that starch-based biomaterials present characteristics of cell 
adhesion/spreading and proliferation that are not disappointing considering their degradable 
nature. In fact as shown in other works these polymers and composites may find several 
applications in orthopaedics and tissue engineering scaffolding. 
 
REFERENCES 
1. CJ Kirkpatrick, F Bittinger, M Wagner, H Kohler, TG van Kooten, CL Klein and M Otto. Current 
trends in biocompatibility testing. Proc Inst Mech Eng [H] 1998;212:75. 
2. B Alliot-Licht, M Gregoire, I Orly and J Menanteau. Cellular activity of osteoblasts in the presence of 
hydroxyapatite: an in vitro experiment. Biomaterials 1991;12:752. 
3. HM Elgendy, ME Norman, AR Keaton and CT Laurencin. Osteoblast-like cell (MC3T3-E1) 
proliferation on bioerodible polymers: an approach towards the development of a bone-bioerodible 
polymer composite material. Biomaterials 1993;14:263. 
4. L Bacakova, V Stary, O Kofronova and V Lisa. Polishing and coating carbon fiber-reinforced carbon 
composites with a carbon-titanium layer enhances adhesion and growth of osteoblast-like MG63 cells 
and vascular smooth muscle cells in vitro. J Biomed Mater Res 2001;54:567. 
5. C Knabe, R Gildenhaar, G Berger, W Ostapowicz, R Fitzner, RJ Radlanski and U Gross. 
Morphological evaluation of osteoblasts cultured on different calcium phosphate ceramics. 
Biomaterials 1997;18:1339. 
6. H Zreiqat, CR Howlett, A Zannettino, P Evans, G Schulze-Tanzil, C Knabe and M Shakibaei. 
Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic 
implants. J Biomed Mater Res 2002;62:175. 
7. MJ Dalby, L Di Silvio, N Gurav, B Annaz, MV Kayser and W Bonfield. Optimizing HAPEX 
topography influences osteoblast response. Tissue Eng 2002;8:453. 
8. MC Belanger and Y Marois. Hemocompatibility, biocompatibility, inflammatory and in vivo studies of 
primary reference materials low-density polyethylene and polydimethylsiloxane: a review. J Biomed 
Mater Res 2001;58:467. 
9. DA Puleo, LA Holleran, RH Doremus and R Bizios. Osteoblast responses to orthopedic implant 
materials in vitro. J Biomed Mater Res 1991;25:711. 
10. L Calandrelli, B Immirzi, M Malinconico, G Orsello, MG Volpe, F Della Ragione, V Zappia and A 
Oliva. Biocompatibility studies on biodegradable polyester-based composites of human osteoblasts: A 
preliminary screening. J Biomed Mater Res 2002;59:611. 
-------------------------------------------------------------------------------------------------------------------------------------------------------------  120 ---- 
----Chapter 4 - Hydroxyapatite reinforcement of different starch-based polymers affects osteoblast-like cells adhesion/spreading and proliferation--- 
 
11. JH Lee, JW Lee, G Khang and HB Lee. Interaction of cells on chargeable functional group 
gradient surfaces. Biomaterials 1997;18:351. 
12. K Anselme. Osteoblast adhesion on biomaterials. Biomaterials 2000;21:667. 
13. P Filippini, G Rainaldi, A Ferrante, B Mecheri, G Gabrielli, M Bombace, PL Indovina and MT 
Santini. Modulation of osteosarcoma cell growth and differentiation by silane-modified surfaces. J 
Biomed Mater Res 2001;55:338. 
14. S Santavirta, D Nordstrom, P Ylinen, YT Konttinen, T Silvennoinen and P Rokkanen. 
Biocompatibility of hydroxyapatite-coated hip prostheses. Arch Orthop Trauma Surg 1991;110:288. 
15. JH Lee, SJ Lee, G Khang and HB Lee. Interaction of fibroblasts on polycarbonate membrane 
surfaces with different micropore sizes and hydrophilicity. J Biomater Sci Polym Ed 1999;10:283. 
16. HL Wang, M Miyauchi and T Takata. Initial attachment of osteoblasts to various guided bone 
regeneration membranes: an in vitro study. J Periodontal Res 2002;37:340. 
17. BD Boyan, TW Hummert, DD Dean and Z Schwartz. Role of material surfaces in regulating bone 
and cartilage cell response. Biomaterials 1996;17:137. 
18. K Anselme, P Linez, M Bigerelle, D Le Maguer, A Le Maguer, P Hardouin, HF Hildebrand, A Iost 
and JM Leroy. The relative influence of the topography and chemistry of TiAl6V4 surfaces on 
osteoblastic cell behaviour. Biomaterials 2000;21:1567. 
19. CH Thomas, CD McFarland, ML Jenkins, A Rezania, JG Steele and KE Healy. The role of 
vitronectin in the attachment and spatial distribution of bone-derived cells on materials with patterned 
surface chemistry. J Biomed Mater Res 1997;37:81. 
20. JM Schakenraad, HJ Busscher, CR Wildevuur and J Arends. Thermodynamic aspects of cell 
spreading on solid substrata. Cell Biophys 1988;13:75. 
21. H Zreiqat, P Evans and CR Howlett. Effect of surface chemical modification of bioceramic on 
phenotype of human bone-derived cells. J Biomed Mater Res 1999;44:389. 
22. K Anselme, M Bigerelle, B Noel, E Dufresne, D Judas, A Iost and P Hardouin. Qualitative and 
quantitative study of human osteoblast adhesion on materials with various surface roughnesses. J 
Biomed Mater Res 2000;49:155. 
23. MJ Dalby, L Di Silvio, GW Davies and W Bonfield. Surface topography and HA filler volume effect 
on primary human osteobasts in vitro. J Mater Sci Mater Med 2000;12:805. 
24. RL Reis, SC Mendes, AM Cunha and MJ Bevis. Processing and in vitro degradation of 
starch/EVOH thermoplastic blends. Polymer International 1997;43:347. 
25. PB Malafaya, C Elvira, A Gallardo, J San Roman and RL Reis. Porous starch-based drug delivery 
systems processed by a microwave route. J Biomed Sci Polym Edn 2001;12:1227. 
26. I Espigares, C Elvira, JF Mano, B Vázquez, J San Roman and RL Reis. New partially degradable 
and bioactive acrylic bone cements based on starch blends and ceramic fillers. Biomaterials 
2002;23:1883. 
27. ME Gomes, JS Godinho, D Tchalamov, AM Cunha and RL Reis. Alternative tissue engineering 
scaffolds based on starch: processing methodologies, morphology, degradation and mechanical 
properties. Mater Sci Eng C 2002;20:19. 
28. K Webb, V Hlady and PA Tresco. Relationships among cell attachment, spreading, cytoskeletal 
organization, and migration rate for anchorage-dependent cells on model surfaces. J Biomed Mater 
Res 2000;49:362. 
29. SA Redey, M Nardin, D Bernache-Assolant, C Rey, P Delannoy, L Sedel and PJ Marie. Behavior 
of human osteoblastic cells on stoichiometric hydroxyapatite and type A carbonate apatite: role of 
surface energy. J Biomed Mater Res 2000;50:353. 
30. U Mayr-Wohlfart, J Fiedler, KP Gunther, W Puhl and S Kessler. Proliferation and differentiation 
rates of a human osteoblast-like cell line (SaOS-2) in contact with different bone substitute materials. J 
Biomed Mater Res 2001;57:132. 
31. T Matsuura, R Hosokawa, K Okamoto, T Kimoto and Y Akagawa. Diverse mechanisms of 
osteoblast spreading on hydroxyapatite and titanium. Biomaterials 2000;21:1121. 
-------------------------------------------------------------------------------------------------------------------------------------------------------------  121 ---- 
----Chapter 4 - Hydroxyapatite reinforcement of different starch-based polymers affects osteoblast-like cells adhesion/spreading and proliferation--- 
 
32. PR Kinneard and CD Gray. SPSS for windows: made simple. Hove: Psychology Press; 1999. 
33. CM Alves, RL Reis and JA Hunt. Preliminary study on human protein adsorption and leukocyte 
adhesion to starch-based biomaterials. J Mater Sci: Mater Med 2003;14:157. 
34. H Zreiqat, C McFarland and CR Howlett. The effect of polymeric chemistry on the expression of 
bone-related mRNAs and proteins by human bone-derived cells in vitro. J Biomater Sci Polym Ed 
1999;10:199. 
35. Y Ikarashi, T Tsuchiya and A Nakamura. Effect of heat treatment of poly(L-lactide) on the 
response of osteoblast-like MC3T3-E1 cells. Biomaterials 2000;21:1259. 
36. KE Healy, CH Thomas, A Rezania, JE Kim, PJ McKeown, B Lom and PE Hockberger. Kinetics of 
bone cell organization and mineralization on materials with patterned surface chemistry. Biomaterials 
1996;17:195. 
37. CJ Kirkpatrick and A Dekker. Quantitative evaluation of cell interaction with biomaterials in vitro. 
Adv. Biomaterials 1992;10:31. 
38. U Meyer, DH Szulczewski, K Moller, H Heide and DB Jones. Attachment kinectics and 
differentiation of osteoblasts on different biomaterials. Cell Mater 1993;3:129. 
39. V Svorcik, V Rybka, V Hnatowicz and L Bacakova. Polarity, resistivity and biocompatibility of 
polyethylene doped with carbon black. J Mater Sci Lett 1995;14:1723. 
40. B Feng, J Weng, BC Yang, SX Qu and XD Zhang. Characterization of surface oxide films on 
titanium and adhesion of osteoblast. Biomaterials 2003;24:4663. 
41. JG Steele, G Johnson, KM McLean, GJ Beumer and HJ Griesser. Effect of porosity and surface 
hydrophilicity on migration of epithelial tissue over synthetic polymer. J Biomed Mater Res 
2000;50:475. 
42. K Cai, K Yao, S Lin, Z Yang, X Li, H Xie, T Qing and L Gao. Poly(D,L-lactic acid) surfaces modified 
by silk fibroin: effects on the culture of osteoblast in vitro. Biomaterials 2002;23:1153. 
43. I Pashkuleva, AP Marques, F Vaz and RL Reis. Surface modification of starch based blends using 
potassium permanganate-nitric acid system and its effect on the adhesion and proliferation of 
osteoblast-like cells. J Mater Sci Mater Med 2004:In press. 
44. JY Martin, Z Schwartz, TW Hummert, DM Schraub, J Simpson, J Lankford, Jr., DD Dean, DL 
Cochran and BD Boyan. Effect of titanium surface roughness on proliferation, differentiation, and 
protein synthesis of human osteoblast-like cells (MG63). J Biomed Mater Res 1995;29:389. 
45. D De Santis, C Guerriero and PF Nocini. Adult human bone cells from jaw bones cultured on 
plasma-sprayed or polished surfaces of titanium or hydroxiapatite discs. J Mater Sci Mater Med 
1996;7:21. 
46. M Lampin, C Warocquier, C Legris, M Degrange and MF Sigot-Luizard. Correlation between 
substratum roughness and wettability, cell adhesion, and cell migration. J Biomed Mater Res 
1997;36:99. 
47. H Zreiqat, OC Standard, T Gegenbach, JG Steele and CR Howlett. The role of surface 
characteristics in the initial adhesion of human bone-derived cells on ceramics. Cell Mater 1996;1-
3:45. 
48. AP Marques, IB Leonor, RL Reis and J Hunt. In vitro evaluation of the effect of starch-based 
biodegradable polymers in human leukocytes. 28th Annual Meeting of The Society for Biomaterials, 
Tampa, Florida, USA, 2002; p 647. 
49. T Okano, N Yamada, M Okuhara, H Sakai and Y Sakurai. Mechanism of cell detachment from 
temperature-modulated, hydrophilic-hydrophobic polymer surfaces. Biomaterials 1995;16:297. 
50. TH Young, CH Yao, JS Sun, CP Lai and LW Chen. The effect of morphology variety of EVAL 
membranes on the behavior of myoblasts in vitro. Biomaterials 1998;19:717. 
51. U Geissler, U Hempel, C Wolf, D Scharnweber, H Worch and K Wenzel. Collagen type I-coating of 
Ti6Al4V promotes adhesion of osteoblasts. J Biomed Mater Res 2000;51:752. 
-------------------------------------------------------------------------------------------------------------------------------------------------------------  122 ---- 
----Chapter 4 - Hydroxyapatite reinforcement of different starch-based polymers affects osteoblast-like cells adhesion/spreading and proliferation--- 
 
52. JH Wang, CH Yao, WY Chuang and TH Young. Development of biodegradable polyesterurethane 
membranes with different surface morphologies for the culture of osteoblasts. J Biomed Mater Res 
2000;51:761. 
53. K Matsuzaka, XF Walboomers, M Yoshinari, T Inoue and JA Jansen. The attachment and growth 
behavior of osteoblast-like cells on microtextured surfaces. Biomaterials 2003;24:2711. 
54. M Bigerelle, K Anselme, B Noel, I Ruderman, P Hardouin and A Iost. Improvement in the 
morphology of Ti-based surfaces: a new process to increase in vitro human osteoblast response. 
Biomaterials 2002;23:1563. 
55. U Jonsson, B Ivarsson, I Lundstrom and L Berghem. Adsorption behavior of fibronectin on well 
characterized silica surfaces. J Colloid Interface Sci 1982;90:148. 
56. WG Pitt, DF Fabrizius-Homan, DF Mosher and SL Cooper. Vitronectin adorption on polystyrene 
and oxidized polystyrene. J Colloid Interface Sci 1989;129:231. 
57. CD McFarland, S Mayer, C Scotchford, BA Dalton, JG Steele and S Downes. Attachment of 
cultured human bone cells to novel polymers. J Biomed Mater Res 1999;44:1. 
58. JG Steele, BA Dalton, G Johnson and PA Underwood. Polystyrene chemistry affects vitronectin 
activity: an explanation for cell attachment to tissue culture polystyrene but not to unmodified 
polystyrene. J Biomed Mater Res 1993;27:927. 
59. CR Howlett, MDM Evans, WR Walsh, G Johnson and JG Steele. Mechanism of initial attachment 
of cells derived from human bone to commonly used prosthetic materials during cell culture. 
Biomaterials 1994;15:213. 
60. CH Thomas, CD McFarland, ML Jenkins, A Rezania, JG Steele and KE Healy. The role of 
vitronectin in the attachment and spatial distribution of bone-derived cells on materials with patterned 
surface chemistry. J Biomed Mater Res 1997;37:81. 
61. A El-Ghannam, P Ducheyne and IM Shapiro. Effect of serum proteins on osteoblast adhesion to 
surface-modified bioactive glass and hydroxyapatite. J Orthop Res 1999;17:340. 
62. PA Underwood and FA Bennett. A comparison of the biological activities of the cell-adhesive 
proteins vitronectin and fibronectin. J Cell Sci 1989;93 ( Pt 4):641. 
63. JS Sun, HC Liu, WH Chang, J Li, FH Lin and HC Tai. Influence of hydroxyapatite particle size on 
bone cell activities: an in vitro study. J Biomed Mater Res 1998;39:390. 
64. EJ Evans. Toxicity of hydroxyapatite in vitro: the effect of particle size. Biomaterials 1991;12:574. 
65. RW Evans, HS Cheung and DJ McCarty. Cultured human monocytes and fibroblasts solubilize 
calcium phosphate crystals. Calcif Tissue Int 1984;36:645. 
66. HS Cheung and DJ McCarty. Mitogenesis induced by calcium-containing crystals. Role of 
intracellular dissolution. Exp Cell Res 1985;157:63. 
67. T Takahashi, N Kurihara, K Takahashi and M Kumegawa. An ultrastructural study of phagocytosis 
in bone by osteoblastic cells from fetal mouse calvaria in vitro. Arch Oral Biol 1986;31:703. 
68. M Gregoire, I Orly and J Menanteau. The influence of calcium phosphate biomaterials on human 
bone cell activities. An in vitro approach. J Biomed Mater Res 1990;24:165. 
69. S Best, B Sim, M Kayser and S Downes. The dependence of osteoblastic response on variations 
in the chemical composition and physical properties of Hydroxyapatite. J Mater Sci Mater Med 
1997;8:97. 
70. ME Gomes, RL Reis, AM Cunha, CA Blitterswijk and JD de Bruijn. Cytocompatibility and response 
of osteoblastic-like cells to starch-based polymers: effect of several additives and processing 
conditions. Biomaterials 2001;22:1911. 
71. SC Mendes, RL Reis, YP Bovell, AM Cunha, CA van Blitterswijk and JD de Bruijn. Biocompatibility 
testing of novel starch-based materials with potential application in orthopaedic surgery: a preliminary 
study. Biomaterials 2001;22:2057. 
72. AP Marques, RL Reis and JA Hunt. The biocompatibility of novel starch-based polymers and 
composites: in vitro studies. Biomaterials 2002;23:1471. 
-------------------------------------------------------------------------------------------------------------------------------------------------------------  123 ---- 
----Chapter 4 - Hydroxyapatite reinforcement of different starch-based polymers affects osteoblast-like cells adhesion/spreading and proliferation--- 
 
73. SC Rizzi, DJ Heath, AG Coombes, N Bock, M Textor and S Downes. Biodegradable 
polymer/hydroxyapatite composites: surface analysis and initial attachment of human osteoblasts. J 
Biomed Mater Res 2001;55:475. 
74. A El-Ghannam, P Ducheyne and IM Shapiro. Porous bioactive glass and hydroxyapatite ceramic 
affect bone cell function in vitro along different time lines. J Biomed Mater Res 1997;36:167. 
 
 
-------------------------------------------------------------------------------------------------------------------------------------------------------------  124 ---- 
  
 
 
 
 
 
 
 
 
 
 
SECTION III 
 
IMMUNOCOMPATIBILITY OF STARCH-BASED 
BIOMATERIALS: POLYMERS AND COMPOSITES 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
------------Chapter 5- Evaluation of the potential of starch-based biodegradable polymers in the activation of human inflammatory cells --- 
 
CHAPTER 5 
EVALUATION OF THE POTENTIAL OF STARCH-BASED BIODEGRADABLE 
POLYMERS IN THE ACTIVATION OF HUMAN INFLAMMATORY CELLS 
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ABSTRACT 
The inflammatory response resulting from the implantation of a medical device may 
compromise its performance and efficiency leading, in certain cases, to the failure of the 
implant. Thus, the assessment of the behaviour of inflammatory cells in vitro, constitutes a 
key feature in the evaluation of the adverse potential, or not, of new promising biomaterials. 
The objectives of this study were to determine whether starch-based polymers and 
composites activated human neutrophils. 
Blends of starch with ethylene-vinyl alcohol (SEVA-C), with cellulose acetate (SCA) and 
polycaprolactone (SPCL), as well as composites based on all these materials filled with 
hydroxyapatite (HA) have been studied. A lysozyme assay was adapted to examine enzyme 
secretion from human neutrophils incubated with different starch-based materials. Changes 
in the free radical and degranulation activity of the neutrophil were also determined by 
measuring the luminescent response of Pholasin®, a photoprotein that emits light after 
excitation by reactive oxygen species. The amount of lysozyme secreted by neutrophils 
incubated with the polymers did not exhibit significant differences between the tested 
materials. Results were in all cases similar to those obtained for the control (polystyrene) 
except for one of the starch blends (corn starch with polycaprolactone reinforced with 
30%(w/w) of HA). 
The chemiluminescence experiments showed that polymers reduce the signal produced by 
activated neutrophils. Furthermore, for some polymers it was demonstrated that the 
phenomenon was due to an effect of the surface of the materials in cell adhesion or a 
simultaneous competition for the photoprotein in solution, which results in the decrease of 
the intensity of light emitted and detected. 
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5.1. INTRODUCTION 
Following the implantation of any medical device, the wound healing mechanisms are 
triggered in response to injury and to the presence of a foreign body. The inflammatory 
response constitutes one of the stages of that complex process aiming to eliminate the cause 
of injury and any accompanying micro-organisms and to initiate the repair of the surrounding 
tissues. Biomaterials are not totally inert to the surrounding tissues and thus, an inflammatory 
reaction is produced by any biomaterial, the severity and duration of which can vary 
according to the properties of the material.1  
Polymorphonuclear leukocytes (PMNs) are the first cells to arrive at the implant site after 
surgery. They play a very important role in host defence processes being stimulated by a 
variety of agents. Their activation may result in several processes such as chemotaxis, 
phagocytosis, degranulation and production of O2- in a metabolic event known as respiratory 
burst2,3. 
 Degranulation of neutrophils causes the release of granule contents into the surrounding 
tissue, which contain human neutrophils peptides, also known as defensins4. Defensins 
perform intracellularly by permeabilising and killing microorganisms5 and outside the 
phagocytic vacuoles by acting as a chemotaxin for monocytes and lymphocytes6,7. 
Lysosomes contain numerous types of enzymes that are secreted into the tissues during 
degranulation and frustrated phagocytosis causing severe injury.8 Neutral proteases such as 
elastase and collagenase, acid hydrolases and lysozyme are some examples.9-11
Together with degranulation the microbicidal activity of neutrophils can result from 
mechanisms dependent on oxygen.12 The oxygen-dependent mechanisms consume oxygen 
as an electron acceptor in reaction initiated by the activation of a multicomponent electron 
transfer system, the NADPH-oxidase.13 In this way  toxic unstable superoxide anions are 
produced which can be dismuted by superoxide dismutase to antimicrobial hydrogen 
peroxide.14
A massive and generalised activation of leukocytes may however, impair the host by the 
excessive release of oxygen radicals and enzymes. This response by leukocytes in the 
presence of biomaterials can be considered an important measure for biocompatibility for this 
reason alone. The factors that minimize inflammation will maximize biocompatibility.15 The 
multiple responses possible during leukocyte activation and an incomplete understanding of 
their interactions, lead to the need to measure more than one response to characterise the 
extent of activation. 
Starch-based biodegradable polymers and composites have been proposed for several 
biomedical applications16-19. Biocompatibility studies were already made20-22 and the aim of 
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this work was to evaluate the potential of these materials in the activation of human 
inflammatory cells using two complementary techniques. 
Neutrophils were isolated from peripheral human blood and challenged, in vitro, with different 
starch-based polymers and composites. The amount of lysozyme released from neutrophils 
after incubation with the materials was quantified by means of an assay previously adapted 
for this type of evaluation.23 The oxidative burst of neutrophils in the presence of the 
materials was measured by chemiluminescence. Two cell stimulants, formyl-methionyl-
leucyl-phenylalanine (fMLP) and phorbol-myristate-acetate (PMA) were used as positive 
controls for both assays. 
 
5.2. MATERIALS AND METHODS 
5.2.1 Materials 
The materials studied were: i) a 50/50 (wt %) blend of corn starch and ethylene vinyl alcohol 
(SEVA-C, Novamont, Italy), ii) SEVA-C reinforced with 10%, 20% and 30% (wt) of 
hydroxyapatite (HA, Plasma Biotal, UK), iii) a 50/50 (wt %) blend of corn starch and cellulose 
acetate (SCA, Novamont, Italy), iv) SCA reinforced with 10%, 20% and 30% (wt) of 
hydroxyapatite, v) a 30/70 (wt %) blend of corn starch and polycaprolactone (SPCL, 
Novamont, Italy) and vi) SPCL reinforced with 10%, 20% and 30% (wt) of hydroxyapatite. In 
the composites the average size of 90% of the HA particles was found to be below 6.5 µm 
(laser granulometry analysis). 
Poly-L-Lactide (PLLA, Purac biochem bv, The Netherlands), being the gold standard for 
biodegradables in biomedical applications, was used as a biodegradable control material and 
borosilicate glass coverslips (BDH, England) for chemiluminescence tests. 
All the materials, both the polymers and the composites were processed into circular 
samples (∅ 1cm) by injection moulding.  
 
5.2.2 Neutrophil Isolation 
Neutrophils were isolated from fresh heparinised peripheral human blood collected from 
healthy volunteers. Blood was mixed with a 6% dextran solution, settled and the supernatant 
layered onto lymphocyte separation medium and centrifuged at 2400 rpm for 25 minutes at 
room temperature. The pellet was washed once with phosphate buffered saline (PBS) 
solution without calcium and magnesium and the remaining red blood cells were removed by 
water lysis. The cell suspension was washed twice with PBS without calcium and 
magnesium at 2400rpm for 5 minutes at room temperature. Cells were counted and kept at 
4°C until use. 
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5.2.3 Lysozyme Assay 
The isolated cells were resuspended in PBS with calcium and magnesium at a concentration 
of 1.5x106 cells/ml. Each material was incubated in polystyrene cuvettes with 1ml of cell 
suspension for 30 minutes at 37°C. A cuvette with cells alone was also used as the negative 
control. After incubation, the tubes were centrifuged at 2400 rpm for 5 minutes at 4°C and 0.5 
ml of the supernatants transferred to new tubes to which was added 0.5ml of Micrococcus 
Lysodeikticus (1.5mg/ml). These tubes were incubated for 30 minutes at 37°C. The lysozyme 
released by the neutrophils when in contact with the materials breaks down the cell wall of 
Micrococcus Lysodeikticus reducing the optical density of the suspension, which can be 
recorded using a spectrophotometer at a wavelength of 541nm. In order to quantify lysozyme 
secretion, a standard curve was prepared with dilutions of neutrophil lysate versus 
absorbance readings. 
 
5.2.4 Chemiluminescence 
Chemiluminescence is often used to study the neutrophil respiratory burst resulting from 
biomaterial interactions. 
Changes in the free radical and degranulation activity of the cells were measured by the 
luminescent response of Pholasin® a photoprotein that emits light after interaction with the 
reactive oxygen species. 
The isolated neutrophils were ressuspended in PBS without calcium and magnesium at a 
concentration of 1x106 cells/ml. Two luminometer cuvettes were prepared for each material 
with 390µl of HBSS/Hepes buffer, 100µl of Adjuvant-P™ (Abel® Cell Activation Test, Knight 
Scientific, UK) and 100µl of cell suspension. Two tubes with 100µl of buffer instead of cells 
were prepared as negative control and another two without any material to work as control in 
order to verify the activation potential of the cells. All the cuvettes were loaded into the 
luminometer (Luminometer 1250, LKB Wallace). The first cuvette was then automatically 
moved to the measuring chamber and 250µl of Pholasin® (Abel® Antioxidant Test, Knight 
Scientific, UK) injected, followed by successive cuvettes. The light output from the solution 
was measured every 250 seconds for 33minutes. At this point, 80µl of formyl-methionyl-
leucyl-phenylalanine (fMLP, 12µML-1) were injected into each cuvette in succession and the 
light emitted measured for 10 minutes after which 80 µl of phorbol-myristate-acetate (PMA, 
8µML-1) were injected into each tube. Measurements were then taken measuring the light 
emitted by each cuvette for a total time of 80 minutes. 
Peak luminescent values were determined plotting the amount of light emitted per second 
(mV) versus time. 
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5.2.5 Evaluation of polymers potential to quench light 
In order to assess the effect of the materials themselves on the reduction of the signal 
produced by activated neutrophils an antioxidant assay was performed in the absence of 
cells but in the presence of free radical donor reagents. 
Two replicates of each tube were prepared with 1.335ml of HBSS/Hepes buffer and 125µl of 
Pholasin® and loaded into the luminometer. After 2 minutes, 40µl of 3-morpholino-
sydnonimine HCl (SIN-1, 2.5mmolL-1, Abel® Antioxidant Test, Knight Scientific, UK) were 
injected to each tube. Superoxide and nitric oxide are simultaneously and continually 
released from the solution of SIN-1. If there are material interactions with the free radicals 
there will be a delay in the time at which the maximum peak of light is emitted or the 
magnitude of the peak. Empty cuvettes were the negative control. 
 
5.2.6 Statistical Analysis 
All data was averaged and standard deviation is reported as a measure of sample deviation. 
The effect of the tested materials on the release of lysozyme was compared statistically with 
Tukey-HDS test.24 All the materials were compared between themselves and the control. If 
probability values were less than 0.05 (p<0.05), differences observed for the two materials 
were considered statistically significant. 
 
5.3. RESULTS AND DISCUSSION 
5.3.1 Lysozyme 
Polymorphonuclear leukocytes comprise one of the immune systems first lines of defence 
through phagocytosis and destruction of microorganisms. Stimulated phagocytes release 
lysozomal enzymes and produce a large amount of superoxide anion with the secondary 
generation of more oxidant species, which result in non-specific damage to surrounding 
tissues and varying degrees of inflammation. 
Several factors influence the phagocytic activity at a biomaterial’s interface. It has been 
shown that the human PMN respiratory burst is influenced by the adhesion to a surface and 
by the wettability of that surface in the presence or absence of proteins.25-30
Lysozyme was released by neutrophils after incubation with the degradable materials in 
study; this was less than 20% of the potential lysed cell maximum for all of the materials (Fig 
5.1). Furthermore, neutrophils incubated with SEVA-C, all SEVA-C composites, SPCL, SCA 
reinforced with 10%HA and PLLA did not secrete lysozyme above the negative control 
(polystyrene test tube). SPCL composites stimulated more enzyme secretion and in fact, the 
results obtained for SPCL reinforced with 30% of HA are statistically different from those 
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obtained for SEVA-C polymer, all their composites and for PLLA and the control. Also for 
SPCL with 20% of HA and SEVA-C with 30% of HA, the difference in the amount of 
lysozyme secreted was significant at the level of 0.05. 
The amount of hydroxyapatite in each composite does not correlate with the amount of 
enzyme secreted in the presence of SEVA-C composites. However, in the case of SPCL, for 
higher percentages of HA, the quantity of lysozyme released tends to increase. The same 
type of behaviour was observed for SCA composites, although in this case the polymer 
without any reinforcement induced an even higher percentage of enzyme secretion than the 
composite with 30% of HA. This seems to indicate that the observed behaviour depends on 
the SCA matrix and when its amount is reduced becomes less intense. 
Higher responses have been detected after PMN interaction with hydrophilic surfaces in vitro 
and in vivo26,31 but in the presence of human serum, neutrophil adhesion and activation is 
triggered on hydrophobic surfaces in vitro27. 
SPCL, SCA and their composites seem to give rise to higher secretion of lysozyme than 
SEVA-C and its composites. As SPCL and SCA have extreme wettability properties, they are 
respectively the most hydrophobic and the most hydrophilic of the starch based blends (with 
a water contact of 70° and 55°, respectively). In fact, the incubation with SCA resulted in 
higher enzyme secretion, which can be a consequence of a higher cell interaction and 
activation previously reported for hydrophilic surfaces26,31. 
One might speculate that SCA composites would induce the highest neutrophil response. 
The capacity of those materials to uptake water is higher than the polymer without 
reinforcement due to the interfaces between polymer and HA particles. In fact it has been 
shown that there is usually a preferential absorption of water and consequent degradation at 
starch/HA interfaces when its processing is not fully optimised.32 Thus these particles due to 
their size, comparing with the matrix, would constitute a preferential site for adhesion, 
phagocytosis with neutrophils experiencing high levels of degranulation. 
PLLA was used as a comparison biodegradable material due to it extensive applications in 
the biomedical field. It was then possible to observe that the results obtained for starch-
based materials were not different from those obtained for the PLLA except in the case of 
SPCL with 30% of HA. These results indicate that almost all of the starch-based biomaterials 
(polymers and composites) disclose a behaviour at least as good as that of the actual gold 
standard in the field. 
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Figure. 5.1 Fraction of Micrococcus Lysodeikticus lysed by the lysozyme released by neutrophils 
incubated with starch-based materials and composites. 
* Statistically different from SPCL+30%HA (p< 0.05), Tukey-HDS test. 
+ Statistically different from SPCL+20%HA (p< 0.05), Tukey-HDS test. 
 
5.3.2 Chemiluminescence 
Neutrophil activation may be either due to a direct effect of the material on the cell 
membrane or mediated by the adsorption of plasma and matrix proteins.33,34
The chemiluminescence assay was used to evaluate the potential of neutrophils to become 
activated after a direct contact with several biodegradable polymers and composites. The 
light resulting from the interaction of free radicals and other oxidants, produced by stimulated 
neutrophils, with the photoprotein Pholasin® was detected and plotted against time. After 
injection of each cell stimulant, fMLP and PMA, a peak for light emission was observed, as 
expected, due to an increase in the production of oxygen intermediates. Those two 
chemicals have two distinct mechanisms of action that explains the differences in the 
intensity of the peaks of light. The receptor stimulant fMLP works via receptors and acts, in 
most cases, solely on the NADPH oxidase system of the plasma membrane whereas PMA 
enters the cells acting directly on protein kinase C, which leads to the activation of the 
NADPH oxidase both on the plasma membrane and on the secondary granules. 
From the results shown in Fig 5.1 and Fig 5.2, it is clear that the maximum response in the 
chemiluminescence tests was significantly reduced when the cells were exposed to polymers 
(Fig 5.2 and Fig 5.3). At the moment of the injection of Pholasin® into the luminometer 
cuvettes the slight increase in the light detected expected, was not observed for some 
materials, which seems to show that the phenomena responsible for the reduction of signal is 
occurring at an early stage of the assay. Furthermore, the response after the injection of the 
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cell stimulants was very low for fMLP and reduced for PMA, about 20% when compared with 
the positive control. 
A mechanism for the down regulation of PMN function was demonstrated in a study by 
Hansch et al35, which gave evidence that the dialysis-membrane-associated L-fructose 
residues participate in a complement–independent neutrophil activation during hemodialysis 
therapy. This monosaccharide was found to be present in cellulose-based polymers in 
picomolar concentrations.36
Moore et al37 related cellulose acetate degradation with PMN activation in vitro and also 
found that glycerol suppresses reactivity before stimulant addition and after stimulation of 
neutrophil activation by fMLP or PMA in vitro in a dose-dependent manner.  
Additionally, it is known that glycerol is used in the manufacturing of starch-based material. 
This compound may serve to mask a more active inflammatory response to the materials in 
study since it is the first compound together with low molecular weight chains to leach out 
from the materials. 
It was not possible to observe a tendency in the results either in the case of SEVA-C and 
composites (Fig 5.2) or in the case of SPCL and composites (Fig 5.3). It is important to point 
out the result obtained for PLLA, as it was similar to the negative control.  
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Figure 5.2. Chemiluminescence measurements of respiratory burst of neutrophils exposed to a 
starch-based polymer (SEVA-C) and composites and to PLLA. Positive control corresponds to the 
polystyrene tube (luminometer cuvette) in the same conditions as the tubes with the materials. The 
negative control corresponds to the luminometer cuvette without cells and buffer instead. Two cell 
stimulants, fMLP and PMA, were injected to all the cuvettes at different times. Graphs represent mean 
of n=4 separate experiments, with 2 replicates of each sample in each experiment. 
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Figure 5.3. Chemiluminescence measurements of respiratory burst of neutrophils exposed to a 
starch-based polymer (SPCL) and composites and to PLLA. Positive control corresponds to the 
polystyrene tube (luminometer cuvette) in the same conditions as the tubes with the materials. The 
negative control corresponds to the polystyrene tube (luminometer cuvette) without cells. Two cell 
stimulants, fMLP and PMA, were injected to all the cuvettes at different times. Graphs represent mean 
of n=4 separate experiments, with 2 replicates of each sample in each experiment. 
 
To verify that the time of the assay was not a limiting factor, the assay was prolonged up to 4 
hours, but no further changes in the oxidative response of the cells was detected (data not 
shown).  
High levels of Mac-1 expression have been described after contact with surfaces of 
polymeric materials, which led to increased adhesiveness to the surfaces with a 
consecutively evoked oxidative burst.38,39 However, studies ex vivo in a murine model 
showed that exudate cells respond more to PMA than implant associated cells.25,40
To assess whether or not this reduction in the light detected was a consequence of a 
cell/material interaction or due to possibly free radical interactions with the material, 
quenching of the light by the material or inhibition of Pholasin®, two types of experiments 
were carried out.  
 Firstly, the initial chemiluminescence assay was time-changed. The first light detected in the 
initial test was almost 4 minutes after the cuvettes being loaded into the luminometer due to 
the fact that the luminometer carrousel has to move to the measurement position. 
Considering this, the number of materials to be tested in each experiment and the number of 
replicates was reduced, which decreased the analysis time. The results are presented in Fig 
5.4; it was possible to observe higher differences between the responses obtained with the 
different materials and a reduction of signal by polymers. Glass was introduced in this test as 
a new variable trying to see if different results were obtained for non-polymeric materials. In 
fact, and as expected, the results were closer to the positive control. 
-------------------------------------------------------------------------------------------------------------------------------------------------------------  135 ---- 
------------Chapter 5- Evaluation of the potential of starch-based biodegradable polymers in the activation of human inflammatory cells --- 
 
 
 
0,0
500,0
1000,0
1500,0
2000,0
2500,0
3000,0
3500,0
4000,0
0 62 124 186 248 310 372 434 496 558 620 682 744
Time (s)
Li
gh
t E
m
itt
ed
 p
er
 S
ec
on
d 
(m
V
) Positive Control
Negative Control
SEVA-C
SPCL
Glass
 
 
 
 
 
 
 
 
 
 
Figure 5.4. Chemiluminescence measurements of respiratory burst of neutrophils exposed to a two 
starch-based polymer (SEVA-C and SPCL) and to glass. Positive control corresponds to the 
polystyrene tube (luminometer cuvette) in the same conditions as the tubes with the materials. The 
negative control corresponds to the luminometer cuvette without cells and buffer instead. Two cell 
stimulants, fMLP and PMA, were injected to all the cuvettes at different and earlier times. Graphs 
represent mean of n=3 separate experiments. 
 
The differences are the greatest when cells were stimulated by PMA especially in the case of 
glass and SPCL. Cells in contact with those two materials presented a similar response in 
the beginning of the assay becoming different after fMLP stimulation. SEVA-C, on the 
contrary, was always the material with the lowest intensity of emitted light. 
This same experiment was repeated with 2 minutes delay in order to verify if the loading and 
setting time were crucial for the results obtained in the initial chemiluminescence assay. The 
results are not shown herein but once again changes were detected. For cuvettes with glass 
and control the same intensity of light was detected but for the tested polymers (SEVA-C and 
SPCL) the peak of light after PMA stimulation was lower. The same type of kinetics was 
observed until this point. 
Secondly, nitric oxide and superoxide were released simultaneously and continually from a 
solution of SIN-1.Those two products reacted forming peroxynitrite that interacts with 
Pholasin® in the assay. Light of gradually increasing intensity is detected, reaching a peak 
after a few minutes (Fig. 5.5). The results confirm that the materials or any antioxidants 
capable of scavenging peroxynitrite are competing for Pholasin®, which results in a peak of 
lower intensity than the control. Furthermore, when comparing the results for SEVA-C and 
SPCL, as they are similar, the previous differences obtained (Fig. 5.4) seem to be due to an 
effect on the adhesion of neutrophils to the surface of those polymers.  
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Figure 5.5. Chemiluminescence measurements of the reaction of peroxinitrite with the photoprotein 
Pholasin® in the presence of two starch-based polymers (SEVA-C and SPCL), respective composites 
and glass. Positive control corresponds to the polystyrene tube (luminometer cuvette) in the same 
conditions as the tubes with the materials. The negative control corresponds to the luminometer 
cuvette without cells and buffer instead. SIN 1, which promotes the simultaneous production of nitric 
oxide and superoxide and that react between them originating peroxinitrite, was injected to all the 
cuvettes. Graph represents one experiment, with 2 replicates of each sample. 
 
There is evidence that indicates that secretion of hydrolytic enzymes and production of 
oxygen metabolites are directly regulated by a dynamic actin filament system through the 
association of components of NADPH-oxidase, β2-integrins and actin cytoskeletal 
structures.27  
In the case of all the materials studied, however, it can be speculated that the reduction of 
light emitted is the result of the surface properties of the materials on neutrophils adhesion 
simultaneously with a competition for the photoprotein in solution. 
 
5.4 CONCLUSIONS 
Both lysozyme and chemiluminescence assays revealed a low response of the neutrophils 
when in contact with starch-based polymers and composites.  
The hypothesis that the results obtained would be due to an effect on cell adhesion or due to 
the presence of antioxidant species that would scavenge the reactive oxygen species, 
considered so harmful for the tissues, was proved, which allows for considering starch-based 
materials with weak potential to break out an inflammatory response. 
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ABSTRACT 
Leukocyte adhesion to biomaterials has long been recognised as a key element to determine 
their inflammatory potential. Results regarding leukocyte adhesion and activation are 
contradictory in some aspects of the material’s effect in determining these events. It is clear 
that together with the wettability or hydrophilicity/hydrophobicity, the roughness of a substrate 
has a major effect on leukocyte adhesion.  Both the chemical and physical properties of a 
material influence the adsorbed proteins layer which in turn determines the adhesion of cells. 
In this work polymorphonuclear (PMN) cells and a mixed population of 
monocytes/macrophages and lymphocytes (mononuclear cells) were cultured separately with 
a range of starch-based materials and composites with hydroxyapatite (HA).   Cell adhesion 
and differentiation was characterised based on the expression of several adhesion 
molecules. A combination of both reflected light microscopy and scanning electron 
microscopy (SEM) was used in order to study the leukocyte responses in terms of 
morphology. The quantification of the enzyme lactate dehydrogenase (LDH) was used to 
determine the number of viable cells adhered to the polymers. The expression of adhesion 
molecules, crucial in the progress of an inflammatory response, was determined by 
immunocytochemistry. 
The work support previous in vitro studies with PMN and monocytes/macrophages, which 
demonstrated that there are several properties of the materials that can influence and 
determine the biological response. In the present work it was found that more hydrophilic 
surfaces induced higher PMN adhesion while in the case of monocytes/macrophages and 
lymphocytes, the opposite was observed.  
The results reported herein indicate the low potential of the starch-based biodegradable 
polymers to induce inflammation especially the HA reinforced composite materials. 
-------------------------------------------------------------------------------------------------------------------------------------------------------------  141 ---- 
----------------------------------------Chapter 6- The effect of starch-based biomaterials on leukocyte adhesion and activation In Vitro-- 
 
It is suggested that the protein layer adsorbed to the surface of the materials immediately 
after contact with culture medium is the more important factor to determine cell adhesion and 
activation in vitro. 
 
6.1. INTRODUCTION 
One of the major stages in the development of biomaterials is the assessment of the 
biological reactions resulting from their interaction with the living tissues.1-3 Clinical 
deployment or application will trigger foreign body reactions that may, according to the 
severity determine the success or failure of the device. 
Cellular recruitment into the interface of tissue and device plays an important role in implant 
loosening. The cell types that predominate in the implantation site during the different phases 
of inflammation are lymphocytes, monocytes and macrophages with polymorphonuclear 
neutrophils (PMN), in acute inflammation or infection4,5.  These cells constitute appropriate 
systems to study, in vitro, the complex biological reactions of cell-material interactions and 
the release of chemotactic mediators that in vivo will control inflammatory responses.  
The mechanisms involved in the development of the inflammatory response are many and 
rather complex, but the activation of leukocytes leading to the up-regulation of adhesion 
molecules on the cell surface plays a central role and has been the focus of some recent 
studies.6,7 Therefore it is of extreme importance to try to understand the mechanisms of 
leukocyte adhesion and it’s relation with the activation state of the cells. Cells adhere by 
utilising three major groups of adhesion molecules8: integrins, selectins and glycoproteins, for 
example members of the immunoglobulin superfamily. Cell-cell contacts formed by integrins 
contribute to activities such as antigen presentation, cytotoxicity, phagocytosis among 
others.8,9 Integrins are constitutively expressed on leukocytes, but are only able to form 
adhesive contacts with other cells following activation to produce structural and affinity 
changes in the external integrin moieties.9  
Several adhesion molecules are known to play primordial roles in the inflammatory process, 
some of them previously used as specific cell-function markers were chosen to be identified 
in this study. The surface antigen known as lymphocyte function-related antigen (LFA-1), 
expressed in all leukocytes, is an integrin consisting of an α subunit, also defined as CD11a, 
and the β2 subunit, denominated as CD18. The subunit α can vary in the heterodimer, 
originating to two other important adhesion molecules, the CD11b or Mac-1 and CD11c, both 
expressed on monocytes/macrophages and granulocytes10 but not on lymphocytes11. CD11a 
is involved in the adhesion of leukocytes to endothelium during inflammatory reactions and 
Mac-1 plays a key role in the adherence of both monocytes and neutrophils to vascular 
endothelium for subsequent extravasation.12 CD11b/CD18 is also involved in a variety of cell-
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cell and cell-substrate interactions such as attachment and phagocytosis of particles coated 
with C3bi by granulocytes and macrophages.13
Integrins have as receptors, specific cell surface molecules belonging to the immunoglobulin 
(Ig) superfamily, which are expressed on endothelial cells. The β2 integrins primarily 
recognise the intracellular adhesion molecule -1 (ICAM-1). In the mediation of cell adhesion, 
lymphocytes mainly use LFA-1 to interact with ICAM-1 whereas neutrophils appear to use 
both LFA-1 and Mac-1 to attach to ICAM-1 expressing cells. These are necessary 
interactions to stop leukocytes rolling along endothelium, enabling migration to the site of 
injury/inflammation.12 ICAM-1 binds not only to leukocyte integrins but also to fibrinogen, 
which may be an important means of recruiting inflammatory cells to places of injury.  
Another feature of inflammation involves the expression of major histocompatibility complex 
(MHC). In particular, during the immune response to pathogens, antigen presenting cells 
process and present selected foreign peptides through the MHC class I or II on their 
surface.13 The capacity of these molecules to avoid interactions between T cells and their 
accessory cells, has been demonstrated previously14. 
In the presence of biomaterials, however, the typical inflammatory process is different, since 
materials can determine the extent and duration. The general mechanism of surface 
dependent cellular responses is believed to be adhesion receptor binding to the surface 
specific adsorbed protein layer, which activates intracellular signal transduction pathways, 
resulting in a modification of cell behaviour15. Therefore, biomaterial surface physical and 
chemical characteristics directly or indirectly dictates cell adhesion and activation by 
determining the types, levels and conformations of adsorbed proteins.5
Starch-based materials and composites have been proposed for a large range of biomedical 
applications.16-20 These materials have shown promising properties in terms of 
cytocompatibility21-23 which leads their evaluation further on to consider their immunogenic 
potential. The aim of the present study was to investigate the contribution of various types of 
starch-based materials and composites and respective changes in their chemical and 
physical properties in leukocyte adhesion and activation, namely in promoting differentiation 
of different subsets of macrophages in order to demonstrate the effect of these materials in 
terms of an immunogenic response. 
 
6.2. MATERIALS AND METHODS 
6.2.1 Materials 
The materials studied were: i) a 50/50 (wt %) blend of corn starch and ethylene vinyl alcohol 
(SEVA-C, Novamont, Italy), ii) SEVA-C reinforced with 10%, 20% and 30% (wt) of 
hydroxyapatite (HA, Plasma Biotal, UK), iii) a 50/50 (wt %) blend of corn starch and cellulose 
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acetate (SCA, Novamont, Italy), iv) SCA reinforced with 10%, 20% and 30% (wt) of 
hydroxyapatite, v) a 30/70 (wt %) blend of corn starch and polycaprolactone (SPCL, 
Novamont, Italy) and vi) SPCL reinforced with 10%, 20% and 30% (wt) of hydroxyapatite. In 
the composites the average size of 90% of the HA particles was found to be below 6.5 µm 
(laser granulometry analysis). 
Poly-L-Lactide (PLLA, Purac biochem BV, The Netherlands), being the gold standard for 
biodegradables in biomedical applications, was used as a biodegradable control material. 
Borosilicate glass (BDH, England) and polystyrene coverslips (PS, Sarstedt Inc, USA) were 
used as experimental controls for assays involving neutrophils and monocytes/macrophages 
separately. 
All the materials, both the polymers and the composites were processed into circular 
samples (∅ 1cm) by injection moulding, under optimised processing conditions and sterilised 
by ethylene oxide (EtO) in conditions that have been described previously24. 
 
6.2.2 Neutrophil Isolation 
Neutrophils were isolated from fresh heparinised peripheral human blood collected from 
healthy volunteers. Blood was mixed with a 6% dextran solution, settled and the supernatant 
layered onto lymphocyte separation medium and centrifuged at 2400 rpm for 25 minutes at 
room temperature. The pellet was washed once with phosphate buffered saline (PBS) 
solution without calcium and magnesium and the remaining red blood cells were removed by 
water lysis. The cell suspension was washed twice with PBS without calcium and 
magnesium at 2400rpm for 5 minutes at room temperature. Cells were counted using a 
haemocytometer and kept at 4°C until use. 
 
6.2.3 Mononuclear Isolation (Lymphocytes and Monocytes/Macrophages)  
A mixed population of lymphocytes and monocytes/macrophages was isolated from healthy 
human volunteers. Blood was layered onto lymphocyte separation medium (LymphoSep, 
ICN Biomedicals, USA) and centrifuged at 2400rpm for 25 minutes at 4°C. Cell suspension 
was washed twice with PBS at 2400rpm for 5 minutes at 4°C and the final concentration set 
with Medium 199 (Gibco BRL, USA) supplemented with 1% of antibiotics (Sigma Chemical 
Co, USA), 10% of foetal calf serum (FCS, Gibco BRL, Life Technologies,USA) and 0.2% of 
fungizone (Sigma Chemical Co, USA). 
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6.2.4 Adhesion and Morphological Analysis 
After isolation, neutrophils were seeded onto the materials at a concentration of 4x104 
cells/ml in 1.5ml of culture medium for ½, 1 and 4 hours and stained with haematoxylin. 
The mixed population of lymphocytes and monocytes/macrophages was also cultured in 
direct contact with the materials for 3, 7 and 14 days, at a concentration of 4x104 cells/ml, in 
1ml of the culture medium used to prepare the cell suspension. 
After each time period, the cells were rinsed in PBS and fixed with glutaraldehyde 2.5% in 
PBS for 1 hour at room temperature. After fixation the cells were rinsed with PBS, distilled 
water and dehydrated in graded ethanol solutions (70%, 90%, and 100%) twice, 15 minutes 
each and critical point dried. Samples were chromium sputter coated (Emitech K575 X, UK) 
and observed on a Leo 1550 field emission SEM (Leo, UK). 
 
6.2.5 Lactate Dehydrogenase Quantification 
Mononuclear cells were seeded in direct contact with the polymers for 3, 7 and 14 days at a 
concentration of 5x104 cells/ml, 1.5ml per well. After each time period, materials were 
transferred to new culture plates together with 500µl of the culture supernatant and all the 
plates were frozen at -80°C for approximately 60 minutes followed by thawing at 37°C for 60 
minutes. This freeze and thaw cycle was repeated 3 times. Supernatant (50µl) of each well 
was transferred to a new 96-well plate and the lactate dehydrogenase (LDH) kit (Promega, 
CytoTox96TM) was used to quantify the enzyme. The absorbance of the reaction product was 
recorded on a multiwell microplate reader at 490nm within 1 hour. A standard curve was 
prepared with dilutions of an LDH standard versus absorbance readings in order to 
determine, the LDH Units of each sample. Each sample was tested in triplicate and in 4 
separate experiments. 
 
6.2.6 Antibodies 
To identify individual leukocyte cell surface molecules the following mouse anti-human 
monoclonal antibodies were used: CD3 (reacts with ε-chain of the CD3/T-cell antigen 
receptor) and CD5 as T-lymphocyte markers (Pharmingen, USA), CD11a also known as 
lymphocyte associated antigen-1 (LFA-1) and expressed by all leukocytes (Pharmingen, 
USA), CD11b which reacts with Mac-1 and CD11c (Pharmingen, USA) as macrophage and 
monocyte markers, CD54 (Pharmingen, USA), which reacts with intracellular adhesion 
molecule-1 (ICAM-1) expressed in activated macrophages, CD68 (Dako A/S, Denmark) a 
marker for macrophages and HLA-DR antibody (Serotec, UK) which recognizes MHC II 
antigen present in activated macrophages.  
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6.2.7 Immunocytochemistry 
After each time period materials with cells were washed twice in PBS, fixed with 4% 
formaldehyde, 2% sucrose solution in water for 30 minutes at room temperature, washed 
with PBS buffer and stained with the avidin-biotin alkaline phosphatase technique. Materials 
were exposed to rabbit serum for 30 minutes to reduce nonspecific reactivity, followed by 
primary antibodies for 1 hour at room temperature. After that time materials were rinsed with 
PBS for 5 minutes and incubated with biotinylated rabbit anti-mouse IgG antibody (Dako A/S, 
Denmark) for 1 hour at room temperature. The Avidin and Biotinylated horseradish 
peroxidase complex (Vector Laboratories Ltd., UK) was added to all materials for 1 hour and 
the substrate reaction was developed using the Alkaline Phosphatase Substrate Kit (Vector 
Laboratories Ltd., UK). Each incubation, except the rabbit serum, was followed by one wash 
with PBS buffer for 5 minutes. Materials were washed and counterstained with haematoxylin 
and mounted in permanent aqueous mounting medium (Serotec Ltd, UK). Each material had 
one sample stained as a control replacing the primary antibody with PBS buffer. 
 
6.2.8 Statistical Analysis 
LDH data was averaged and the standard deviation is reported as a measure of sample 
variation. The data was statistically analysed by a one way ANOVA analysis using a Tukey-
HDS test.25 All the materials were compared between themselves and the control. If 
probability values were less than 0.05 (p<0.05), differences observed for the two materials 
were considered statistically significant. 
 
6.3. RESULTS 
6.3.1 Cell Adhesion and Morphology 
6.3.1.1 PMN 
Neutrophils were cultured in contact with the different materials and their morphology 
observed by reflected microscopy after haematoxylin staining. The control materials (PLLA 
as a biodegradable control and glass as the material which induces high PMN activation) 
showed reduced neutrophil adhesion with a very uniform round morphology. A qualitative 
microscopic comparison of the amount of cells on the surface of the materials was done. 
Comparing equivalent times of culture, the blend of starch and cellulose acetate presented 
higher cell adhesion in contrast with the blend with polycaprolactone which showed a low 
number of cells on their surfaces. Furthermore, while for SEVA-C, SCA and respective 
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composites the highest adhesion time was 2 hours of culture, for SPCL and composites it 
was possible to observe more adherent cells after 4 hours of culture (Fig. 6.1 A, B, C).  
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Figure 6.1. PMN cultured on the surface of starch-based polymers and stained with haematoxylin 
(X20). A) SEVA-C after 2h of culture; B) SPCL after 4h of culture; C) SCA after 2h of culture; D) 
SEVA-C+10%HA after 2h of culture; E) SPCL+30%HA after 4h of culture; F) SCA+20%HA after 2h of 
culture. 
 
The presence of ceramic26 resulted in different affinities, in terms of number of adherent cells, 
depending on the blend. While starch and ethylene vinyl alcohol composites presented a 
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tendency for lower numbers of adherent cells, the surface of SCA composites seemed to 
promote cell adhesion and the reinforcement of SPCL did not show any significant adhesion 
effect (Fig. 6.1 D, E, F).  
The three starch-based biomaterials showed various cell morphologies depending on the 
type of blend, but morphology also changed in the presence of HA. Some neutrophils on the 
surface of SEVA-C adopted a spindly, elongated morphology suggestive of motility (Fig. 
6.1A). However, in the presence of ceramic at 10% HA, the majority of the cells spread 
extensively (Fig. 6.1D) and in the presence of 20 and 30% of HA, cells remained quite round.  
For the starch with cellulose acetate materials, variations in the morphology of adherent cells 
were only observed in the presence of the composite with 20% ceramic (Fig. 6.1F) where it 
was possible to see some individual cells with extended philopodia.  The unreinforced 
polymer and the composites with 10 and 30% of HA showed that neutrophils on these 
surfaces assumed a round morphology although with some spreading, having the tendency 
to agglomerate forming clusters.  
For the starch-based blends with polycaprolactone there was only a percentage of HA that 
showed differences in neutrophil adhesion. For SPCL and it’s composites with 10 and 20% of 
HA, cells presented a round morphology comparable to isolated cells (Fig. 6.1B) while in the 
composite with 30% of HA, adherent cells were bridging to other cells forming structure with 
a chain-like shape (Fig. 6.1E). It should be noted that these differences were observed after 
4 hours of culture and after 2 hours they looked alike on the surface of any of the starch-
polycaprolactone polymers or composite materials. 
 
6.3.1.2 Monocytes/macrophages and Lymphocytes 
The SEM observation of the mixed mononuclear population of monocytes/macrophages and 
lymphocytes cultured in direct contact with the materials in the study demonstrated that, in 
fact, the different types of cells present in culture were adhered to the different surfaces. 
Lymphocytes were identified by being much smaller in size than monocytes/macrophages 
and presented a very round morphology. The morphology of monocytes/macrophages varied 
depending on the material. Non activated monocytes were round cells without philopodia and 
with many microvilli on the cell membrane surface. PLLA and PS were used as control 
materials; these materials presented a smooth surface, and it can be seen in figure 6.2A and 
2B that cells showed cytoplasm extensions towards the materials surface. SCA and it’s 
composites were found to be the surfaces where monocytes/macrophages spread out (Fig. 
6.2E). The majority of the cells displayed long cytoplasmic extensions especially in the case 
of the unreinforced polymer. On the SCA composites, cells presented fine philopodia which 
seemed to be looking for the HA particles.  
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In contrast to starch-cellulose acetate materials, cells adherent to SPCL and it’s composites 
were found to maintain a round morphology comparable to non activated cells (Figure 6.2C). 
Neither the presence of ceramic nor its amount affected cell adhesion.  
Comparing all the materials, SEVA-C and its composites resulted in an intermediate mode of 
adhesion. It was possible to observe a considerable amount of monocytes/macrophages 
spread on these surfaces, although not showing significant philopodia. Cells were flattened 
on the surfaces using all of their cytoplasm instead of fine cell extensions (Fig. 6.2D). 
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Figure 6.2. Scanning electron micrograph showing a mixed population of monocytes/macrophages 
and lymphocytes cultured on the surface of different polymers for 7 days. A) PLLA; B) PS; C) SPCL; 
D) SEVA-C; E) SCA+30%HA. 
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Figure 6.3. Concentration of lactate dehydrogenase (LDH) in the cell cytoplasm, from a mixed 
population of monocytes/macrophages and lymphocytes, adhered to the polymers and composites 
after 3, 7 and 14 days of culture. 
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The quantification of cells by LDH determined that SEVA-C and it’s composites were the 
surfaces that promoted more monocyte/macrophage and lymphocyte adhesion (Fig. 6.3A) 
and that for SCA and it’s composites less cells adhered (Fig. 6.3B). 
Considering all blends, the results for unreinforced polymers and composites with 10% of HA 
were found to be similar as well as the results between the composites with 20 and 30% of 
ceramic. Thus, for each blend and considering the amount of adherent cells it was possible 
to divide the materials in two groups. For the materials based on starch with ethylene vinyl 
alcohol and cellulose acetate (Fig. 6.3 A, B) higher amounts of HA results in fewer adherent 
cells, while in the case of SPCL materials the opposite was verified (Fig. 6.3C).  
The number of cells on the surface of SEVA-C and SCA materials was also found to 
increase from 3 to 7 days of culture and decrease from that time on, while in the case of 
materials of starch with polycaprolactone the number of cells tends to decrease from 3 days 
until the end of the experiment. 
The number of cells on the surface of the control materials was equivalent to SCA and its 
composite with 10% of HA (Fig. 6.3 A, B).  
 
6.3.2 Immunocytochemistry 
Although in vitro conditions may influence the functional behaviour of cells, this study was 
performed in order to correlate morphological observations and the functional activity of 
monocytes/macrophages and lymphocytes, in vitro, in the presence of novel potential 
biomaterials. Image analysis was attempted in order to quantify the number of cells 
expressing each antigen, however it was not possible to apply that technique since many 
details, apart from the cells, on the surface of starch-based materials were also stained 
which resulted in significant errors in the numbers obtained.  
The surface markers on macrophages have shown modulated expression because of 
contact with materials. Our results highlighted the presence of distinct functional subsets of 
macrophages. These subsets exhibit morphological, immunophenotypic and functional 
differences depending on the polymer substrate. From SEM analysis, lymphocytes were 
quite easy to identify presenting a very round shape. This was confirmed from positive 
staining using CD3 (Fig. 6.4A) and CD5 antigens. Adherent lymphocytes on the surface of all 
the tested materials demonstrated that the expression of CD3 and CD5 was affected by the 
type of material and for some materials, also by the time of culture. For the surfaces of PS 
and SPCL the number of CD3 positive lymphocytes seemed to decrease with time. In the 
case of the other materials the amount of cells expressing CD3 did not change significantly 
for longer periods of culture. Furthermore, the amount of CD5 positively stained cells did not 
significantly vary with increasing time. Moreover, the composites presented a similar number 
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of cells expressing both CD3 and CD5 antigens, compared with the unreinforced polymer. 
Lymphocytes seemed to be present in higher numbers on the surface of PS after 3 days of 
culture, decreasing to fairly similar amounts to the other materials after 7 days. It should be 
stressed that these statements are based on microscopical observations; the total number of 
cells on the surface of the materials does not vary as demonstrated by the statistical analysis 
of the LDH quantification. 
The identification of the CD11/CD18 integrins expressed by leukocytes adhered to the 
surface of the different polymers by immunostaining with anti- LFA-1, Mac-1 and CD11c 
antibodies, confirmed the existence of different sub-populations of cells. It was possible to 
identify CD11c positive macrophages as a sub-population of cells which spread according to 
substrata (Fig. 6.4D). Two other sub-sets of macrophages showing different levels of 
attachment/spreading were found to be CD11b positive (Fig. 6.4C). Cells stained with anti-
CD11a antibody confirmed the attachment of different cell types, lymphocytes and 
monocytes and the sub-populations of macrophages (Fig. 6.4B). 
The culture time influenced the number of cells expressing CD11/CD18 molecules, although 
the numbers of mature macrophages (CD68 positive cells, Figure 6.4E) seemed to increase 
on PS and SPCL for longer culture periods. In particular, In the presence of PS and SEVA-C 
the number of CD11b positive cells appear to increased with the time of culture. An opposite 
tendency was presented by cells expressing CD11c after adherence to PLLA which seem to 
be in lower amounts for longer times of culture. Furthermore for increasing time of culture, 
more cells expressing LFA-1 and CD11c, were found adherent to SEVA-C and SPCL 
respectively. 
The different materials in the study also affected the monocyte/macrophage phenotype. The 
number of macrophages (positive cells for CD11c) adherent to the surface of the PS control 
is much higher than on any of the other polymers, which were found to induce CD11c 
expression at similar levels. PS, SCA and SPCL were also found to up-regulate the 
expression of Mac-1 when compared to SEVA-C and PLLA.  
Another interesting result involves the presence of HA. The presence of the ceramic did not 
seem to affect CD11c expression in the cultured cells when comparing to unreinforced 
materials. However, although increasing amounts of HA did not seem to induce significant 
differences in the expression of CD11/CD18 adhesion molecules, it was possible to observe 
that HA down-regulates Mac-1 expression on cellulose acetate and polycaprolactone 
containing composites and induces spreading on cells adherent to SCA composites and 
expressing LFA-1. Furthermore, CD68 antigen was found to be down-regulated in the 
presence of all the composites when compared to the polymers without ceramic. 
Considering the activation state of the cells cultured in contact with starch-based materials it 
was possible to observe that in fact, macrophages expressing CD54 (ICAM-1), showed a 
-------------------------------------------------------------------------------------------------------------------------------------------------------------  152 ---- 
----------------------------------------Chapter 6- The effect of starch-based biomaterials on leukocyte adhesion and activation In Vitro-- 
 
particular morphology when compared with other cells stained with different antibodies (Fig. 
6.4F). Cells were shown to be well spread on the surface of the polymers and in lower 
numbers on SCA and PLLA. In addition, SEVA-C and SPCL composites induced a down 
regulation in ICAM-1 expression. 
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Figure 6.4. Immunostaining of mixed cell populations of monocytes/macrophages and lymphocytes 
cultured for 3 days (D), 7 days (A,B,F) and 14 days (C,E) on: A) SEVA-C+20%HA, B) SCA+20%HA; 
C) SEVA-C, D) SEVA-C+10%HA, E) PS, F) PLLA. Cells were stained using CD3 (A), CD11a (B), 
CD11b (C), CD11c (D), CD68 (E) and CD54 (F) antibodies (red cells) and counterstained with 
haematoxylin (purple cells). Magnification (X10) 
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This study also demonstrates a significant difference in antigen-presenting phenotype in 
adherent cells. SEVA-C, PLLA and PS showed fewer cells expressing the HLA-DR antigen, 
however for longer culture times, the number of cells presenting antigen decreased for 
SEVA-C and increased for PLLA as well as for SCA.   
 
6.4. DISCUSSION 
Polymorphonuclear neutrophils are found at the surface of the materials 10 minutes after 
blood exposure and the cells become activated after 30 minutes to an extent that depends 
on the implanted device27. These cells may become activated either directly through 
adhesion receptors, or indirectly via platelet-derived mediators. However, the adhesion-
mediated mechanisms of PMN activation are not well understood and several works have 
shown conflicting results. Some studies presented evidence that cell adhesion has an 
important role in supporting or preventing neutrophil apoptosis.28,29 In addition, interactions 
between neutrophils and a biomaterial surface have been suggested to cause premature 
activation of cells which causes a long-term down-regulation of neutrophil function on 
biomaterial surfaces in vitro30. Other researchers have shown reduced oxidative responses 
from adherent PMNs on different surfaces.31,32 A previous study with starch-based materials 
also revealed that the production of degradative enzymes and reactive oxygen species was 
reduced when in contact with those materials.32 Based on this it could be suggested that 
SPCL and composites would not promote immediate neutrophil adhesion, which would result 
in a more intense short-term activation that would be reduced after adhesion.  
It is defended33-35 that in vivo and in vitro (in the presence of serum) biomaterials instantly 
become associated with plasma and/or matrix proteins, which have the potential to modify 
the interactive effects of materials and cells. Proteins may however act in different ways. 
Some studies33,35 demonstrated that some proteins enhance neutrophil activation, but other 
research  showed that they can inhibit PMN resulting in a diminished inflammation33,34. The 
amount of protein pre-adsorbed on a surface can also affect cell adhesion by masking the 
surface properties of the underlying substrate and thus minimising the non-specific 
interactions.36 Not only the type of proteins or their concentration, but also the way they 
adsorb to the materials is determinant for cell adhesion. This dependence ultimately relies on 
the physical and chemical nature of the surfaces. In fact, oxidised surfaces were shown to 
stimulate granulocyte activation 37. Moreover, PMN were observed to use different receptors 
to adhere onto hydrophilic and hydrophobic surfaces 38. 
The present in vitro study was performed in the presence of serum, a complex system of 
different proteins which adsorb to the surface of the different materials and consequently 
modulate cell adhesion, depending on the material properties. Previous studies with starch-
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based blends showed that the three materials present a different surface in physical16 and 
chemical terms39. In fact the SCA polymer, the material with higher number of adhered 
PMNs, has a higher oxygen content on it’s surface 39.  
It can also be speculated that the presence of HA influences neutrophil adhesion in highly 
(SCA) and moderate (SEVA-C) hydrophilic surfaces in different ways respectively inducing 
and reducing the number of adherent cells probably due to their wettability. The incorporation 
of ceramic reduces hydrophilicity which will reach a more favourable value in the case of 
SCA, but transforming SEVA-C to a less adherent surface for neutrophils. 
The neutrophil spreading and migration over a surface requires rearrangements of the actin 
cytoskeleton, which together with focal contacts regulate the dynamic interactions between 
β2-integrins and extracellular matrix proteins. A correlation between cell spreading, 
pseudopodia formation and activation state was previously suggested by Wettero et al. 40 
Other authors41 reported similar results although suggesting a dependence of cell adhesion 
for oxygen radical production. 
Thus considering the predisposition of each material in the study to attract PMNs, the 
morphology cells assume when adherent and previously reported results on reactive oxygen 
production and degradative enzyme release in the presence of starch-based polymers, it can 
be suggested that starch-based materials that promote more neutrophil adhesion tend to 
inactivate PMN. 
Contrarily to PMNs, macrophage lineage is known to be heterogeneous, and considerable 
variability in cell morphology has been noted after activations for example by cytokines or 
other chemical moderators such as lipopolysaccharides (LPS).42,43 Under the influence of 
cytokines, macrophages show various features of activation. Morphologically, the cell 
increases in size. The number of cytoplasmic granules increases and the plasma membrane 
becomes more ruffled. Phagocytic activity is also another characteristic that activated 
macrophages may exhibit upon attachment to a surface. Activated macrophages spread 
more rapidly and extensively than resting macrophages44.Therefore, cellular adhesion and 
spreading on material surfaces appears to be an attempt by the macrophage to phagocytose 
the implanted device.  
Some studies45,46 have focused on the capacity of macrophages to degrade ceramic coatings 
or to phagocytose HA particles through the extension of cytoplasmic pseudopodia around 
particles until completely encapsulated. 
The lower numbers of cells in the presence of SEVA-C and SCA composites and their 
tendency to decrease with increasing percentages of HA might suggest preferential 
monocyte/macrophage adhesion to ceramic particles when comparing the surface of the 
polymers. It may be hypothesised that polymer/HA interfaces were more susceptible to 
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degradation inducing the release of HA particles which in turn attract the phagocytes 
therefore decreasing the number of cells on the surface of the materials. 
When in contact with starch-based materials and composites, leukocytes were not observed 
bridging and no apparent macrophage fusion into giant cells was determined, although 
macrophage aggregation, fusion and formation of foreign body giant cells (FBGC) on the 
surface of biomaterials has been previously observed in vitro47, and also at the interface 
between tissue and retrieved smooth surface implants48. Several studies49,50 have shown that 
long-term macrophage densities and FBGC formation can be greatly influenced by substrate 
chemistry.  
There is some controversy about the factors that affect and how they affect leukocyte 
adhesion to biomaterials surfaces. Wettability and morphology of the materials were shown 
to play an important role; porous and more hydrophilic surfaces were found to have more 
adhered monocytes51,52 but some authors53-55 have concluded that macrophages 
preferentially accumulate on rough and hydrophobic surfaces in vitro. Considering each one 
of these variables independently, we could say that from our study monocyte/macrophages 
and lymphocytes adhere in similar amounts to more hydrophobic (SPCL) and to moderately 
hydrophilic (SEVA-C) surfaces and do not adhere preferentially to rougher substrates since 
SCA is the polymer with the most irregular surface. 
However, not only those properties of the surfaces of biomaterials are known to affect 
monocyte/macrophage adhesion and activation. Since these cells bear a negative charge 
due to their lipoprotein membrane structure therefore inhibiting cell adhesion to negatively 
charged surfaces, it was suggested that electrostatic forces may influence leukocyte 
adhesion. Furthermore Anderson et al52 identified the potential of surface chemistry-
dependent conformational alterations, which may occur in proteins adsorbed to surfaces. 
Specific fibronectin fragments are potent chemoattractants for human blood monocytes, 
while the intact molecule is not chemotactically active56. On the other hand, surfaces that 
preferentially adsorb vitronectin from serum containing medium are favourable for 
macrophage adhesion57,58. A previous study with starch-based materials showed that from 
human serum, vitronectin adsorbs onto starch ethylene vinyl alcohol based materials and 
that more monocytes/macrophages and lymphocytes were present at short times of culture 
on these surfaces.59 In the present study, proteins play a crucial role, since all the 
experiments were performed in culture medium containing serum, which provides a rich 
assortment of adsorbed ligands for adhesion receptors. The results are in accordance with 
that study since SEVA-C and composites were the materials that showed higher cell 
adhesion, which suggests a possible mediation of vitronectin in monocyte/macrophage and 
lymphocyte adhesion to that starch-based blend. 
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For leukocytes, cell-cell-contacts formed by integrins contribute to several activities such as 
antigen presentation, cytotoxicity and phagocytosis.9 However, in the presence of 
biomaterials, leukocyte integrins undergo an activation process during which changes in 
affinity (conformation) and avidity (post-receptor occupancy) can up-regulate ligand-binding 
activity. Conformationally sensitive integrin binding with specific adsorbed peptide sequences 
is believed to provide anchorage and stimulate signal transduction pathways of adherent 
cells in a surface dependent manner.60  
Mac-1 (CD11b/CD18) plays a key role in the adherence of both monocytes and neutrophils 
to vascular endothelium and has been implicated in the evaluation of cell activation.61-63 
Following stimulation CD11b/CD18 is rapidly mobilised from intracellular stores to the cell 
membrane and although an increase in receptor expression of CD11b/CD18 can result in 
increased cell adhesion it was previously suggested that not all newly recruited receptors are 
believed to be functional.63 Instead further modifications are needed in order to render the 
receptors functionally competent thus, the expression of CD11b/CD18 cannot fully predict 
the degree of cell activation.61,62
CD11b/CD18 expressing cells are also known to be involved in the phagocytosis. Allying a 
hypothetical activated state of the CD11b/CD18 positively stained cells with their phagocytic 
role it might be possible to identify, from the cells adherent to the surface of the materials in 
study, those which are in fact activated. The sub-type of monocytes/macrophages 
expressing CD11b/CD18 with a larger spread morphology characteristic of cells which are 
involved in the phagocytosis process, can be presumed to correspond to those activated 
cells. 
ICAM-1 is part of the immunoglobulin superfamily of adhesion molecules, found to be up-
regulated by inflammatory regulators and is used in vitro as a marker of activation.44,64 
Bernatchez et al44 also suggested that ICAM-1 expression at the surface of the cell may be 
linked more with the extent of cell spreading than to the concentration of soluble inducers. 
Therefore, the materials which presented lower number of cells expressing ICAM-1 
molecules (SCA and PLLA) are expected to induce less short-term inflammation.  
Probably a little unexpected, since it would be natural the maturation/activation of 
monocytes/macrophages in an in vitro system where cells are exposed to foreign materials, 
was the fact that the expression of ICAM-1 did not seem to be affected by the time of culture. 
The presence of HA down-regulates the maturation of monocytes into macrophages that 
some composites down-regulates the expression of ICAM-1 molecules together with the 
expression of CD11b/CD18 integrins. 
Polymers can induce a specific immune response in two ways mainly; materials can release 
various products by interacting with the surrounding tissue and these products can bind 
adequate tissue carriers and become antigenic or self-proteins are altered, which can be 
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endocytosed and presented by antigen presenting cells (APCs) to T cells.65,66 The results for 
MHCII identification could be explained by considering that SCA is the material that takes up 
more water and consequently degrades more rapidly. It is possible that the surface changes 
not only from the materials but also in terms of adsorbed proteins, with the time of culture 
resulting in increased activity from antigen-presenting cells. The amount of activated 
macrophages (CD54 positive) was found to be lower in the presence of SCA, which was not 
in agreement with the results for antigen-presenting cells identification. 
Although the protein layer adsorbed to the surface of starch-based biomaterials varied 
according to the synthetic component of the blend59, it is not only the type of proteins which 
are believed to determine the cellular response. It can be speculated that in fact the surfaces 
themselves induce different conformations and affinities in the adsorbed proteins, which 
result in diverse signalling mechanisms and consequently in varied cell adhesion molecules 
expression. 
 
6.5 CONCLUSIONS 
An in vitro model was established simulating aspects of the in vivo inflammatory response. 
The aim was to evaluate individual and collective cellular effects resulting from the interaction 
of the different populations of inflammatory cells with starch based biodegradable 
biomaterials.    
The inflammatory response to biomaterials was demonstrated to be a very complex process, 
certainly influenced by the chemical and physical properties of the materials. These factors 
did not necessarily act independently and also affected the diverse components of the 
biological system in different ways. 
While SCA promoted higher PMN adhesion and lower activation, the number of cells from a 
mixed population of monocytes/macrophages and lymphocytes was found to be lower on 
that material also showing a reduced amount of activated macrophages.  
In addition, the hydroxyapatite reinforcement induced changes in cell behaviour for some 
materials but not for others. However, HA generally showed reduced 
monocytes/macrophage adhesion and less potential to activate the cells. 
Comparing the control materials, there was no significant difference between the 
biodegradable materials; that is between starch-based and PLLA biomaterials. It was 
possible to verify that PS was from the tested polymers the one that showed the greatest 
inflammatory potential. 
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ABSTRACT 
The cytokine network is one of the major controlling systems of the inflammatory process, 
driving the magnitude and duration of the host response against invading microorganisms, 
foreign materials or altered internal stimuli. Pro and anti-inflammatory cytokines were 
quantified after in vitro culture of a mixed population of monocytes/macrophages and 
lymphocytes with biodegradable polymers. Different blends of starch-based polymers and 
their composites filled with hydroxyapatite were studied and compared with Poly-L-Lactide 
(PLLA). Interleukin-1 beta (IL1-β) , interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-
α) were investigated as the markers of immunological reactivity as they are known to act at 
the early stages of injury/invasion. Interferon-gamma (IFN-γ), recognised as a pro-
inflammatory cytokine, although not present during early responses was also investigated. 
Contrarily, interleukin-4 (IL-4) derived from T lymphocytes, was investigated as it is an 
immunoregulator that counteracts some aspects of inflammation. T lymphocyte activation 
was also determined by quantifying interleukin-2 (IL-2). 
The results support the hypothesis that different biodegradable polymers can affect 
mononuclear cell activation and the production of several cytokines associated with the 
inflammatory process. No IL-2 or IFN-γ was found in the culture supernatants after 3, 7 and 
14 days in the presence of any of the materials. IL-6 was detected in the highest amounts, 
for all the conditions, followed by TNF-α. IL-1β was produced in very low amounts, being 
undetectable with some of the starch-based materials. IL-4 was the only cytokine that did not 
demonstrate any significant difference within this group of materials. 
Starch-based polymers and composites induced lower production of pro-inflammatory 
cytokines in comparison to PLLA.  
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7.1. INTRODUCTION 
It is now recognised that the failure of implanted medical devices can be  associated with 
several inflammatory and infectious processes, with the overproduction of cytokines by 
persistent leukocytes potentially being a significant inherent factor in these.1-3 Adherent and 
activated mononuclear cells, monocytes/macrophages and T lymphocytes produce 
inflammatory cytokines and chemokines that recruit other inflammatory cells to the site of 
implantation.1,4 Furthermore, cytokines may stimulate non-inflammatory cells to secrete 
enzymes and cytokines that will compromise the success of the implant by altering cell 
phenotype and function.5,6  
Mononuclear cells comprising monocytes and lymphocytes were cultured in vitro to 
determine the effect biomaterial surfaces had on the production and release of IL1-β, IL-6, 
TNF-α, IL-2, IL-4 and IFN-γ, which was analysed by enzyme linked immunosorbent assay 
(ELISA). The cytokines were selected considering their established roles in influencing the 
foreign body response to implanted materials by controlling local inflammation, cellular 
activation and chemotaxis7,8. It is recognised that anti-inflammatory cytokines can also be 
present to act to reduce inflammation8, balancing the effects of pro-inflammatory cytokines 
and maintaining homeostasis. IL-4 was investigated as an important anti-inflammatory 
cytokine.  
The in vitro model was composed of different cell types, which produce specific cytokines. IL-
1β although produced by many different cell types including neutrophils, natural killer cells, B 
and T-lymphocytes, is produced in great abundance by blood monocytes and tissue 
macrophages.9
Mononuclear phagocytes also produce IL-6, one of the earliest cytokines of the inflammatory 
process and a major inducer of acute phase proteins.10,11
Lymphocytes, present in the mononuclear population cultured in direct contact with the 
materials, also produce IL-6 and IL1-β. Nonetheless, IL-212, IL-413 and IFN-γ14,15 are 
specifically lymphocyte derived cytokines and their quantification can help to determine the 
potential roles of lymphocytes in direct contact with materials. 
TNF-α is produced in large amounts by activated mononuclear phagocytes, macrophages, 
and lymphocytes16,17 and for that reason represents a valuable activation marker. 
Besides the induced level of stimulation of each population of cells, the model enabled the 
analysis of interactions between the cytokines themselves. IL-1β is known to have multiple 
roles in the regulation of normal tissue repair and chronic inflammation. It stimulates the 
production of acute phase-reactant proteins11 and has the ability to activate wound healing 
cells (fibroblasts), lymphocytes and monocytes9,18. IL-6 is a cytokine with pleiotropic activities 
produced by a variety of cells including fibroblasts, endothelial cells, mononuclear 
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phagocytes, neutrophils, hepatocytes and T and B lymphocytes.19 This cytokine can down 
regulate fibroblast and endothelial cell growth and alternatively it can promote the growth and 
differentiation of monocytes and lymphocytes19 . The lymphocyte-derived cytokines have 
significant influence in the monocyte/macrophage population synergising and/or reducing the 
effect of the cytokines produced by those cells. In particular, in response to IL-2, 
macrophages will synthesise IL-1 that further activates T cells to produce more IL-2 to 
activate more macrophages in a feed-back cycle.20 IL-4, secreted predominantly by T helper 
2 (Th-2) lymphocytes13, inhibits production of IL-1 and TNF-α, by activated monocytes21. IL-4 
has also been shown to promote monocyte/macrophage fusion to form foreign body giant 
cells (FBGC).22 IFN-γ exerts important activities on both monocyte/macrophage and 
lymphocytes, which generally results in macrophage activation and T cell differentiation 
towards a Th-1 (T helper 1) type of immune response23.  
In this work the potential of starch-based materials, previously proposed for a wide range of 
biomedical applications24-27, to induce cytokine production by mononuclear cells in vitro was 
investigated and compared to PLLA. 
 
7.2. MATERIALS AND METHODS 
7.2.1 Materials 
The materials studied were: i) a 50/50 (wt %) blend of corn starch and ethylene vinyl alcohol 
(SEVA-C, Novamont, Italy), ii) SEVA-C reinforced with 10%, 20% and 30% (wt) of 
hydroxyapatite (HA, Plasma Biotal, UK), iii) a 50/50 (wt %) blend of corn starch and cellulose 
acetate (SCA, Novamont, Italy), iv) SCA reinforced with 10%, 20% and 30% (wt) of 
hydroxyapatite, v) a 30/70 (wt %) blend of corn starch and polycaprolactone (SPCL, 
Novamont, Italy) and vi) SPCL reinforced with 10%, 20% and 30% (wt) of hydroxyapatite. In 
the composites the average size of 90% of the HA particles was found to be below 6.5 µm 
(laser granulometry analysis). 
Poly-L-Lactide (PLLA, Purac Biochem BV, The Netherlands), being the gold standard for 
biodegradables in biomedical applications, was used as a biodegradable control material and 
Polystyrene (PS) coverslips (Sarstedt, UK) as a reference material.  
All the materials were processed into circular samples (∅ 1cm) by injection moulding under 
optimised processing conditions. 
 
7.2.2 Mononuclear Cell Isolation and Culture 
A mixed population of lymphocytes and monocytes/macrophages was isolated from healthy 
volunteers. Blood was layered onto lymphocyte separation medium (LymphoSep, ICN 
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Biomedicals, USA) and centrifuged at 400g for 25 minutes at 4°C. The cell suspension was 
washed twice with PBS at 400g for 5 minutes at 4°C and the final cell concentration 
controlled and taken into cell culture conditions with Medium 199 (Gibco BRL, USA) 
supplemented with 1% of antibiotics (Sigma Chemical Co, USA), 10% of foetal calf serum 
(FCS, Gibco BRL, Life Technologies,USA) and 0.2% of fungizone (Sigma Chemical Co, 
USA). 
Cells were seeded in direct contact with the polymers for 3, 7 and 14 days at a concentration 
of 5x104 cells/ml, 1ml per well.  
  
7.2.3 Cytokine Quantification 
After each time period, plates were centrifuged in order to avoid cells in suspension and 
200µl of the supernatant of each well was transferred to a new 96-well plate and kept at -
80°C, previously shown to be unaffected by up to three freeze thaw cycles28, for analysis 
using ELISA. The following cytokines were quantified by enzyme immunoassay. Human 
Interferon-gamma (IFN-γ) with a minimal detectable dose of <4pg/ml, Human Interleukin-2 
(IL-2) with a minimal detectable dose of <5.1 pg/ml, Human Interleukin-4 (IL-4) with a 
minimal detectable dose of <2.0 pg/ml, Human Interleukin-6 (IL-6) with a minimal detectable 
dose of <2 pg/ml,  Human Interleukin-1 Beta (IL-1β) with a minimal detectable dose of 1 
pg/ml, and Human Tumour Necrosis Factor Alpha (TNF-α) with a minimal detectable dose of 
1.7 pg/ml.  (All ELISA kits obtained from Biosource International, Inc, USA) 
For each cytokine all samples were tested in duplicate on each plate and repeated at least 3 
times in independent experiments except for IFN-γ and IL-2, which were found to be 
undetectable after 2 experiments and stopped. ELISA plates were read using a LUCY 1 
luminometer plate reader at wavelength 450nm (Bio-Stat, Biochem Immunosystems, Italy). 
For each measurement a standard concentration curve was generated according to the 
indication of the assay kit and used to calculate the concentration of released cytokine. 
 
7.2.4 Statistical Analysis 
The data was statistically analysed using a one way ANOVA analysis using a Tukey-HDS 
post hoc test29. The results were compared for all the materials at the different times of 
culture, and between themselves at each time of culture. If probability values were less than 
0.05 (p<0.05), differences observed were considered to be statistically significant. 
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7.3. RESULTS  
Cytokine production is summarised in table 7.1. IL-6 was detected in the highest amounts, 
for all the conditions, followed by TNF-α. IL-1β was produced in lower amounts and was 
undetectable with some of the starch-based materials. No IL-2 or IFN-γ was produced at any 
of the tested times of culture in the presence of any of the materials. 
There were differences in the amount of released cytokines with respect to culture time, the 
amount decreasing with increasing culture time. In a previous study30, the same experimental 
conditions were used for the quantification of the intracellular LDH of cells adherent to the 
surface of the materials. That data showed that the number of adherent cells varied 
according to the material, although not statistically significant. The results demonstrated that 
the cytokine production was affected by the material and not by the adherent cell number. 
 
 
Table 7.1: Cytokine production at 3, 7 and 14 day Time Periods 
 
 IL-4 IL-6 IL-1β TNF-α IFN-γ IL-2 
 Time Culture 3 7 14 3 7 14 3 7 14 3 7 14 3 7 14 3 7 14 
Material                   
SEVA-C + + + + + + + - - + + + - - - - - - 
SEVA-C+10%HA + + + + + + - - - + + + - - - - - - 
SEVA-C+20%HA + + + + + + - + - + + + - - - - - - 
SEVA-C+30%HA + + + + + + - - - + + + - - - - - - 
SPCL + + + + + + + + + + + + - - - - - - 
SPCL+10%HA + + + + + + + + - + + + - - - - - - 
SPCL+20%HA + + + + + + + + + + + + - - - - - - 
SPCL+30%HA + + + + + + + + - + + + - - - - - - 
SCA + + + + + + + + + + + + - - - - - - 
SCA+10%HA + + + + + + - - - + + + - - - - - - 
SCA+20%HA + + + + + + + - - + + + - - - - - - 
SCA+30%HA + + + + + + - - - + + + - - - - - - 
PS + + + + + + + + + + + + - - - - - - 
PLLA + + + + + + + + + + + + - - - - - - 
 
 
7.3.1 IL-4 
The amount of IL-4 detected varied between 16 and 29 pg/ml. No significant differences 
were observed except in the case of SCA+20%HA (Fig. 7.1c). The levels of IL-4 tended to 
increase with the culture period in the presence of composites, reaching values after 7 and 
14 days of culture which were statistically different from those obtained for 3 days of culture. 
There was no correlation between the IL-4 released and the different starch-based blends or 
with the percentage of HA that was reinforcing each of them.  
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Figure 7.1. IL-4 release from monocytes/macrophages and lymphocytes when in culture with (a) 
SEVA-C and respective composites with HA and PS, (b) SPCL and respective composites with HA 
and PLLA, (c) SCA and respective composites with HA, for 3, 7 and 14 days. Data represents mean ± 
standard deviation, n≥3. + Indicates significant difference with 7 and 14 days of culture. 
 
7.3.2 IL-6 
In the case of IL-6, the results obtained were complex and influenced by the type of material 
and the presence of ceramic reinforcement. It was possible to observe that the amount of IL-
6 released decreased with the time of culture for most of the materials although these 
differences were not statistically significant. 
IL-6 was the cytokine detected in highest quantity in the harvested supernatants and varied 
between about 1200 and 70 pg/ml. PLLA and PS were the two materials which induced the 
highest IL-6 release. The results obtained in the presence of SEVA-C and composites (Fig. 
7.2a) and in the presence of SCA and composites (Fig. 7.2c), after 3, 7 or 14 days of culture 
were found to be statistically different from those obtained for these two control materials, 
except SCA after 7 days (p<0.05 only when compared with PS). For SPCL and composites 
(Fig. 7.2b), these materials induced a release of IL-6 similar to that of PS after 3 days (except 
+
C 
0,00
5,00
15,00
20,00
25,00
30,00
35,00
40,00
3 7 14
Time of Culture (Days)
4
pg
/m
l)
10,00
IL
-
 (
SEVA-C SEVA-C+10%HA
SEVA-C+20%HA SEVA-C+30%HA
PS
 
0,00
5,00
10,00
15,00
20,00
25,00
30,00
35,00
40,00
3 7 14
Time of Culture (Days)
IL
-4
g/
m
l)
 (p
SPCL SP CL+10%HA
SPCL+20%HA SP CL+30%HA
PLLA
 
0,00
5,00
10,00
15,00
20,00
25,00
30,00
35,00
40,00
3 7 14
Time of Culture (Days)
IL
-4
 (p
g/
m
l)
SCA SCA+10%HA
SCA+20%HA SCA+30%HA
 
-------------------------------------------------------------------------------------------------------------------------------------------------------------  168 ---- 
----------------------Chapter 7 - Cytokine secretion from mononuclear cells cultured in vitro with starch-based polymers and PLLA--- 
 
SPCL+30%HA) and comparable with PLLA after 7 days. After 14 days, the levels of IL-6 
induced by SPCL and composites reached lower values, and these were significantly 
different from PS and PLLA and therefore closer to those obtained for SCA and composites 
except in the case of SPCL+20%HA which was still comparable with PS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2. IL-6 release from monocytes/macrophages and lymphocytes when in culture with (a) 
SEVA-C and respective composites with HA and PS, (b) SPCL and respective composites with HA 
and PLLA, (c) SCA and respective composites with HA, for 3, 7 and 14 days. Data represents mean ± 
standard deviation, n≥3. *Indicates significant difference when comparing with PLLA and PS. 
**Indicates significant difference when compared with PLLA. oIndicates significant difference when 
compared with SCA. #Indicates significant difference when compared with SEVA-C and respective 
composites. §Indicates significant difference when compared with SEVA composites with 20% and 
30% of HA. ¿Indicates significant difference when compared with SEVA-C+20%HA. ¤Indicates 
significant difference when compared with SPCL and respective composites with 10% and 20%HA. 
¢Indicates significant difference when compared with SPCL+20%HA. ¥Indicates significant difference 
when compared with SPCL+30%HA. Indicates significant difference between the connected bars. 
 
SEVA-C and composites seemed to stimulate less leukocyte activation (Fig. 7.2a). The 
amounts of IL-6 detected in the presence of those materials was lower than those obtained 
with any of the other materials without any differences being measured between polymer and 
composites although a decrease was observed with increasing HA percentages. After 3 days 
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of culture these were found to be statistically different from SPCL and it’s composites with 
10%HA, 20%HA and SCA, as well as the results between SPCL+30%HA and SEVA-C 
composites, only changing after 7 days when comparing SEVA-C+30%HA and 
SCA+20%HA. After 14 days of culture, the results for SEVA and composites and SCA 
became closer and only SEVA-C+20%HA was found to induce significant IL-6 production 
when compared with SCA. Also when compared with SPCL and it’s composites with 10%HA 
and 20%HA, only SEVA-C reinforced with 20%HA and 30%HA were found to be different. 
Furthermore the SEVA-C+10%HA result was also different from SPCL+20%HA. 
Following SEVA-C and composites, SCA and respective composites were the materials that 
induced the production of IL-6 (Fig. 7.2c). Again, the same trend, in terms of the amount of 
released cytokine and percentage of HA was observed. However, some statistical 
differences were found after 3 days of culture between SCA and the composite with 30%HA 
and after 7 days of culture between SCA and the composites with 10%HA and 30%HA. 
Furthermore, at 3 and 7 days of culture it was observed that the results in the presence of 
SCA composites were different from the results in the presence of SPCL composites. 
 
Table 7.2: Statistical summary for IL-6 expression for different pair of polymers (Statistically significant 
p values) 
 
Time 
Culture Material SEVA-C 
SEVA-C 
+ 
10%HA 
SEVA-C 
+ 
20%HA 
SEVA-C 
+ 
30%HA 
SPCL 
SPCL 
+ 
10%HA 
SPCL 
+ 
20%HA 
SCA PS PLLA 
SEVA-C         0 0 
SEVA-C+10%HA         0 0 
SEVA-C+20%HA         0 0 
SEVA-C+30%HA         0 0 
SPCL 0.004 0 0 0      0.006 
SPCL+10%HA 0.007 0 0 0      0.004 
SPCL+20%HA 0 0 0 0      0.045 
SPCL+30%HA  0.01 0 0     0.013 0.001 
SCA 0.022 0       0.032 0.001 
SCA+10%HA     0.012 0.018 0.001  0 0 
SCA+20%HA     0.027 0.041 0.003  0 0 
3 Days 
SCA+30%HA     0.007 0.011 0.001 0.037 0 0 
SEVA-C         0 0 
SEVA-C+10%HA         0 0 
SEVA-C+20%HA         0 0 
SEVA-C+30%HA         0 0 
SPCL 0.017 0 0 0     0.005  
SPCL+10%HA 0.007 0 0 0     0.012  
SPCL+20%HA 0.011 0 0 0     0.007  
SPCL+30%HA  0.001 0 0     0  
SCA 0.046 0 0 0     0.002  
SCA+10%HA     0.015 0.006 0.010 0.042 0 0 
SCA+20%HA   0.050  0.031 0.012 0.021  0 0 
7 Days 
SCA+30%HA     0.014 0.006 0.009 0.040 0 0 
SEVA-C         0 0 
SEVA-C+10%HA         0 0 
SEVA-C+20%HA         0 0 
SEVA-C+30%HA         0 0 
SPCL   0.032 0.042     0.025 0.010 
SPCL+10%HA   0.029 0.038     0.028 0.011 
SPCL+20%HA  0.025 0.012 0.016      0.024 
SPCL+30%HA         0.007 0.003 
SCA   0.041      0.020 0.008 
SCA+10%HA         0 0 
SCA+20%HA         0 0 
14 
Days 
SCA+30%HA         0 0 
-------------------------------------------------------------------------------------------------------------------------------------------------------------  170 ---- 
----------------------Chapter 7 - Cytokine secretion from mononuclear cells cultured in vitro with starch-based polymers and PLLA--- 
 
In the presence of SPCL and composites, in contrast with the other starch-based materials, it 
was possible to detect and quantify almost 3 times more IL-6. The amount of HA did not 
seem to have any influence (Fig. 7.2b).  
 
7.3.3 IL-1β 
IL-1β production was material dependent and in some cases with the time of culture. SEVA-
C and composites, as well as the SCA composites did not show any differences with the time 
of culture. However, SCA and PS showed significant decreases in IL-1β production with 
increasing time of culture. The amount of cytokine released in the presence of SPCL with 
10%HA and 20%HA also showed that tendency, although in the case of the composite with 
10%HA, the difference was only statistically significant after 14 days. IL-1β was detected in 
very low amounts after contact with the starch-based materials when compared to the control 
materials (Fig. 7.3). In fact after 3 and 7 days of culture, all the materials, except for SCA and 
SPCL (p<0.05 only when compared with PS) showed a significantly different result from PS 
and PLLA. After 14 days of culture, almost no IL-1β was detected in the supernatants.  
 
Table 7.3: Statistical summary for IL-1β expression for different pair of polymers (Statistically 
significant p values) 
 
Time Culture 
Material 
SPCL 
+ 
20%HA 
SCA PS PLLA 
SEVA-C  0 0 0 
SEVA-C+10%HA 0.017 0 0 0 
SEVA-C+20%HA 0.017 0 0 0 
SEVA-C+30%HA 0.049 0 0 0 
SPCL  0 0 0 
SPCL+10%HA  0 0 0 
SPCL+20%HA  0 0 0 
SPCL+30%HA  0 0 0 
SCA   0 0 
SCA+10%HA  0 0 0 
SCA+20%HA  0 0 0 
3 Days 
SCA+30%HA 0.017 0 0 0 
SEVA-C  0.025 0 0.01 
SEVA-C+10%HA  0.010 0 0 
SEVA-C+20%HA   0 0.010 
SEVA-C+30%HA  0.010 0 0 
SPCL   0.022  
SPCL+10%HA   0 0.002 
SPCL+20%HA   0.001 0.030 
SPCL+30%HA   0 0.003 
SCA     
SCA+10%HA  0.010 0 0 
SCA+20%HA  0.020 0 0.01 
7 Days 
SCA+30%HA  0.010 0 0 
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Figure 7.3. IL-1β  release from monocytes/macrophages and lymphocytes when in culture with (a) 
SEVA-C and respective composites with HA and PS, (b) SPCL and respective composites with HA 
and PLLA, (c) SCA and respective composites with HA, for 3, 7 and 14 days. Data represents mean ± 
standard deviation, n≥3. *Indicates significant difference when compared with PLLA and PS. 
**Indicates significant difference when compared with PS. o Indicates significant difference when 
compared with SCA. ¢Indicates significant difference when compared with SPCL+20%HA. 
Indicates significant difference between the connected bars. 
+ Indicates significant difference with 7 and 14 days of culture. x Indicates significant difference with 14 
days of culture. 
 
 
Comparing the amounts of IL-1β released in the presence of starch-based materials after 3 
days of culture, SCA induced production in significantly different quantities (Fig. 7.3c). That 
difference was only maintained after 7 days of culture for SEVA-C and SEVA-C composites 
with 10%HA and 30%HA (Fig 7.3a) and for SCA composites (Fig. 7.3c). 
Although only after incubation of cells with SPCL composites, HA was found not to reduce 
the amount of produced IL1-β, when compared with the non reinforced polymers.  The 
amount was only different after 3 days and only between SPCL+20%HA and SEVA-C 
composites and SCA+30%HA. 
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7.3.4 TNF-α 
The results obtained for TNF-α demonstrated significant variations according to the type of 
material, in some cases also being influenced by the percentage of ceramic filler and by the 
time of culture. Again, as for IL-6 the general tendency was a reduction in release with time 
of culture for most of the materials. For some of the materials there were detectable 
differences after 7 and 14 days of culture (SEVA-C+10%HA, PLLA), others only revealed 
variations in the amount of cytokine after 14 days in culture (SEVA-C, SEVA-C+20%HA, 
SPCL+10%HA and PS).  
The level of TNF-α detected in the supernatants of the cultures was between 3 and 190 
pg/ml (Fig. 7.4). The higher amounts of TNF-α were detected in the presence of PLLA and 
PS. After 3 days of culture in contact with all the materials and composites, the released 
TNF-α was found to be significantly different from PS and PLLA, except for SPCL+30%HA 
and SCA (p<0.05 only when compared with PLLA). After 7 days differences were observed 
for SEVA-C and composites, SPCL and SCA composites while the results for SPCL 
reinforced with 10%HA and 30%HA were similar to PS. After 14 days of culture only the 
SEVA-C composites were found to be different from the control materials. However, the 
amount of cytokine released during contact with SEVA-C, SPCL and SCA composites was 
still different from PLLA. 
Analysing the amount of TNF-α in the presence of SEVA-C and composites a similar trend to 
IL-6 was observed, lower levels were detected when compared with all the other materials 
(Fig. 7.4a). Comparing the polymer and composites, it was found that the amount of cytokine 
released decreased with increasing percentages of HA. Furthermore, after 3 days of culture, 
the amount of TNF-α detected in the presence of SEVA-C was found to be significantly 
different for the result obtained with SEVA-C+30%HA.  
Comparing the results obtained with SEVA-C and composites, with all the other materials, 
after 3 and 7 days statistically significant differences were found with SCA. After 14 days, 
only the difference between SEVA-C+30%HA and SCA remained. SEVA-C composites were 
found to be significantly different from SPCL composites after 3 and 7 days, except for 
SPCL+30%HA after 7 days (p<0.05 only when compared with SEVA-C with 20%HA and 
30%HA). The amount of TNF-α released in contact with SEVA-C+30%HA was also found to 
be different from the SPCL composite with the same amount of HA at the 14 day time period. 
When comparing all the starch-based materials, higher amounts of TNF-α were released in 
the presence of SPCL and composites (Fig. 7.4b). In this case, and contrary to SEVA and it’s 
composites, increasing percentages of HA resulted in increasing amounts of cytokine 
release. In fact, and in addition to the statistical differences reported after 3 days in culture, 
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TNF-α released in the presence of SPCL was found to be different from the amount detected 
in the presence of SEVA-C with 20%HA and 30%HA.  
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Figure 7.4. TNF-α  release from monocytes/macrophages and lymphocytes when in culture with (a) 
SEVA-C and respective composites with HA and PS, (b) SPCL and respective composites with HA 
and PLLA, (c) SCA and respective composites with HA, for 3, 7 and 14 days. Data represents mean ± 
standard deviation, n≥3. *Indicates significant difference when compared with PLLA and PS. o 
Indicates significant difference when compared with SCA. #Indicates significant difference when 
compared with SEVA-C composites. §Indicates significant difference when compared with SEVA 
composites with 20% and 30% of HA. ¥Indicates significant difference when compared with 
SPCL+30%HA. Indicates significant difference between the connected bars. 
+ Indicates significant difference with 7 and 14 days of culture. x Indicates significant difference with 14 
days of culture. 
 
Once again, and in agreement with IL-6 quantification, the level of TNF-α produced in 
contact with SCA composites was lower than that detected for SPCL composites and higher 
than the amount obtained for SEVA-C composites. However, in the case of the unreinforced 
polymer (SCA) the amounts detected were the highest when comparing with SEVA-C or 
SPCL. 
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Table 7.4: Statistical summary for TNF-α expression for different pair of polymers (Statistically 
significant p values) 
 
Time 
Culture 
Material SEVA-C 
SEVA-C 
+ 
10%HA 
SEVA-C 
+ 
20%HA 
SEVA-C 
+ 
30%HA 
SPCL 
+ 
30%HA 
SCA PS PLLA 
SEVA-C      0.011 0 0 
SEVA-C+10%HA      0 0 0 
SEVA-C+20%HA      0 0 0 
SEVA-C+30%HA 0.017     0 0 0 
SPCL   0.033 0.003  0.049 0 0 
SPCL+10%HA  0.005 0 0   0.034 0 
SPCL+20%HA  0.008 0 0   0.023 0 
SPCL+30%HA  0.01 0 0    0.001 
SCA        0.007 
SCA+10%HA     0.020 0.003 0 0 
SCA+20%HA     0.022 0.003 0 0 
3 Days 
SCA+30%HA     0.014 0.002 0 0 
SEVA-C      0.021 0 0 
SEVA-C+10%HA      0.001 0 0 
SEVA-C+20%HA      0 0 0 
SEVA-C+30%HA      0 0 0 
SPCL       0.010 0.001 
SPCL+10%HA  0.045 0.007 0.005    0.028 
SPCL+20%HA  0.022 0.003 0.002     
SPCL+30%HA   0.009 0.002    0.023 
SCA         
SCA+10%HA       0.007 0.001 
SCA+20%HA       0.014 0.002 
7 Days 
SCA+30%HA       0.003 0 
SEVA-C        0.004 
SEVA-C+10%HA       0.012 0.001 
SEVA-C+20%HA       0.002 0 
SEVA-C+30%HA      0.040 0.001 0 
SPCL        0.026 
SPCL+10%HA         
SPCL+20%HA         
SPCL+30%HA    0.043     
SCA         
SCA+10%HA        0.021 
SCA+20%HA        0.013 
14 Days 
SCA+30%HA        0.014 
 
Contrary to any of the other starch-based blends, the presence of HA in the starch blend with 
cellulose acetate induced a decrease in the amount of TNF-α production although the 
percentage of ceramic had no influence. After 3 days of culture, the results obtained for SCA 
were found to be different from those obtained for composites. In addition, the results for 
composites were also different from the result obtained for SPCL+30%HA. 
 
7.4. DISCUSSION 
Several studies31,32 have demonstrated that leukocytes attach and adhere to biomaterial 
surfaces. Upon adherence, those cells undergo morphological and physiological changes 
such as membrane perturbation and frustrated phagocytosis that can lead to cell activation 
and the release of chemical mediators such as cytokines.1,32-34 These cytokines can influence 
the initiation, duration and resolution of the host response to injury, which is determined by 
the prolonged presence of the biomaterial.35
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It has been reported that there are several factors that modulate the cellular activation 
process and mediate production of cytokines. Surface physical and chemical properties36-38 
and adhesion specific signals31,36,37 are believed to have an important role, however, some 
authors39 defend that unknown factors also might be involved in monocyte differentiation and 
activation.  
IL-1 β, TNF-α and IL-6 were considered as markers for polymer-induced macrophage 
activation and it was shown that starch-based polymers and composites significantly reduce 
the release of these cytokines compared to PS and PLLA.  
It was reported by Chomyszyn-Gajewska et al40 that in the absence of serum, PLLA did not 
stimulate the release of IL-6, IL-12 and TNF-α. However, following an initial incubation with 
serum, the release of IL-6 and IL-12 increases dramatically, which was related to the fact that 
the studied materials have no surface ligands recognisable by macrophages to trigger the 
synthesis of certain cytokines.  
Activation of monocytes may occur following adhesion to a surface, or alternatively, through 
cell-cell or cell-mediator interaction without adhesion to the surface. Studies with tissue 
culture polystyrene found the greatest release of IL-1β, IL-6 and TNF-α by 
monocytes/macrophages cultured in contact with that polymer in comparison with other 
polymers. Ung et al41 assumed that the surface treatment performed in tissue culture plates 
to achieve maximum adhesion leads to increasing activation of monocytes/macrophages.  
In the present work, cytokines were determined in the cell supernatant, therefore the 
detected levels reflected the combination of adherent and nonadherent cells. We have 
previously demonstrated (paper in press)30 that the number of cells adhered to the surface of 
PS was lower than in the case of certain starch-based polymers and composites. Therefore, 
we may speculate that non-adherent cells had a major contribution in the production of pro-
inflammatory cytokines in the presence of PS. 
Khouw et al42 found that applying monoclonal antibodies against IFN-γ inhibited the foreign 
body reaction to hexamethylenediisocyanate which indicated the important role played by 
that cytokine in the inflammatory process as a well as the possibility to modulate its activity. 
Some authors43 defend that macrophages, besides NK cells and T lymphocytes, are also 
able to produce IFN-γ however, T cell inhibition results in a foreign body reaction delay which 
could suggest an active role of T-lymphocytes in the host response. 
Although the polymers in this study were cultured with a mixed population of 
monocytes/macrophages and lymphocytes, T-cells did not demonstrate significant activation. 
TNF-α has a crucial role in the inflammatory response, resulting in a great number of cases 
in osteolysis around the implant.1,2,5,6 Several studies found that this cytokine can be 
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produced at much higher levels than IL-6 and IL-1β by macrophages in the presence of 
polymer or metal particles.44-46
The regulation of TNF-α production is complex and can be inhibited by IL-4, IL-10 or IL-13 
and greatly enhanced by IFN-γ. Levings et al47 proved that IL-4-mediated inhibition of TNF-α 
release occurs by a transcription factor STAT6-dependent mechanism. However, in the 
presence of IFN-γ, another and physiologically more important STAT6-independent 
mechanism is active. In this study, no IFN-γ was detected and the amount of produced IL-4 
was similar in the presence of all materials. Therefore it might be considered that IL-4 has no 
additional effect in the TNF-α released in the presence of the studied materials. 
TNF-α and IL-6 were released in higher amounts and with an almost similar distribution, 
which may reflect monocyte differentiation, as IL-6 has been implicated in monocyte 
differentiation19 and TNF-α has been described as an autocrine regulator of macrophage 
differentiation48. 
IL-1β is produced in response to many stimuli which include bacterial LPS, numerous 
microbial products, cytokines (TNF-α, IFN-γ, GM-CSF and IL-2), T-cell/antigen presenting 
cell interactions and immune complexes and was found to stimulate the production of IL-6 in 
peripheral blood monocytes.49
The IL-1β production detected was zero or minimal in the presence of some materials, 
suggesting resting or non-stimulated monocytes and macrophages. It seems that no cross 
effect was happening between TNF-α release and IL-1β production or that the amount of 
released TNF-α was not enough to stimulate IL-1β production. Furthermore, the amount of 
detected IL-6 was significantly higher than the amount of IL-1β. 
It has been reported that the hydrophilic/hydrophobic character of a polymer surface, 
characterised by the contact angle, may influence cytokine production from monocytes36 
however, other factors may also be important, since other studies have reported that similar 
compositions and contact angles result in different IL-1 production39. Yun et al37 reported that 
specific surfaces like hydrophilic and neutral surfaces may be the least likely to adhere and 
activate monocytes. 
In fact starch-based polymers have different surfaces wettabilities. The more hydrophilic 
surfaces (SCA) induced higher TNF-α and IL-1β production while SPCL, the polymer with the 
most hydrophobic surface together with SCA showed the highest secretion of IL-6. It could 
be speculated that in the case of IL-6, hydrophilicity is not the most important factor for 
monocyte/macrophage activation, while the TNF-α and IL-1β production seems to be 
dependent on and more evident in more hydrophilic surfaces. 
Protein adsorption can directly influence the activation of monocytes and macrophages on a 
surface in a time dependent manner. DeFife et al31 found that fibrinogen and IgG 
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preadsorption resulted in different IL-1β, IL-6 and TNF-α concentrations in the supernatants 
depending on the polymers and the time of culture. Previous studies with starch-based 
polymers and human serum demonstrated that SPCL was the polymer that presented the 
highest levels of protein adsorption.50 If protein adsorption implies cell adhesion and 
consequently cell activation, the results obtained, in terms of IL-1β and TNF-α production, did 
not support this theory.  
Concerning the HA reinforcement, although some authors report improved performance of 
those implants in terms of femoral remodelling and bone density51,52, others report that 
ceramic coatings may produce particulate wear debris and osteolysis53,54. Ninomiya et al5 
reported that HA enhanced the production of IL-1β, IL-6 and TNF-α by human fibroblasts in 
vitro. In the present study HA resulted in a significant reduction of those inflammatory 
cytokines, especially in the case of SCA and for shorter culture periods. SEVA-C composites 
also showed a lower effect in the secretion of IL-6 and TNF-α while in the case of SPCL 
composites the only evident effect was the secretion of TNF-α, in this case, HA induced 
higher production of TNF-α.  
 
7.5 CONCLUSIONS 
The isolation and culture of a mixed population of mononuclear cells enabled the evaluation 
of the inflammatory potential 
Starch-based polymers and composites did not elicit a very strong reaction from immune 
system cells in vitro, demonstrated by a lower production of cytokines when compared to 
PLLA biodegradable material. 
HA reinforcement resulted in lower cell activation, potentially enabling better mechanical 
properties to be combined with reduced levels of cytokine production. 
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ABSTRACT 
Implant failure is one of the major concerns in the biomaterials field. Several factors have 
been related to the fail but in general these biomaterials do not exhibit comparable physical, 
chemical or biological properties to natural tissues and ultimately, these devices can lead to 
chronic inflammation and foreign body reactions. 
Starch-based biodegradable materials and composites have shown promising properties for 
a wide range of biomedical applications as well as a reduced capacity to elicit a strong 
reaction from immune system cells in vitro. In this work, blends of corn starch with ethylene-
vinyl alcohol (SEVA-C), with cellulose acetate (SCA) and polycaprolactone (SPCL), as well 
as hydroxyapatite (HA) reinforced starch-based composites, were subcutaneously implanted 
in rats.  
The aim of the work was to assess the host response evoked for starch-based biomaterials, 
identifying the presence of important cell types. The tissues surrounding the implant were 
harvested together with the material and were analysed using immunohistochemistry. 
Markers for resident and recruited macrophages as well as for T lymphocytes were used in 
order to identify the types of cells and their subpopulations present in the implant area. 
Furthermore markers for activated macrophages and for antigen presenting cells expressing 
Major Histocompatibility Complex (MHC) class II molecules were used to try to understand 
the intensity of the tissue reaction.   
At implant retrieval there were no macroscopic signs of a considerable inflammatory reaction 
in any of the animals; no cellular exudate was formed around the implants. A thin fibrous 
capsule, invariably containing inflammatory cells ranging from diffuse to concentrated density 
surrounded all implants. The histological analysis of the interface tissue after 
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immunohistochemistry using ED1, ED2, CD54, MHCII and α/β antibodies showed positively 
stained cells for all antibodies, except for α/β for all the implantation periods, where it was 
different for the various polymers and for the period of  implantation. The presence of blood 
vessels was also observed in the majority of the cases.  
SPCL and respective composites were the materials that stimulated the stronger tissue 
responses but generally biodegradable starch-based materials did not induce a severe 
reaction for the studied implantation times which contrasts to other types of degradable 
polymeric biomaterials. 
 
8.1. INTRODUCTION 
The challenge in the development of new devices for orthopaedics is to ensure long-term 
stability, anchorage and function. Loosening of joint prosthesis resulting in failure is a major 
concern in the biomaterials field for orthopaedic applications1,2 with revision surgery 
occurring at both early and late implantation periods depending on the cause of failure. 
Unpredictable adverse reactions to some commonly used traditional implants have been 
reported during the years3-7. Key factors are believed to be the generation of wear particles 
and the biological response to them in periprosthetic tissues2,4 as well as the degradation 
products of biodegradable materials which result in osteolytic reactions5,6,8.  
The presence of activated macrophages9-13, foreign body giant cells9,11,13 and the formation of 
fibrous capsule14,15 are tissue-specific responses that have been the focus of investigation in 
the evaluation of biomedical implants. Additionally, the evaluation of angiogenesis12,13,16,17 in 
the implant area has been realised as an important factor which may significantly influence 
the polymer-tissue interface. The presence of giant cells is frequently observed9,11,13 and if 
the duration and severity of the reaction may or may not compromise the role of the device.. 
Phagocytic cells, normally involved in inflammation are thought to be responsible for 
removing the final products of degradation. In fact, both clinical applications4-6 and animal 
studies18-21 have suggested that degradation products directly and indirectly affect tissue 
remodelling respectively by interaction with the cells responsible for the formation of de novo 
tissue and through the induction of inflammatory cytokines released by activated 
macrophages, particle size has therefore been suggested as an important factor in the 
different tissue reactions. Macrophages tend to engulf  smaller particles22 and form 
multinuclear giant cells to surround larger objects23 although the differences in duration of the 
response may also be related to the material properties23. The duration of the inflammatory 
reaction has also been correlated with the angiogenesis around an implant 12,13,16,17. A co-
dependence has been proposed between inflammation and angiogenesis24,25. Activated 
macrophages are capable of releasing numerous angiogenic growth factors24,26which may be 
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responsible for the angiogenesis around an implant. The up-regulation of adhesion 
molecules is known to have a significant role in the process of transvascular migration of the 
inflammatory infiltrate27,28. 
Lymphocytes have also been observed at the interface of some implants18,29-31. These cells 
are able to secrete various mediators which, in turn, have functions in immunological and 
inflammatory responses. Although in the majority of the cases they are identified in low 
numbers, lymphocytes may secrete IL(interleukin)-432 and interferon (IFN)-γ31 which can 
induce macrophage fusion and activation. Serious complications have been demonstrated 
when lymphocytes were the main type of cell found in a retrieved cell suspension with a low 
number of mononuclear phagocytes29, which suggested a lymphocyte-mediated specific 
immunological reaction against the implant. Studies with T-cell deficient rats30 have shown 
that T cells play a major role in the formation of giant cells and in the phagocytic activity of 
macrophages and giant cells during the tissue response to biomaterials. Presenting the 
possibility the tissue reaction to biomaterials might be modulated by controlling T-cell 
activation in the case of unwanted or secondary reactions, or in the case of too-fast 
degradation of biomaterials.   
Starch-based biodegradable biomaterials, proposed for several biomedical applications33-36,  
have also been shown to be degraded by α-amylase37-39 and phagocytosed by 
macrophages38,39. This process has demonstrated an excellent low inflammatory tissue 
reaction when implanted both in rats and mice39,40. In works by other groups41,42 starch-based 
materials implanted in rabbits and goats performed well without adverse reactions.  The host 
response to cross-linked high amylose starch (Contramid®) was found to be in accordance 
with the main phases of the inflammatory and foreign body responses to injuries caused by 
implanted devices43-46. After 4 months only a small residual scar was apparent 
macroscopically and was related to a less severe early reaction than a skin incision and 
closure with suture material sham39.  
In this work, starch-based biomaterials were subcutaneously implanted in rats for different 
time periods in order to evaluate their immunogenicity. The tissues surrounding the implant 
were harvested together with the material and were analysed using immunohistochemistry. 
Markers for resident and recruited macrophages as well as for T lymphocytes were used in 
order to identify the types of cells and their subpopulations present in the implant area. 
Furthermore markers for activated macrophages and for antigen presenting cells expressing 
Major Histocompatibility Complex (MHC) class II molecules were used in order to try to 
understand the intensity of the tissue reaction.   
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8.2. MATERIALS AND METHODS 
8.2.1 Materials 
The materials studied were: i) a 50/50 (wt %) blend of corn starch and ethylene vinyl alcohol 
(SEVA-C, Novamont, Italy), ii) a 50/50 (wt %) blend of corn starch and cellulose acetate 
(SCA, Novamont, Italy), iii) SCA reinforced with 10%, 20% and 30% (wt) of hydroxyapatite, 
iv) a 30/70 (wt %) blend of corn starch and polycaprolactone (SPCL, Novamont, Italy) and v) 
SPCL reinforced with 10%, 20% and 30% (wt) of hydroxyapatite. In the composites the 
average size of 90% of the HA particles was found to be below 6.5 µm (laser granulometry 
analysis). 
All the materials were processed by injection moulding under optimized processing 
conditions. Samples were cut into rectangular-shaped blocks 13mm x 10mm x 7mm and a 
hole, with 5mm diameter and 10 mm length was drilled (Fig. 8.1 A and B). Before 
implantation the edges of the samples were trimmed and samples were rolled for 1 week in 
glass flasks to round machined edges and reduce the magnitude of edge effects.   
 
 
 
 
 
 
 
 
 
1cm 
1cm 
CA B
Figure 8.1. (A) Schematic representation of the implanted materials (scale in cm); (B) Two of the 
materials implanted; (C) Implant positions in the back of the rat (arrows). 
 
8.2.2 Animals and Subcutaneous Implantation 
The experiments were performed in Wistar rats, anaesthetized using Immobilon. Four 
different materials were implanted subcutaneously in the back, two either side of the spine, 
for 7, 14 and 21 days, with three repeats for each material per time period (Fig. 8.1C). 
Different positions and combinations of materials for each animal were performed to control 
site specific responses and the potential effect of degradation products. At the end of the 
implantation period, rats were sacrificed by CO2 and the tissue surrounding the implant was 
carefully dissected and snap frozen using isopentane in cardice and stored at -80°C until 
sectioned.  
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8.2.3 Immunohistochemistry 
Serial sections (7µm) were obtained at -20°C using a 5040 Microtome (Bright, England), 
sections were mounted in 3-aminopropyl-triethoxysilane (APES) coated slides,   fixed with 
acetone for 5 minutes, air dried and kept at 4°C until staining. 
Tissue sections were washed with phosphate buffer saline (PBS) solution and stained using 
an avidin-biotin alkaline phosphatase technique47. Materials were exposed to rabbit serum for 
30 minutes to reduce nonspecific reactivity, followed by primary antibodies for 45 minutes at 
room temperature. After that time materials were rinsed with PBS for 5 minutes and 
incubated with biotinylated rabbit anti-mouse IgG antibody (Dako A/S, Denmark) for 1 hour at 
room temperature. The Avidin and Biotinylated horseradish peroxidase complex (Vector 
Laboratories Ltd., UK) was added to all materials for 1 hour and the substrate reaction was 
developed using the Alkaline Phosphatase Substrate Kit (Vector Laboratories Ltd., UK). 
Each incubation, except the rabbit serum, was followed by one wash with PBS buffer for 5 
minutes. Materials were washed and counterstained with haematoxylin and mounted in 
permanent aqueous mounting medium (Serotec Ltd, UK). Each material had one sample 
stained as a control replacing the primary antibody with PBS buffer. 
 
8.2.4 Antibodies 
Individual leukocyte cell surface molecules were identified using the following panel of mouse 
anti-rat monoclonal antibodies:  α/β  (Serotec, UK) to targeting the α/β T cell antigen receptor 
found in 97%of peripheral T lymphocytes, ED1 (Serotec, UK) labelling monocytes and 
immature macrophages, ED2 (Serotec, UK) specific for resident/mature macrophages, CD54 
y(Pharmingen, USA), which reacts with intracellular adhesion molecule-1 (ICAM-1) 
expressed in activated macrophages and HLA-DR antibody (Serotec, UK) which recognizes 
MHC II antigen present in activated macrophages and B lymphocytes.  
 
8.3. RESULTS  
At implant retrieval there were no macroscopic signs of a considerable inflammatory reaction 
in any of the animals; no cellular exudate was formed around the implants. 
A thin fibrous capsule, invariably containing inflammatory cells ranging from diffuse to 
concentrated density surrounded all implants. The histological analysis of the interface tissue 
after immunohistochemistry using ED1, ED2, CD54, MHCII and α/β antibodies showed 
positively stained cells for all antibodies, except for α/β for all the implantation periods, where 
it was different for the various polymers and for the period of  implantation. The presence of 
blood vessels was also observed in the majority of the cases.  
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8.3.1 SEVA-C 
SEVA-C composites were not used in this study in order to keep a reasonable number of 
animals and consequently conditions and due to the in vitro results, which suggested being 
similar to the unreinforced polymer SEVA-C. The starch-ethylene vinyl alcohol blend (SEVA-
C) showed, within the studied implantation period, a mild inflammatory reaction (Fig. 8.2). 
A moderate cellular infiltration composed of macrophages was observed at the tissue-
material interface for all periods of implantation. Recruited macrophages identified using the 
ED1 antibody were found in moderate amounts and mainly located in the tissue close to the 
interface with the material (Fig. 8.2A). After 21 days of implantation however, the staining 
increased indicating denser cellularity (Fig. 8.2B).  Contrarily to recruited macrophages, 
tissue macrophages (ED2 positively stained) were in considerable numbers but dispersed in 
the surrounding outer layers of tissue (Fig. 8.2C).  
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Figure 8.2. Inflammatory response to SEVA-C. Light micrographs of sections immunocytochemically 
stained for ED1 (A, B); ED2 (C) and MHCII (D). Explants shown here were taken after 14 (A, C, D) 
and 21 (B) days. Magnification (x10) 
 
Antigen presenting cells (APC) expressing MHC class II molecules were distributed 
throughout the tissue surrounding the implant and also at the tissue-material interface 
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suggesting that these cells can belong to either macrophage sub- population (Fig. 8.2D). As 
for ED1 macrophages at 21 days of implantation the MHC class II staining pattern seems to 
be more intense.  
A number of activated macrophages were also identified through the expression of ICAM-1. 
Contrarily to what might be expected, due to an increased intensity of the MHC II staining, 
the amount of cells expressing ICAM-1 did not seem to change over time. CD54 positive 
cells were defining the tissue-material interface, like the ED1 macrophages, but were also 
dispersed in the surrounding tissues. In addition, cells positive for CD54 were found to be 
adjacent to blood vessels at 14 days of implantation which suggests the infiltration of 
inflammatory cells in that period of time. 
Few T lymphocytes were found and these few were in the tissue surrounding SEVA-C at 21 
days of implantation. 
 
8.3.2 SCA and Composites 
The blend of starch with cellulose acetate seemed to demonstrate the lowest level of 
inflammation for the studied implantation periods which correlates with in vitro results48 
showing a lower number of cells from a mixed population of monocytes/macrophages and 
lymphocytes and a reduced amount of activated macrophages on that material. No T 
lymphocytes were found at the interface or in the tissues adjacent to the implant. Low 
numbers of recruited and resident macrophages were observed, which was comparable for 
all the times of implantation. Like for SEVA-C, the staining pattern showed ED1 
macrophages at the interface tissue-material (Fig. 8.3A) and ED2 macrophages in the 
outside layer of the tissue (Fig. 8.3B). 
The cells expressing MHC class II antibody were, in the case of SCA (Fig. 8.3C), slightly 
different than those observed for SEVA-C (Fig. 8.2D). Comparing the staining pattern of ED1 
and ED2 macrophages with MHC II positive cells, it can be suggested that some of the 
recruited and resident macrophages are expressing those molecules. This statement is 
particularly valid for 7 days of implantation (Fig. 8.3). For longer times the intensity of the 
staining at the interface (comparable to ED1 pattern) decreased. 
Similar to the results obtained for SEVA-C, the amount of activated macrophages, 
expressing ICAM-1 was moderate. However, these cells were only present at tissue-material 
interface on day 7. In addition, from day 14, CD54 positive cells were defining blood vessels 
near the tissue-implant interface (Fig. 8.4), which could indicate the influx of inflammatory 
cells to the site of implant. 
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Figure 8.3. Inflammatory response to SCA. Light micrographs of sections immunocytochemically 
stained for ED1 (A); ED2 (B); MHCII (C). Explants shown here were taken after 7 days. Magnification 
(x10) 
 
 
 
 
 
 
 
 
Figure 8.4. Expression of the adhesion molecule ICAM-1 in a section immunocytochemically stained 
for CD54. SCA was explanted at day 14. Positive macrophages and blood vessels are defined. 
Magnification (x10) 
 
-------------------------------------------------------------------------------------------------------------------------------------------------------------  190 ---- 
------Chapter 8 - An In Vivo study of the Host Response to Starch-Based Polymers and Composites Subcutaneously Implanted in Rats--- 
 
In terms of tissue reaction, the implantation of the SCA reinforced with HA, induced a greater 
effect. While in the presence of the SCA polymer no T lymphocytes were observed, for SCA 
composites the T cells which were recruited to the implantation site, although very few at day 
7 remained there at 21 days (Fig. 8.5). 
 
 
 
 
 
 
 
 
Figure 8.5. Expression of the α/β T cell antigen receptor in a section immunocytochemically stained 
for T cells. SCA+10%HA, day 21. Magnification (x10) 
 
 
Surprisingly, higher percentages of HA seem to stimulate a greater tissue response. We 
might speculate that, since ED1 staining was more intense, the number of inflammatory cells 
attracted to the site of implantation of SCA composites was higher, particularly for 21 days of 
implantation (Fig. 8.6A). Furthermore, ICAM-1 expressing cells were found in the periphery 
of blood vessels from day 7 for SCA+20%HA (Fig. 8.6B) and SCA+30%HA (Fig. 8.6C) and 
only for 21 days of implantation in the case of SCA+10%HA (Fig. 8.6D). 
The distribution pattern of recruited and resident macrophages did not show significant 
differences as compared with the other materials. ED1 positive cells were defining the 
interface, while ED2 positive cells were dispersed within the surrounding tissue. Cells 
expressing ICAM-1 however, were highly concentrated at the interface at the longer 
implantation periods (Fig. 8.6 B, C, D). 
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Figure 8.6. Inflammatory response to SCA composites;(A, D) SCA+10%HA; (B) SCA+20%HA; (C) 
SCA+30%HA. Light micrographs of sections immunocytochemically stained for ED1 (A); CD54 (B, C, 
D). Explants shown here were taken after (B, C) 7 and (A, D) 21 days. Magnification(x10) 
 
The pattern of cells expressing MHC class II molecules was different in the presence of SCA 
composites compared to the unreinforced material, also showing variations for different 
percentages of HA. Thus, a greater number of cells extrapolated from the staining intensity, 
appear to express MHC class II after implantation of SCA with 20% and 30% of HA (Fig. 
8.7A) comparatively to SCA+10%HA (Fig. 8.7B). Additionally, after 21 days of implantation of 
SCA+30%HA, the concentration of cells expressing MHC class II seems to increase being 
dispersed all over the tissue surrounding the implant Fig. 8.7C). Like for SCA, many of the 
cells expressing MHC II were probably macrophages especially due to the pattern similarity 
with the immunopositive macrophages ED1 at 21 days of implantation. 
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Figure 8.7. Expression of MHC class II molecule in sections immunocytochemically stained for 
antigen presenting cells. (A, C) SCA+30%HA; (B) SCA+10%HA. Explants shown here were taken 
after (A) 7 and (B, C) 21 days. Magnification (x10) 
 
8.3.3 SPCL and Composites 
The SPCL provoked a strong tissue reaction. ED1 macrophages were abundant at the SPCL 
interfaces from day 7 (Fig. 8.8A), persisting for the whole duration of the study. A high 
staining intensity of the cells expressing MHC class II molecules (Fig. 8.8B) was also 
observed. The highest amount of positive cell staining was observed for ED1 and MHC II 
antibodies in the sections obtained after 21 days of SPCL implantation.  
Although not as abundant as ED1 and MHC II immunopositive cells, macrophages 
expressing ICAM-1 were also found in high intensity patterns. These were stronger for longer 
implantation times, demarcating blood vessels at 21 days of implantation (Fig. 8.8C).   
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Figure 8.8. Inflammatory response to SPCL. Light micrographs of sections immunocytochemically 
stained for ED1 (A); MHC II (B); CD54 (C). Explants shown here were taken after (A, B) 7 and (C) 
21days. Magnification (x10) 
 
As in the case of the other materials, cells marked with ED1 and ED2 we distributed within 
the tissue in the close line that describes the material-tissue interface (ED1) and in the outer 
layer (ED2).  Once again, many of the cells expressing MHC II antibodies seem to 
correspond to cells stained either with ED1 or ED2 therefore suggesting that some of the 
APC are both sub populations. Compared to the observations for SCA composites, the 
incorporation of HA in the SPCL polymer seemed to affect the tissue reaction differently. A 
rare presence of T lymphocytes at the SPCL-tissue interface was noted from day 14. 
However, in the case of SPCL composites, T lymphocytes were identified at earlier 
implantation times (7days) and at moderate concentrations in the tissues surrounding 
SPCL+30% of HA after 21 days of implantation (Fig. 8.9A). 
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Figure 8.9. Inflammatory response to SPCL composites; (A, B) SPCL+30%HA; (C) SPCL+10%HA. 
(A) Expression of the α/β T cell antigen receptor in a section immunocytochemically stained for T cells; 
Light micrographs of sections immunocytochemically stained for ED1 (B); ED2 (C). Explants shown 
here were taken after (B) 7 and (A, C) 21 days. Magnification (x10) 
 
Considering the ED1 stained cells the implantation of SPCL composites did not attract as 
many cells as the unreinforced material, although an intense stain seemed to be observed at 
the SPCL+20%HA interface for shorter implantation periods (Fig. 8.9B). Curiously a very 
similar pattern between SPCL and its composite reinforced with 20%HA was observed for 
activated macrophages (CD54 positive). These ICAM-1 expressing cells were abundant from 
day 7and were observed both at the interface and in the surrounding tissues. At the interface 
of the other two SPCL composites with 10% and 30% HA, activated macrophages were 
found in moderate concentrations in the same pattern of distribution. 
ED2 positive cells after 21 days of the implantation of SPCL+10%HA presented a different 
morphology. These positive cells were present, like for the other materials, in the outer layer 
of the tissue but were bigger (Fig. 8.9C). For all the other composites, ED2 macrophages 
were comparable in terms of morphology and pattern of distribution. 
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A higher concentration of cells expressing MHC class II molecules were observed, as for 
CD54 in the tissues surrounding SPCL+20%HA implant. Similar results were also found for 
SPCL+10%HA. 
 
8.4. DISCUSSION 
The sequence of wound healing processes can be subdivided into two phases: the 
inflammatory phase, which normally takes about 2 weeks, and the repair phase. The 
presence of an implant can provide a continuous inflammatory stimulus and as a result the 
inflammatory phase can be prolonged. This is associated with increased cellular activity and 
the tissue repair will be delayed and enhanced. Thus, chronic inflammation is characterised 
by the presence of macrophages, monocytes, lymphocytes and plasma cells with the 
proliferation of blood vessels and connective tissue. In a final stage, is comprised of foreign 
body giant cells apposed to the biomaterial surface, surrounded by granulation tissue and 
fibrous encapsulation of the implant.44,49-51
The aim of this study was to determine the presence of the important cell types observed in 
the tissue response evoked for starch-based biomaterials implanted subcutaneously in rats. 
The differential activation and expansion of distinct macrophage populations, the recruitment 
of T cells and the up-regulation of cell-adhesion molecules were evaluated. 
It has been suggested that a mild inflammatory reaction to biomaterials includes the 
formation of a fibrous tissue rich in fibroblasts and with few phagocytic cells20. However, the 
expected response for degradable materials includes a strong inflammatory reaction due to 
the continued release of the degradation products. Biodegradable starch-based biomaterials 
did not induce such a severe reaction for the studied implantation times. A comparison 
between materials with different rates of degradation demonstrated that polymers with faster 
degradation rates provoked a stronger tissue reaction. The starch-based materials that 
stimulated stronger tissue responses for the times of implantation studied were SPCL and its 
composites. These materials were however the polymers with lowest degradation rates, 
which suggests that this factor was not the most significant factor in the host response to 
starch-based.  
Macrophages stained with ED1, immediately migrated within the first days of implantation 
and only for some materials their number was increased at longer times of implantation. 
Thus, the ED1 positive macrophage layer at the implant interface was shown to vary in 
thickness depending on the material. Mature tissue macrophages (ED2) were only observed 
in the loose connective tissue surrounding the capsule of the implants and no significant 
differences were detected with time except for SPCL+10%HA implanted for 21 days. 
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Some works9,52-54 have demonstrated varying behaviour and roles for ED1 and ED2 
macrophages. ED1 positive macrophages were shown to accumulate quickly and to be 
active in phagocytosis9,53, while ED2 macrophages accumulate slowly and play a role in 
regeneration. One study55 suggested that ED1 macrophages play a role in material 
resorption because they mainly act at the material interface.  Khouw et al9 reported that giant 
cells were never ED2 positive which could suggest that resident macrophages are not 
involved in the phagocytosis of implanted biomaterials.  
Our results for subpopulation distribution are in accordance with those works in terms of 
recruited macrophages, it was possible to observe the HA reinforcement of SCA induced 
stronger ED1 staining. We might speculate that within the studied implantation periods there 
was some HA dissolution from the SCA composites since these are the materials with the 
higher capacity to uptake water. Thus, macrophages would be recruited to phagocytose 
these particles.  
Nonetheless, the mechanism of cell recruitment and the subpopulations at the inflammation 
site is still unknown. Some authors9 question if ED2 macrophages migrate from the loose 
connective tissue into the biomaterial where they become activated for phagocytosis, loosing 
their ED2 antigen and turn ED1 positive cells. Others10 suggest that vascular recruitment of 
blood born monocytes contributes to the initial macrophage response against the material. In 
addition, ED2 macrophages capable of express MCP-154 were also implied in the stimulation 
or recruitment of additional macrophages10. The duration of the inflammatory reaction has 
also been correlated with the angiogenesis in the implant 12,13,16,17. In fact a co-dependence of 
inflammation and angiogenesis was suggested by some authors24,25. Activated macrophages 
are capable of releasing numerous known angiogenic growth factors.24,26 The up-regulation 
of adhesion molecules is known to have a significant participation in the process of 
transvascular migration of the inflammatory infiltrate27,28. Phagocytes adhere to endothelium 
through ICAM-1, the influx of macrophages was analysed considering the expression of 
ICAM-1 by macrophages and blood vessel. Angiogenesis varied with the implantation times 
and also with the materials implanted. A marked vascular response with macrophages 
infiltrating was observed in the tissues surrounding SCA and SPCL composites especially for 
higher percentages of HA. However, close to the implants in areas of high cellularity, blood 
vessels were sparse. 
The up-regulation of adhesion molecules is not only useful in the influx evaluation. Cell/cell 
adhesion predominantly involves binding of ICAM-1 to CD11a or CD11b56 and macrophages 
require this interaction to form giant cells. Previous studies found that in interface tissue, 
ICAM-1 was expressed by giant cells. These multinucleated cells are elemental to 
phagocytose implanted materials and their degradation products,   being found often on the 
implant side of the membrane but not deeper within the tissue16,57. 
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It is believed that macrophage activation and formation of foreign-body giant cells is 
influenced by the physico-chemical properties of the implant.18,58 Implants with higher water 
and carboxylic group content have been shown to inhibit macrophage adhesion and 
multinucleation, probably because hydrophobic interactions participate in cell-matrix 
interactions58. 
We found that although for some of the materials an abundant number of activated 
macrophages, expressing ICAM-1, could be identified, no foreign-body giant cells were 
present at the implantation site. This observation may be the consequence of the variable 
rate of degradation of the starch-based material at the time point of the assay, not 
demanding high phagocytic activity and also of their physical-chemical properties, not 
appropriated for macrophage adhesion and fusion. 
It is known that macrophages have an interactive role with T-helper cells, the activation of T-
cells occurs after antigen presentation by the macrophages with the MHC class II molecule50. 
Class II molecules predominantly present antigenic peptides derived from soluble exogenous 
proteins or extracellular domains of transmembrane proteins mostly to T helper cells. In turn 
T cells secrete cytokines and provide the necessary signals to promote and regulate humoral 
and cell-mediated immune responses and inflammation. In particular, activated T-cells may 
secrete lymphokines like IL-432 and IFN-γ31, two cytokines involved in the regulation of MHC 
class II molecules and in the formation of FBGC.  
This study demonstrated a significant increase in antigen-presenting phenotype at the 
interface with some materials which can be associated with persistent local chronic 
inflammation. However, the almost complete lack of lymphocytes may be indicative of an 
innate mild foreign body reaction against these materials. 
 
8.5 CONCLUSIONS 
The in vivo observations validated the in vitro results confirming that the established in vitro 
models are reliable and can be used to estimate a potential inflammatory reaction provoked 
by newly developed biomaterials before implantation.  
The subcutaneous implantation of starch-based biomaterials in rats allow for concluding that 
the materials in study possess a weak potential to break out an inflammatory reaction. No 
macroscopic signs of considerable inflammation were observed and no cellular exudate was 
formed. SPCL and respective composites were the materials that stimulated the stronger 
tissue responses but generally biodegradable starch-based materials did not induce a severe 
reaction for the studied implantation times which contrasts to other types of degradable 
polymeric biomaterials. 
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CHAPTER 9 
MAIN CONCLUSIONS 
9.1 Cytocompatibility of starch-based biomaterials: polymers and composites 
The short-term effect of the degradation products of SEVA-C, SCA and respective 
composites with 30% of HA reinforcement was evaluated exposing L929 cells to their 
extracts. The cytotoxicity screening revealed that SEVA-C was the less toxic biomaterial and 
that its reinforcement with 30% HA induced higher percentage of cell dead due to the 
leaching of low molecular weight chains formed during processing (thermal degradation) and 
to the faster degradation rate of the composite.  
Despite the less promising results in terms of extract cytotoxicity, when L929 were seeded 
onto the materials, a slight delaying on cell proliferation was observed in the presence of 
SEVA-C+30%HA but only for early culture times. The quantification of the number of cells 
adhered to SEVA-C and SCA did not shown a significant difference comparatively to TCPS. 
In addition, the cell adhesion behaviour was shown to be determined by surface properties; 
on SCA, the most hydrophilic and rougher surface, cells presented the typical fibroblast 
morphology. 
Other methodologies were also used to study the cytotoxic potential of starch-based 
materials with a higher grade of certainty. In addition they also provided the guaranty that if 
the leachables from the materials interfere with one test system the results are not 
misinterpreted. It was possible to prove that not only the extract of the materials but also their 
three-dimensional form has to be biologically tested in order to analyse material-associated 
parameters that are not possible to consider within the degradation extract.  
Therefore, both direct and indirect tests with osteoblast-like cells (SaOs-2) allowed to 
determine that SCA induced some cytotoxicity and did not present the ideal surface 
properties for osteoblast-like cells adhesion and proliferation. Contrarily, SPCL extract was 
not deleterious for cells but did not support their proliferation. Comparatively to the gold 
standard biodegradable biomaterial (PLLA), SEVA-C and SPCL showed a clearly better 
behaviour than PLLA in terms of cytotoxicity. The adhesion and proliferation of osteoblast-
like cells on SEVA-C and SPLA70 was however, comparable to that of PLLA.  
The incorporation of hydroxyapatite had different effects on cytocompatibility according to the 
polymer matrix studied. In the case of SCA it seemed to change its degradation behaviour 
and consequently the degradation products released to the culture medium which delayed 
cell proliferation. In the case of SPCL, the incorporation of HA induced changes in the 
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surface properties that provoked cell detaching for longer culture times. Different 
percentages of HA did not seem to change significantly osteoblast-like cell behaviour. 
The three blends of starch-based biomaterials induced significantly different adhesion, 
proliferation and morphology/spreading behaviour of osteoblast-like cells. Depending on the 
starch-based blend, thus on its synthetic component and the properties that it confers to the 
surface, cells proliferate at different rates. While SPCL does not support osteoblast-like cells 
proliferation, SEVA-C and SCA surface properties are respectively the most and the less 
appropriated for SaOs-2 adhesion and proliferation. 
Overall results indicate that starch-based biomaterials present characteristics of cell 
adhesion/spreading and proliferation that are not disappointing considering their degradable 
nature, that are in general better that what is observed for PLA based systems. However it 
must be stressed that different cell types might have dissimilar behaviour on the same 
surface.  
 
9.2 Immunocompatibility of starch-based biomaterials: polymers and composites 
The in vitro evaluation of the immunocompatibility of starch-based polymers and composites 
was focused on changes in the free radical and degranulation activity of neutrophils as well 
as on their potential to activate immune system cells in vitro. 
The amount of lysozyme secreted by neutrophils in contact with starch-based polymers and 
composites was less than 20% of the potential maximum and not significantly dependent on 
the material except for some SPCL composites. In fact, SPCL+30%HA which induced the 
production of the higher amount of degradative enzyme. 
The chemilluminescence experiments showed that in the presence of starch-based polymers 
and composites the signal produced by activated neutrophils is reduced. The hypothesis that 
the results obtained would be due to an effect on cell adhesion or due to the presence of 
antioxidant species that would scavenge the reactive oxygen species, considered so harmful 
for the tissues, was proved. 
Both lysozyme and chemiluminescence assays revealed a low response of the neutrophils 
when in contact with starch-based polymers and composites, which allows for considering 
these materials with weak potential to break out an inflammatory response. 
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An in vitro model was established simulating aspects of the in vivo inflammatory response to 
evaluate individual and collective cellular effects resulting from the interaction of the different 
populations of inflammatory cells with starch based degradable biomaterials.    
The adhesion of PMN’s to the surface of starch-based biomaterials was found to be 
dependent on the blend and on the time of culture. In the presence of ceramic this different 
affinities also vary according to the unreinforced matrix. 
Distinct functional subsets of macrophages together with lymphocytes were found to be 
adhered to the surface of starch-based polymers and composites. While SCA promoted 
higher PMN adhesion and lower activation, the number of cells from a mixed population of 
monocytes/macrophages and lymphocytes was found to be lower on that material, which 
also showed a reduced amount of activated macrophages.  
In terms of inflammatory response, the hydroxyapatite incorporation resulted in low 
monocyte/macrophage adhesion and in a less potential to activate the cells. 
In addition starch-based polymers and composites did not elicit a very strong reaction from 
immune system cells in vitro, demonstrated by a lower production of cytokines when 
compared to a control PLLA biodegradable material. 
There were differences in the amount of released cytokines with respect to culture time, the 
amount decreasing with increasing culture time. IL-6 was detected in the highest amounts 
followed by TNF-α. IL-1β was produced in lower amounts and was undetectable in the 
presence of some of the starch-based materials. No IL-2 or IFN-γ was produced at any of the 
tested times of culture in the presence of any of the materials.  
In general HA reinforcement resulted in lower cell activation, particularly in the case of 
SEVA-C and SCA potentially enabling better mechanical properties to be combined with 
reduced levels of cytokine production. On the contrary, SPCL composites did not have a 
significant effect on cytokine production comparatively to unreinforced SPCL except for TNF-
α, which was highly produced. 
The subcutaneous implantation in rats allow for concluding that the materials in study 
possess a weak potential to break out an inflammatory reaction. No macroscopic signs of 
considerable inflammation were observed and no cellular exudate was formed. Although 
there were some materials (SPCL and composites) that stimulated stronger tissue 
responses, all the materials were surrounded by a thin fibrous capsule. 
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The in vivo observations validated the in vitro results confirming that the established in vitro 
models are reliable and can be used to estimate a potential inflammatory reaction provoked 
by newly developed biomaterials before implantation.  
The inflammatory response to biomaterials was demonstrated to be a very complex process, 
certainly influenced by the chemical and physical properties of the materials. These factors 
did not necessarily act independently and also affected the diverse components of the 
biological system in different ways. 
In general, the cytocompatibility and immunocompatibility studies showed that starch-based 
polymers and composites are promising biomaterials. Comparatively to the currently used 
biodegradables, they possess properties that induce similar to better cytotoxicity behaviour. 
The adhesion and proliferation of osteoblast-like cells on some of these materials was also 
comparable to that of PLLA which demonstrates their potential to be used in orthopaedic 
applications. The in vitro and in vivo immunocompatibility remarks further support the 
suitability of starch-based biomaterials to be used in biomedical applications due to their 
weak potential to break out an inflammatory reaction.  
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